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Abstract
Na+-K+-Cl" cotransporters (NKCC) are important membrane proteins involved in cell
ion homeostasis and cell volume regulation. NKCC mediates electroneutral
cotransport of lNa+, 1K+ and 2C1" across cell membranes, followed by osmotically
obligated water. The first aim of this thesis was to study the phosphorylation of
NKCC found in ferret erythrocytes. Immunoprecipitation and subsequent western
blotting using total phosphothreonine antibodies showed low levels of
phosphorylation even when cotransport was not stimulated. This was reduced by
-40% when cotransport was inhibited by the use of kinase inhibitors or Mg2+
removal. When cells were stimulated by deoxygenation or calyculin A
phosphorylation increased 2-3 fold. Although western blot evidence is presented that
ferret erythrocytes express SPAK (Ste20-related proline alanine rich protein kinase)
and phosphorylated SPAK, use ofNKCC-P, an antibody that detects threonine
residues on the cotransporter phosphorylated by SPAK/OSR1 (oxidative stress
response kinase 1), showed no significant increase in cotransporter phosphorylation
in response to deoxygenation. This suggests that SPAK/OSR1 do not phosphorylate
the cotransporter in response to this potent cotransport stimulus. A second aim was
to isolate the differently phosphorylated forms ofNKCC. A proteomic approach was
used, including standard 2-dimensional (2-D) gel electrophoresis. Improvements
were made in the overall appearance of 2-D gels, but did not result in identification
of the cotransporter itself. However, distinct spots were observed on western blots
using phospho-specific NKCC antibodies indicating that this method could be of use
for studying differentially phosphorylated NKCC proteins. Blue-native PAGE was
employed to look at proteins that interact with NKCC. The cotransporter was found
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to separate into two major complexes with apparent molecular masses of 250 and
440 kDa. Mass spectrometric methods identified the erythrocyte anion exchanger,
Band 3, in complex with NKCC. This was confirmed by co-IP of Band 3 with
NKCC, using an NKCC1 specific custom-made antibody. The third aim was to
identify different isoforms ofNKCC in erythrocytes. Although it has always been
assumed that this isoform is NKCC1, evidence to support this has never been
published. Using western blot and PCR techniques, this thesis provides evidence to
suggest that not only is NKCC1 present in red blood cells, but that NKCC2 is also
present. This has implications for the study of cotransport regulation in these cells.
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Abbreviations
l-D/l-DE One-dimensional gel electrophoresis
2-D/2-DE Two-dimensional gel electrophoresis
AATYK1 Apoptosis-associated tyrosine kinase 1
BN-PAGE Blue-native polyacrylamide gel electrophoresis
BSC Bumetanide-sensitive cotransporter
CCC Cation-coupled chloride cotransporter
CO-IP Co-immunoprecipitation
ESI Electrospray ionisation
FBM Ferret basic medium
HEK-293 Human embryonic kidney cell line
HSP70 Heat shock protein 70 kDa isoform
IEF Isoelectric focussing
IP Immunoprecipitation
IPG Immobilised pH gradient
KCC K+-Cf cotransporter
LC Liquid chromatography





OSR1 Oxidative stress-response kinase 1
Pi Isoelectric point
PP1 Protein phosphatase 1
PPli Src tyrosine kinase inhibitor, PP1
PrxII Peroxiredoxin-2
RBC Red blood cell
SDS-PAGE Sodium dodecyl sulphate polyacrylamide gel electrophoresis
SPAK Ste20-related proline alanine rich protein kinase
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Chapter 1 - Introduction
Cell ion homeostasis and the maintenance and regulation of cell volume are
processes fundamental to all organisms. Amongst important membrane proteins
involved in these processes are the Na+-K+-Cl" cotransporters (NKCC). NKCCs
mediate electroneutral cotransport of Na+, K+ and CI" ions across cell membranes
(Geek et al, 1980), followed by osmotically obligated water (Haas, 1994). In order
for cotransport to occur, all three ions must be present on the same side of the
membrane (Russell, 2000). The third defining characteristic of NKCC is that it is
bound and inhibited by the "loop" diuretics, which have been useful drugs in the
study of the cotransporter. NKCC activity has been found in a wide variety of
animal cells, and homologous proteins may also be present in prokaryotic organisms
(Park and Saier, 1996). The stoichiometry of ion transport is 1 Na+, 1 K+ and 2C1" in
all known cases, apart from the squid giant axon, which transports 2 Na+, 1 K+ and
3C1" (Russell, 2000). In mammals, two distinct isoforms of the cotransporter are
known. NKCC1 is expressed in nearly all cell types, whereas NKCC2 is found only
in the kidney. However, both isoforms share the same basic properties mentioned
above. Cotransport via NKCC occurs in response to cell shrinkage, reduced
intracellular CI" concentration, hormonal stimuli and hypoxia (Lytle, 2003; Haas and
Forbush, 2000). How cells respond to such stimuli to produce the resultant Na+-K+-
Cl" cotransport, and how this system is regulated, are not well understood and
represent important areas of research. This thesis presents evidence that cotransport
is regulated in ferret erythrocytes by direct phosphorylation ofNKCC and that this is
altered in response to physiological and pharmacological stimuli.
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1.1 - The Cation-Coupled Chloride Cotransporters
NKCCs are part of a larger family of cation-coupled chloride cotransporters (CCC),
members of the solute carrier family 12 (SLC12). These proteins couple the
movement ofNa+ and CI" (with or without K+) or K+ and CI" ions across cell
membranes (Gamba, 2005; Russell, 2000; Mount et al, 1998). So far, nine proteins
have been designated members of the SLC12 family (Hebert et al, 2004). There are
three transporters that move sodium with chloride. These are the Na-Cl (NCC) and
Na-K-Cl cotransporters (NKCC1 and NKCC2). There are four K-Cl cotransporters
(KCC1-4) and two orphan members, SLC12A8 and 9 (Gamba, 2005). SLC12A8
(CCC9) is not well understood, but appears to be a candidate gene for psoriasis
pathogenesis (Hewett et al, 2002). SLC12A9 is known as the cation-chloride
cotransporter interacting protein (CIP) due to evidence that human CIP (hCIP) is co-
immunoprecipitated from cell lysates ofHEK-293 cells (transfected with hCIP), with
endogenous IiNKCChek- Although when expressed in Xenopus oocytes and HEK-
293 cells this protein does not transport Na, K or CI, it does appear to have inhibitory
actions on NKCC cotransport (Caron et al, 2000). Figure 1.1 shows how these
proteins relate to one another on the basis of amino acid sequence with percentage
homologies shown between closely related members.
1.2 - Na-K-2CI Cotransporter Isoforms
With the advent ofmolecular biology, full length clones of two NKCC isoforms have
been isolated from a number of different species and tissues (Gamba, 2005). The
proteins are coded for on different genes and the gene products are of different size.
Human NKCC1 is coded for on chromosome 5q23.2 and the product is 1212 amino
acids in length, whereas human NKCC2 is coded for on 15ql5-q21.1 and is 1099
3
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amino acids in length (Russell, 2000). The numbers of amino acids vary from
species to species, but NKCC1 is the larger of the two. More detail about each
isoform is given in the following sections.
Figure 1.1 - Phylogenetic Tree Diagram of the SLC12 Cation-Chloride
Cotransporter Family
All the proteins are human and the following sequences (accession numbers) used:
NKCC1 (P55011), NKCC2 (Q13621), NCC (P55017), KCC1 (Q9UP95), KCC2
(Q9H2X9), KCC3 (Q9UHW9), KCC4 (Q9Y666), CCC9 (AAM73657), and CIP
(AAF88060). These were aligned based on amino acid sequence identity using the
CLUSTALW tool from www.ebi.ac.uk/clustalw/index.html and the resulting alignment
used to create a tree diagram. This was achieved using the TreeTop phylogenetic tree
prediction tool from www.genebee.msu.su/services/phtree_reduced.html. Sequence
homology percentages were obtained from comparison of amino acid sequences in




NKCC1 (BSC2; SLC12A1) is often referred to as the basolateral isoform, as it is
present in the basolateral membranes of the cells of secretory tissues (Russell, 2000).
This isoform was first cloned from shark rectal gland epithelium (Xu et al, 1994).
Delpire et al (1994), show that this isoform is not solely specific to polarised cells
such as secretory epithelia, but is found in non-polarised cells such as myocytes. It is
known to be present in a wide variety of tissues and other cell types (Lytle et al,
1995; Haas and Forbush III, 1998; Xu et al, 1994), and is thought to be the isoform
present in red blood cells (Lytle, 1997; Flatman, 1991; Pewitt et al, 1990). Due to its
wide distribution this isoform has been referred to as the 'housekeeping' isoform, as
well as the 'secretory' isoform when in relation to secretory epithelia (Russell, 2000).
Two splice isoforms have been identified, in both mouse and human tissues. Randall
et al (1997), using a PCR approach, found a form ofmouse NKCC1 in brain and
skeletal muscle, that was shorter than the full-length protein by 16 amino acids.
Similarly, Vibat et al (2001) found an NKCC1 splice variant in human ocular
trabecular meshwork cells that was analogous to the mouse variant. They named
these NKCCla and NKCClb and upon further investigation it was revealed that
these transcripts were present in a variety of human tissues. The most abundant
expression ofNKCCla was in salivary gland, whereas NKCClb was most prevalent
in brain tissue. In both cases the NKCClb form is missing a region within the C-
terminus that contains a putative consensus site for phosphorylation by protein kinase
A. As such, it has been speculated that these variants may have different affinities
for ions or are regulated differently, however, the truth of this is not yet known.
Moore-Hoon and Turner (2000) have demonstrated that NKCC1 exists as a
5
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homodimer in the membrane of rat parotid gland cells, forming a complex of
approximately 355 kDa. Yeast-2-hybrid (Y-2-H) mapping analysis narrowed the
interaction ofNKCC1 dimers to regions in the C-terminus (Simard et al, 2004a), and
these were found to be able to interact within a single NKCC1 molecule. However,
it appears from cross-linking studies that the cotransporter exists in an oligomeric
state and that these regions are likely to interact with regions in other NKCC
molecules rather than be solely self-interacting. Using chimeras, chemical cross-
linking and co-immunoprecipitation (co-IP), Parvin et al (2007) further investigated
the significance of these interactions. Chimeras with alternative C-termini, as well as
C-terminal truncation mutants, are unable to form dimers with full-length NKCC1
and the important residues lie within region 751-998 of the rat cotransporter. This
work also suggested that NKCC1 did not form heterodimers with NKCC2 or CIP and
only a weak interaction was observed with NCC. Simard et al (2007) found that
NKCC1 forms heterodimers with KCC4. These findings could represent an extra
level of regulation to the functioning of the various CCC family members.
1.2.2 - NKCC2
Full-length clones ofNKCC2 (or the bumetanide sensitive cotransporter (BSC1);
SLC12AY) were first identified in rabbit kidney by Payne and Forbush (1994) and in
rat kidney by Gamba et al (1994) by screening cDNA libraries from these tissues.
Both showed Northern blot analyses suggesting that NKCC2 is expressed
exclusively in the kidney. Immunocytochemical investigations and immunoelectron
microscopy reveal that it is localised in apical membranes in the thick ascending limb
(TAL) of the Loop of Henle and macula densa (Nielsen et al, 1998). Six main
isoforms have been identified, comprising three splice variants combined with two
6
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truncation variants. The splice isoforms are generated by splicing of cassette exons
and the products of these events are termed A, B and F isoforms (Payne and Forbush,
1994). Yang et al (1996) cloned a variant from rat kidney that has both A and F
exons (NKCC2AF), which was localised to the mTAL and Gagnon et al (2002) have
found a similar situation from shark kidney. They are spatially distributed within the
kidney and exhibit different affinities for Na+, K+ and CF ions, as measured by their
transport characteristics when cDNAs were expressed in Xenopus oocytes (Gimenez
et al, 2002). "Long" and "short" isoforms are generated by splicing at a
polyadenylation site between exons 16 and 17 (Mount et al, 1999), as found in the
gene for mouse NKCC2. The truncated "short" isoform loses the last 327 C-terminal
amino acids, but ends with 55 amino acids unique to this form only. The functional
characteristics of the "long" isoforms have been investigated, by measurement of
oz
Rb transport under different ion concentrations, bumetanide inhibition and in
response to cell swelling, after microinjection ofXenopus oocytes with the various
murine A, B and F forms (Plata et al, 2002). They found that NKCC2-A exhibited
the greatest transport capacity, but showed similar ion affinities with the B isoform.
The F isoform had the lowest affinities for ions and bumetanide, but was most
susceptible to inhibition by cell swelling. This group also found that although the
"short" isoforms do not transport ions when expressed in Xenopus oocytes, co-
injection with the longer forms exerts a dominant negative effect which is reversed
by the activation of protein kinase A (Plata et al, 1999). The AF isoform does not
appear to have cotransport capability (Gagnon et al, 2002). Figure 1.2 describes
where the main splice variants are distributed within the kidney. The distribution of
these different forms coincides with the reduced concentration of transported ions in
7
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the lumen of the TAL and the functional significance of this will be described in
section 1.4.2.
Figure 1.2 - Representation of NKCC2 splice isoform localisation within the kidney
This depicts the positions of the various splice isoforms of NKCC2 (BSC1) along the thick
ascending limb of the Loop of Henle. This diagram was created from information sourced
from Gamba (2005) and Plata et al (2002).
8
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1.3 - Structural features of NKCCs
Based on hydropathy analysis ofNKCC protein sequences it has been proposed that
they have 12 transmembrane (TM) spanning regions with large cytoplasmic N and C
termini (Russell, 2000; Haas, 1994; Xu et al, 1994). Park and Saier (1996) formed
an average hydropathy plot from seven different animal NKCCs. They agree that a
12 -TM model for NKCC structure is likely, although they show membrane regions
9 and 10 (m9-ml0), and 11 and 12 (ml 1-ml2) appearing as one spanning unit each.
Using an in vitro transcription and translation method (described in figure 1.3),
Gerelsaikhan and Turner (2000) have provided experimental evidence that each of
the proposed TM sections (from rat NKCC1) insert into canine pancreatic
microsomes. They continued this work to look at the membrane insertion of larger
sections ofNKCC in intact mammalian cells (Gerelsaikhan et al, 2006). Again, they
conclude that a 12 TM conformation is likely. More recent data from this group
(Nagy and Turner, 2007) has shown that membrane domains ml l-ml2 form a tight
hairpin with a very short extracellular linker, which they also suggest is true for m9-
mlO. They note that these features are generally missed in hydropathy analyses and
are likely the reason why these sections are seen as single membrane spanning
regions in various hydropathy plots. There are also several pieces of experimental
evidence to support the idea that both N and C termini are intracellular. Again,
hydropathy analyses suggest that overall these regions are hydrophilic and are
therefore likely to be intra or extracellular (Park and Saier, 1996). Payne and
Forbush (1995) produced a hypothetical model of human colonic NKCC1 showing
that both termini are intracellular. Using antibodies specific to regions in the N and












Figure 1.3 - Depiction of experiments that show membrane integration of NKCC Tm
domains
Lysed cells or microsomes, that expressed the EGFP-NKCC-Tag fusion protein construct, were
subjected to SDS-PAGE and western blotting. The sections of NKCC are coloured in blue and
refer to membrane sections 11 and 12. EGFP has a strong signal for position within the
cytoplasm. Depending on whether the parts of NKCC expressed as part of the construct span the
membrane once or twice determines if the glycosylation tage is present extra- or intracellularly. If
it is outside it can be glycosylated and produces a 14 kDa mass shift which is easily detected on
western blots. This helps identify orientation ofNKCC regions within the cell or membrane. This
figure was created from data and ideas presented by Gerelsaikhan and Turner (2000),
Gerelsaikhan et al (2006) and Nagy and Turner (2007).
antibodies were only detected by confocal immunofluorescence microscopy when
the cells studied were permeabilised, suggesting that these regions are indeed
intracellular. Both termini have sites for phosphorylation, which again provides
evidence for their positions inside the cell (Darman and Forbush, 2002; Lytle, 1997).
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The importance of the transmembrane domains to ion transport and bumetanide
binding were demonstrated by the construction of chimeras of human and shark
NKCC1 (Isenring and Forbush, 1997). These transporters exhibit different affinities
for ions and bumetanide. Substitution ofN- and/or C-termini in these chimeras,
• • 86
expression in HEK-293 cells and subsequent bumetanide-sensitive Rb flux
measurements were made. It was found that in all cases (six different chimeras in
total) ion and bumetanide affinities corresponded to the species from which the
central hydrophobic domain came from. Site-specific mutagenesis of another set of
human-shark NKCC1 chimeras in HEK-293 cells implicated transmembrane domain
2 as playing an important role in cation transport (Isenring et al, 1998a). Further
work by this group, utilising the same approach, gave a more complete map of the
domains involved in ion transport and bumetanide binding (Isenring et al, 1998b).
They found that mutations in transmembrane domains 4 and 7 altered the affinity for
chloride ions and that bumetanide binding was altered by mutations in these regions,
and others in transmembrane domains 11 and 12. The findings of this study, with
relation to bumetanide binding, contradict earlier work suggesting that bumetanide
binds at one of the cotransporter CI sites. Haas and McManus (1983) suggested that
their kinetic evidence showed that CI and bumetanide compete for the same site on
the cotransporter. This was based on evidence that higher concentrations of
bumetanide were required for half maximal inhibition of cotransport when
extracellular chloride concentrations were increased. It seems likely from these
studies that the exact mechanisms by which bumetanide inhibits will be more
complicated to elucidate. In the absence of crystal structures of the NKCC proteins it
may well be far from being understood. The cotransporter has three potential sites
11
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Figure 1.4 - Representation of major structural features of NKCC proteins
This cartoon depicts the major features of NKCCs and was compiled from all of the sources
referred to in section 1.3. Transmembrane domains of known importance are numbered.
for N-linked glycosylation within the extracellular loop between transmembrane
domains 7 and 8, as suggested by Xu et al (1994) during their study of the shark
rectal gland cotransporter. The level of glycosylation on the cotransporter is not
known, but is likely to vary between tissues and species. This is supported by data
presented in this thesis as well as findings in Lytle et al (1995) showing that NKCC
from different cell types migrate at similar positions on SDS-PAGE after enzymatic
12
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deglycosylation, but not before. It is, as yet, unknown as to the functional
significance of these oligosaccharides.
Figure 1.4 depicts a predicted two-dimensional structure of the NKCC protein, with
the discussed features shown.
1.4 - Physiological Roles
1.4.1 -NKCC1
NKCC1, as well as the other members of the SLC12 family, is involved in the
regulation of cell volume. The transport of ions allows the cell to make changes to
the osmolarity of its contents when exposed to altered extracellular osmolarity.
NKCC 1 is ubiquitously expressed and is responsible for the movement of ions, and
therefore water, into or out of cells. For most cells, the gradients of potassium,
sodium and chloride mean that NKCC1 transports ions into cells and as such this
isoform is postulated to be a main player in regulatory volume increase (RVI) after
cells have lost volume (Russell, 2000). O'Brien et al (1988) showed that inhibition
ofNKCC with the phorbol ester 12-0-tetradecanoylphorbol-13-acetate (TPA)
reduced cell volume by 25%, whereas a Na-K-2C1 cotransport deficient mutant cell
line showed no cell volume reduction in response to TPA. Prolonged exposure of
Ehrlich ascites tumour cells to hypertonic medium results in increased expression of
NKCC in the membrane (Jensen and Hoffmann, 1997) and the NKCC activity was
increased. Due to the increased NKCC synthesis and membrane insertion an
adaptive response to hypertonic media is implied, where NKCC plays an important
role in Ehrlich cell maintenance.
NKCC1 also functions to set intracellular CP concentration above electrochemical
equilibrium. Some evidence for this comes from observations that dogfish rectal
13
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gland cells exposed to external furosemide (an NKCC inhibitor) are seen to lose CI"
(Greger et al, 1994) and lost intracellular CI" could not be recovered in frog dorsal
root ganglion cells that were exposed to bumetanide (Alvarez-Leefmans et al, 1988).
This function ofNKCC 1 appears to be of particular importance in the developing
nervous system. In the mature central nervous system, the response to the
neurotransmitter GABA (Gamma-aminobutyric acid) is inhibitory due to influx of
chloride resulting in hyperpolarisation of post-synaptic membranes. However, there
is high expression ofNKCC 1 in immature neurons, which causes chloride
accumulation in cells. Schomberg et al (2003) demonstrate that activation of
GABAa receptors causes CI" efflux and reduction of [CI"], in immature cortical
neurons. This CI" efflux produces a depolarizing effect and is excitatory.
Throughout maturation, K-Cl cotransporters are expressed and NKCC1 levels are
reduced giving the conditions for GABA to become inhibitory (Payne et al, 2003).
However, there is some evidence that GABA still produces depolarising currents in
mature sensory neurons. CI" accumulation in the dorsal root ganglion neurons is
mediated by NKCC1, as knock-out mice show no chloride accumulation in these
cells (Sung et al, 2000). These mice show an increased pain threshold, consistent
with NKCC1 involvement in modulation of sensory input to the spinal cord.
In red blood cells the concentration of cell chloride is determined by the HCO37CI"
anion exchanger 1 (Band 3), which is by far the most abundant erythrocyte
membrane protein. The nature of the role ofNKCC in the erythrocyte is not certain,
but they are thermodynamically poised to allow either inward or outward flux
depending on the concentrations ofNa+, and K+, /K+0 (Lytle, 2003). As such, it has
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been speculated that red blood cell NKCC may function to buffer changes in plasma
potassium.
In secretory epithelia, the NKCC1 isoform is polarised to the basolateral membrane.
This provides CI" entry to the cell from the interstitium, which is secreted at the
apical membrane by other transport proteins. Recycling ofNa+ and K+ by the Na+ -
K+-ATPase maintains the driving force for the transport of ions via NKCC1 (Gamba,
2005). However, in epithelial cells of the choroid plexus, NKCC1 (and the Na+ -K+-
ATPase) are expressed apically (Praetorius and Nielsen, 2006; Wu et al, 1998; Keep
et al, 1994) where it is proposed to reabsorb K+ from the cerebrospinal fluid back to
the blood. NKCC 1-null mice show salivation impairment, growth retardation and
reduced intestinal secretions. These result in death due to blockade and bleeding of
the caecum and colon (Gamba, 2005). Inner ear dysfunction is evident, with
deafness and balance impairement. This is thought to be due to the inability of
epithelial cells to uptake K+ basolaterally for secretion apically into the cochlear
chamber (Flagella et al, 1999).
NKCC1 also appears to have a role in neurite outgrowth in response to nerve growth
factor (NGF). RNAi-knockdown experiments showed that NGF-induced neurite
growth of a cell line originating from adrenal medulla was significantly reduced,
although the mechanisms underlying the importance ofNKCC 1 are as yet unknown
(Nakajima et al, 2007).
NKCC1 has been found to play more of a role in the kidney than previously thought.
Plasma renin levels were found to be significantly higher in NKCC-null mice, an
effect that is also shown in wild-type mice treated with furosemide (Castrop et al,
2005). The NKCC 1-deficient mice showed greater recruitment of granular cells to
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afferent arterioles of the juxtaglomerular apparatus. Renin release from wild type
and NKCC-null juxtaglomerular granule (JG) cells in culture was measured and
showed that this was increased in wild type cells upon treatment with furosemide.
Basal renin release in NKCC-null JG cells was higher than wild type and was not
affected by furosemide. The authors suggest that NKCC1 suppresses basal release of
renin and that the higher levels of renin seen upon administration of furosemide are
due to NKCC1 inhibition. Also, mouse inner medullary collecting duct cells absorb
NH4+ from the basolateral surface via NKCC1, a function that may be required for
the deposition ofNH4+from the collecting duct to the urine (Glanville et al, 2001).
1.4.2-NKCC2
NKCC2 is expressed in the apical membrane of epithelial cells of the TAL in the
kidney. Inward absorption ofNa+, K+ and CI" helps to recover water and salts from
the glomerular ultrafiltrate resulting in more concentrated urine. As mentioned in
section 1.2.2, there are six main forms ofNKCC2. The A, B and F isoforms are
expressed at different positions within the TAL (see figure 1.2) and are associated
with different ion affinities and cotransport capacities (table 1.1 shows the ion
binding capacities of these different isoforms). NKCC2F is present in the medullary
TAL only where the concentration of transported ions is the highest. Of the three
splice isoforms, NKCC2F has the lowest affinity for ions, but was found to be the
most sensitive to changes in osmolarity (Plata et al, 2002). NKCC2A is found in
both cortical and medullary TAL and has the highest capacity for cotransport. It has
a higher affinity for ions than NKCC2F, but less than NKCC2B. This splice isoform
is found solely in the cortical TAL, where the concentration of ions is lowest. The
expression of these isoforms at different positions within the TAL allows for
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maximal concentration of urine. As mentioned previously, Gagnon et al (2002)
found that shark NKCC2AF was a non-functional cotransporter. Co-expression of
this form with either A or F in Xenopus oocytes showed a reduction of cotransport
from expression ofA or F alone. This suggests that NKCC2AF can exert a
dominant-negative effect on cotransport. This may be through interaction of the
different isoforms as suggested by yeast-two-hybrid studies (Brunet et al, 2005).
NKCC2F NKCC2A NKCC2B
Na+ 20.6 ±7.2 5.0 ±3.9 3.0 ±0.6
K+ 1.54 ±0.16 0.96 ±0.16 0.76 ±0.07
ci- 29.2 ±2.1 22.2 ±4.8 11.6 ± 0.7
Table 1.1 - Ion Binding Properties of the A, B and F NKCC2 Splice Isoforms
Data shown here was sourced from Gamba, 2005 and are the Km values (in mM)
from mouse NKCC2.
As well as the A, B and F splicing events, there are those that produce the short
(BSC-S) and long (BSC-L) isoforms. Several lines of evidence suggest that the short
isoform acts a regulatory molecule in order to modulate the function of the long
isoform. In Xenopus oocytes, Plata et al (1999) show that the BSC-S exerts a
dominant-negative effect on cotransport via the long isoform, a function that was
halted when cAMP was raised. In vivo it appears that this effect is mediated by
preventing delivery of the long isoform to the plasma membrane (Meade et al, 2003),
as demonstrated by fluorescence confocal microscopy. The short isoform, in the
mouse, is mostly found in the mTAL and may confer regulation of cotransport in
response to cAMP-generating hormones such as vasopressin (Mount et al, 1999).
The short form also has transporting properties, as shown by expression in Xenopus
oocytes (Plata et al, 2001). The BSC-S is inhabitable by the "loop" diuretic
furosemide, but unlike the longer isoform appears to only transport sodium and
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chloride. The cotransport was inhibitable by raised cAMP and activated by
inhibitors ofPKA. Tubules isolated from mouse mTAL showed a shift from Na-Cl
to Na-K-Cl cotransport when cAMP was raised after treatment with vasopressin (Sun
et al, 1991). A model has been proposed for the actions of these forms in the mTAL.
During periods of increased extracellular osmolarity or in the presence of vasopressin
the long isoform is the predominant form cotransporting Na, K and CI. However, in
the converse situation, BSC-S provides apical Na and CI cotransport as well as
preventing expression of BSC-L at the apical membrane (Plata et al, 2002 and 1999).
1.5 - Regulation of cotransport
1.5.1 - Dependence of Cotransport on ATP
The transport of one sodium, one potassium and two chloride ions via the NKCC
protein is an example of secondary active transport, where the movement of ions
against the electrochemical gradient is coupled to the diffusion of ions down their
chemical gradient (Russell, 2000). However, early on it was noted that ATP was
required for cotransport of ions. Russell (1976) found that influx of CI into squid
giant axons was reduced when the axons were dialysed with ATP-free solutions, a
phenomenon which was reversible by repletion of ATP. Further evidence from study
of the squid giant axon (Russell 1979) showed that a furosemide-sensitive coupled
Na-Cl influx was dependent on the presence ofATP. The dependence ofNa-K-Cl
cotransport on ATP was described in the seminal paper by Geek et al (1980) and was
then observed in a number of different species and cell types (Hall and Ellory, ferret
erythrocytes (1985); Palfrey and Rao, avian erythrocytes (1983); Rindler et al,
Madin-Derby Canine Kidney cells (1982)). The focus was then to identify whether
ATP was required as an energy source to drive the transport of ions against their
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electrochemical gradients, as an allosteric activator of cotransport by altering ion
binding affinities, or as a phosphate donor for the phosphorylation of the cotransport
9+
protein. Flatman (1988) showed the importance of intracellular Mg concentration
to cotransport, where reduced internal magnesium slows cotransport rate and vice
versa. However, an increase in intracellular Mg2+ concentration did not stimulate
cotransport rate when cells were depleted ofATP (Flatman, 1991). This evidence
• 9+ •
implies that ATP and Mg work in concert to influence cotransport rate, perhaps as
necessary components of kinase activation of the cotransporter. In 1988, Altamirano
et al conducted experiments to investigate whether the requirement ofATP was in
phosphorylation of the protein responsible for cotransport or for driving the
cotransport process by ATP hydrolysis. They found that dialysis of squid giant axon
with vanadate or fluoride had little effect on Na-K-Cl cotransport. However, the
treatments substantially reduced the rate of cotransport inactivation when ATP was
depleted from the axon. They suggested that vanadate and fluoride must inhibit a
phosphatase that is normally responsible for keeping the cotransporter
dephosphorylated and inactive. Pewitt et al (1990) studied the effects of kinase
inhibitors and the phosphatase inhibitor okadaic acid on cotransport in avian
Of-
erythrocytes. Stimulation of Rb flux by cpt-cAMP (a lipophilic cAMP analogue
that activates cAMP-dependent kinases), hypertonicity and NaF was blocked by the
kinase inhibitors K-252a and H-9. Also, okadaic acid was found to stimulate
cotransport. This study also identified a protein of approximately 150 kDa that
bound the photoaffinity probe BSTBA (a bumetanide analogue) and was
phosphorylated (by 32P measurement). These studies together gave strong evidence
that phosphorylation and dephosphorylation events were important in the regulation
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ofNa-K-Cl cotransport. The next set of studies furthered these ideas. Palfrey and
Pewitt (1993) took another look at the dependence of cotransport on ATP and Mg2+,
but from the viewpoint of protein phosphorylation. They tested whether a number of
different cotransport activating stimuli were sensitive to ATP depletion by
• • 2"T
Antimycin A and to intracellular Mg removal by the ionophore A23187 and
^9
EDTA. To monitor protein phosphorylation they examined P changes in the avian
erythrocyte membrane protein goblin (which is now thought to be ankyrin).
Cotransport stimulated by cAMP was reversed by metabolic depletion, but not when
the phosphatase inhibitor calyculin A was the stimulus. Likewise, goblin
phosphorylation was reduced when cAMP stimulated cells were depleted ofATP or
Mg2+, but not in calyculin A stimulated cells. This work greatly supported the
9+
hypothesis that Mg and ATP were required as kinase cofactors in the regulation of
Na-K-Cl cotransport. Studies of cotransport in the shark rectal gland by Lytle and
Forbush (1992) gave direct evidence that the cotransport protein itselfwas
phosphorylated. Using antibodies directed against the shark cotransporter, they were
■> 9
able to immunopurify a 195 kDa protein which showed a 4-fold increase of P under
conditions of increased cotransport activity. By acid hydrolysis and subsequent thin
layer chromatographic separation it was found that the active cotransport protein had
increased radioactive phosphothreonine and phosphoserine present. They were able
to sequence one of the phosphopeptides by Edman degradation and by relating this
back to the shark cotransporter cDNA sequence identified residue Thr189 as
phosphorylated under conditions of cotransport activation. Although the data for this
are unpublished, Lytle and Forbush also claim to have identified Thr1114, in the C-
terminus of the cotransporter, as phosphorylated (Xu et al, 1994). Evidence from the
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avian salt gland showed that this feature was not restricted to the shark rectal gland.
A protein of 170 kDa that was detectable using the antibodies raised against shark
cotransporter (from the study by Lytle and Forbush) showed increased
phosphorylation in response to forskolin and vasoactive intestinal peptide (which can
cause cAMP levels to rise and stimulate NKCC activity).
1.5.2 - Phosphorylation of NKCC
Once it became clear that phosphorylation ofNKCC proteins was required for
activating cotransport activity a great deal of work went into further understanding
this process. Many studies showed that cotransport activating stimuli caused
increases in cotransporter phosphorylation (Lytle (1997); Haas et al (1995);
O'Donnell et al (1995)). Tanimura et al (1995) provided evidence for three
I j 32
phosphorylation sites on the rat parotid Na -K -CI" cotransporter. They digested P-
labelled ppl75 (rat parotid NKCC) with V8 protease from acini treated with or
without isoproterenol and separated the resultant peptides by gel electrophoresis.
Autoradiography showed three peptides of different size, which were all recognised
by a rabbit parotid NKCC antibody. Only one of these peptides showed increased
phosphorylation in response to isoproterenol. Study of the cotransporter in the avian
erythrocyte by Lytle (1997) showed increased cotransport activity and
phosphorylation in response to four different stimuli (cell shrinkage, cAMP, fluoride
and calyculin-A). Chemical cleavage (at tryptophan residues by N-
chlorosuccinimide) of immunoprecipitated 32P-cotransporter resulted in two
phosphorylated fragments that were 82 and 41 kDa in size. Only the smaller
fragment was recognised by a C-terminal NKCC antibody, indicating some
phosphorylation of the cotransporter in this domain. As was found in the shark
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cotransporter (Lytle and Forbush, 1992), only phosphothreonine and phosphoserine
residues were present on avian erythrocyte NKCC under conditions of increased
cotransport activity. Studies ofNKCC recovered from shark rectal gland have
identified three key threonine residues, in the cytoplasmic N-terminal region, that are
phosphorylated when the cotransporter is active (Darman and Forbush, 2002). 32P-
labelled NKCC was immunoprecipitated from shark rectal gland tubules, which were
treated with forskolin to activate cotransport, and then digested with trypsin.
Radiolabelled peptides were separated by high-performance liquid chromatography
and then subjected to MALDI-TOF mass spectrometry. Peptides observed to lose
phosphate (by measuring peptide masses before and after treatment of samples with
alkaline phosphatase) were sequenced by Edman degradation. By comparison with
the complete sequence (obtained from cDNA) these residues were identified as
Thr184, Thr189 and Thr202. Point mutants of these were expressed in HEK-293 cells
and led to the discovery of several interesting features. Firstly, Thr189
phosphorylation is an absolute requirement for shark NKCC cotransport activity in
response to low intracellular CI". Secondly, Thr184 and Thr202 appeared to modulate
this activity by increasing the rate of cotransport and the sensitivity to changes of CF
concentration and cell volume. Importantly, these residues are conserved among
NKCC1, NKCC2 and NCC from a variety of species. The importance of these
threonines has been demonstrated in vivo by Flemmer et al (2002), using
immunofluorescent microscopy and an antibody raised to a diphosphorylated peptide
from human NKCC1 (containing Thr212 and Thr217 which correspond to Thr184 and
Thr189 from shark NKCC). This antibody (dubbed R5) was able to detect rises in
cotransporter phosphorylation with cotransport activity and showed NKCC
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phosphorylation in sections from shark rectal gland, rat colon, parotid gland and
trachea. They are also phosphorylated on the actively transporting NKCC2 isoform
(Gimenez and Forbush, 2003). These three threonine residues are well conserved
between NKCC1 and NKCC2 and also between different species, and as such it has
been suggested that this cluster of threonines represent a universal regulatory locus
for the activation ofNKCC (Gimenez and Forbush, 2003; Darman and Forbush,
2002). However, there may be other threonine or serine residues whose
phosphorylation could modulate cotransporter function. Indeed, Lytle showed (by
measurement of stoichiometry of P incorporation) that activation ofNKCC in duck
erythrocytes causes the cotransporter to be phosphorylated at five sites within the N-
and C-termini (Lytle, 1997). Although the discovery of the three threonine residues
within the N-terminus was a great leap forward in understanding cotransport
regulation, their identification did not implicate a cotransporter kinase, as they do not
lie within consensus sites for any known kinases.
1.5.3 - Kinases and Phosphatases
A great many studies, involving the use of phosphatase and kinase inhibitors, have
provided complementary evidence to show that in order to activate cotransport the
protein must be phosphorylated and then dephosphorylated to inhibit cotransport.
These studies have also suggested that such phosphorylation events may involve
different kinases activated in response to differing stimuli. The main kinases and
phosphatases that have been studied with reference to NKCC regulation are
discussed here as well as some of the difficulties involved in using inhibitors to infer
function of a particular kinase or phosphatase.
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1.5.3.1 - Protein Kinase A and Protein Kinase C
Once the NKCC1 protein had been sequenced it became evident that it possessed
consensus sites for phosphorylation by protein kinase A (PKA) and protein kinase C
(PKC), as well as sites for casein kinase II (Russell, 2000). As yet, there is little
evidence to suggest an involvement of casein kinase II, but there is to implicate PKA
and PKC. PKA is known as cAMP-dependent kinase as it requires binding of the
cyclic nucleotide in order for the catalytic subunits of the kinase to dissociate from
the regulatory subunits and become active. Indeed, cAMP-generating agonists cause
upregulation ofNKCC cotransport in some cell types, including the avian
erythrocyte (Lytle, 1997; Palfrey et al, 1980), avian salt gland cells (Torchia et al,
1992) and human colon adenocarcinoma HT29 cells (Turner et al, 1990).
Interestingly, shark rectal gland cell NKCC activity is also stimulated by raised
cellular cAMP even though this cotransporter does not contain the known PKA
consensus phosphorylation site (Xu et al, 1994; Palfrey et al, 1984). The effects of
PKA and cAMP on NKCC activity are also inhibitory in a great many cell types. In
mature skeletal muscle inhibition of the cAMP-dependent protein kinase A (PKA)
pathway stimulates NKCC activity during hyperosmotic challenge (Gosmanov and
Thomason, 2003). They also found that in cultured rat skeletal muscle (L6) and
intestinal epithelial (IEC-6) cells cotransport by NKCC was inhibited by
isoproterenol and forskolin (cAMP-elevating substances). Direct inhibition ofPKA
(by H-89) produced an increase in NKCC activity. The inhibitory actions of cAMP-
elevating substances have also been observed in cultured endothelial smooth muscle
cells (Smith and Smith, 1987) and human fibroblasts (Owen and Prastein, 1985).
Overall, it appears that the response to cAMP and the involvement ofPKA in NKCC
activation is cell specific and may be more likely due to the actions of these factors
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on other cell transport systems and the resultant changes in cell ion levels (e.g. CI").
Indeed, evidence has been presented from giant squid axon (Breitwieser et al, 1990),
shark rectal gland and canine tracheal epithelial cells (Lytle and Forbush, 1996; Haas
et al, 1995) that low intracellular CI" concentration can stimulate cotransport in the
absence of any other stimulus.
PKC is a serine/threonine protein kinase that can stimulate or inhibit NKCC activity
depending on the cell type examined. For example, NKCC cotransport is inhibited in
human pigmented ciliary epithelial cells by the PKC activator phorbol 12-myristate,
13-acetate (PMA) (Layne et al, 2001). In human tracheal epithelial cells shrinkage
induced NKCC activation is dependent on the actions of PKC-5 (Liedtke and Cole,
2002) and elevated activity of this PKC isoform has been shown to stimulate NKCC 1
activity in human airway epithelial cells (Liedtke et al, 2003). Like the situation for
PKA, no direct phosphorylation ofNKCC by PKC has yet been determined.
1.5.3.2 - Myosin Light Chain Kinase
Cell shrinkage induces raised activity ofNa-K-Cl cotransport. O'Neill and Klein
(1992) found that hypertonic cell shrinkage increased the bumetanide-sensitive influx
ofNa, K and CI into bovine aortic endothelial cells, producing recovery of cell ion
and water content. Myosin light chain (MLC) was identified as a protein that was
phosphorylated in shrunken aortic endothelial cells by Klein and O' Neill (1995),
which was reversed by cell swelling. ML-7, an inhibitor of myosin light chain
kinase (MLCK), was found to prevent MLC phosphorylation and was able to reduce
cotransport in shrunken cells. Krarup et al (1998) also found that inhibition of
myosin light chain kinase by ML-7 resulted in reduced cotransport in response to
hypertonic stimulation in Ehrlich cells. The ML-7-sensitive cotransport was 2-fold
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greater during regulatory volume increase (RVI) than after stimulation of cotransport
by treatment with calyculin A, suggesting a possible role forMLCK as a modulator
ofNKCC cotransport in response to cell shrinkage. Rho kinase plays a role in
hypertonic MLC phosphorylation, and its activity is enhanced in response to cell
shrinkage (Di Ciano-Oliveira et al, 2003). Inhibition of this kinase did not affect
86 • •Rb uptake under isosmotic conditions and only reduced hyperosmotic stimulation
by around 10% in porcine aortic endothelial cells and kidney tubular epithelial cells,
whereas, as shown previously, the MLCK inhibitor ML-7 reduced isosmotic activity
and almost completely inhibited NKCC activation. However, recent data suggest
that while ML-7 does inhibit Na-K-Cl cotransport, this is not via inhibition ofMLCK
and is not dependent on the phosphorylation of myosin light chain (Di Ciano-
Oliveira et al, 2005). Another inhibitor ofMLCK, K-252a, prevented the increase of
MLCK phosphorylation seen on hypertonic stimulation. Whilst cotransport by
hypertonic stimulation was reduced by 36%, K-252a did not prevent cotransport
induced by CI" depletion. Flatman and Creanor (1999a) found that high
concentrations of K-252a had only a modest effect on cotransport in ferret
erythrocytes, reducing cotransport rate by around 20%. Expression of a non-
phosphorylatable form ofmyosin light chain (MLC) in porcine kidney tubular LLC-
PK1 cells exerted a dominant-negative effect on endogenous MLC phosphorylation.
This mutant suppressed hyperosmotically induced phosphorylation ofMLC, but did
not prevent cotransport via NKCC. Also, a constitutively active MLC mutant was
not itself an activator of cotransport in LLC-PK1 cells. These data suggest that MLC
phosphorylation is neither required nor sufficient for the activation ofNa-K-Cl
cotransport in response to hypertonic stimulation (Di Ciano-Oliveira et al, 2005).
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This group concluded that myosin ATPase activity was important after studying the
effects of blebbistatin (inhibitor ofmyosin II ATPase) on hypertonic and CI"
depletion-induced stimulation ofNa-K-Cl cotransport. This inhibitor only affected
hypertonic stimulation of cotransport. It has since been found that myosin II-
depleted cytoplasts (plasma membrane vesicles) from Ehrlich ascites cells are
insensitive to stimulation ofNKCC by cell shrinkage, whilst still being responsive to
stimulation of cotransport by calyculin A (Hoffmann and Pedersen, 2007). These
data together suggest that MLCK could affect myosin ATPase activity independent
ofMLC phosphorylation in response to cell shrinkage and that these steps are
important in activation ofNa-K-Cl cotransport under hypertonic conditions.
1.5.3.3 - Stress-Activated and Mitogen-Activated Protein Kinases
The stress-activated protein kinases (SAPK) and mitogen-activated protein kinases
(MAPK) are serine/threonine kinases that are activated in response to cellular
stresses and extracellular mitogens. These kinases are structurally similar but are
functionally distinct, resulting in downstream activation of different targets (Tibbies
and Woodgett, 1999). There is evidence to suggest involvement of both kinase sets
in NKCC regulation. Studying the effects of arsenite (an activator of SAPKs) in
ferret red blood cells, Flatman and Creanor (1999b) found that it produced a large
stimulation of cotransport. In combination with the phosphatase inhibitor calyculin
A, which stimulates NKCC activity, the level of cotransport was higher than when
either treatment was used alone and that this stimulation was prevented by prior
removal of cell Mg2+. The additive effects of these compounds indicated that there
may be different pathways involved in this activation of cotransport in ferret
erythrocytes. This study showed, however, only a very small decrease in cotransport
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when inhibitors of p38 MAPK and p42/p44 MAPK (ERK) were applied (SB203580
and PD98059 respectively) and a general activator (anisomycin) ofMAPKs and
SAPKs had a mild but inhibitory effect on cotransport. Klein et al (1999) presented
evidence using an in-gel kinase assay that stress-activated c-Jun NEE-terminal kinase
(JNK) was responsible for NKCC phosphorylation in shrunken aortic endothelial
cells, but there is little other evidence to implicate this kinase in vivo. Other studies,
however, show greater effects ofMAPK inhibition on cotransport. Pre-treatment
with PD98059 prevented stimulation of cotransport in skeletal muscle (Wong et al,
2001). The more potent MEK 1/2 inhibitor U-0126 completely abolished all
cotransport in response to an activating stimulus. NKCC activity was found to be
increased in rat skeletal muscle after exercise and that this activity was associated
with an increase in ERK phosphorylation (Gosmanov et al, 2002). Phenylephrine
induced ai-adrenoceptor activation has been shown to increase NKCC activity in
isolated rat cardiomyocytes and that this activation is linked to ERK-dependent
phosphorylation of the cotransporter (Andersen et al, 2004). PD98059 was found to
eliminate the NKCC response to phenylephrine.
1.5.3.4 - Tyrosine Kinases
Although it has been shown that the cotransporter is not phosphorylated on tyrosine,
Flatman and Creanor (1999a) found that genistein, an inhibitor of tyrosine kinases,
caused a 60% reduction of 86Rb uptake in ferret erythrocytes. Likewise, the potent
Src family tyrosine kinase inhibitor, PP1 (PPli; 4-amino-5-(4-methylphenyl)-7-(t-
butyl)pyrazolo[3,4-d]pyrimidine) reduced cotransport. Genistein inhibits the
response ofNKCC to hyperosmotic stress in L6 rat skeletal muscle cells, but isolated
cotransporter under these conditions shows no tyrosine phosphorylation (Zhao et al,
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2004). These data imply the involvement of tyrosine kinases at some stage of the
activation of cotransport. However, a recent examination of a wide range of kinase
inhibitors shows that what were once thought to be very selective inhibitors may not
actually be so. Indeed, although more selective than many inhibitors, PPli has been
shown to inhibit some serine/threonine kinases (Bain et al, 2007; Bain et al, 2003).
Whilst these studies have provided some insight into the proteins involved in
regulating cotransporter function they do also highlight the difficulties when using
inhibitors. Recent studies by Bain et al (2007 and 2003) have shown that many of
the commonly used small-molecule inhibitors are far less specific than previously
thought. For example, 20 pM ML7, used in the studies linked to MLCK, also
inhibits mitogen- and stress-activated protein kinase 1 (MSK) by 50% in vitro (Bain
et al, 2003). SB 203580, widely used to inhibit p38 MAPKs, inhibits other kinases
with similar potency, such as casein kinase I. At a 1 pM concentration, SB 203580
inhibits p38 MAPK activity by about 90%, but was found to inhibit receptor-
interacting protein 2 (RIP) kinase with even greater potency (Bain et al, 2007).
Although these inhibitors can imply or rule out the activity of a particular kinase in
cotransporter regulation users should be aware that any observed effects may result
from inhibition of several targets, which complicates any findings.
1.5.3.5 - Serine/Threonine Protein Phosphatases
Calyculin A and okadaic acid are serine/threonine protein phosphatase inhibitors that
inhibit PP1 and PP2A (Resjo et al, 1999; Ishihara et al, 1989). Okadaic acid is more
specific at inhibiting PP2A, whereas calyculin A affects both phosphatases similarly.
Both okadaic acid (Pewitt et al, 1990) and calyculin A (Palfrey and Pewitt, 1993)
were stimulators ofNa-K-Cl cotransport in duck red blood cells. Darman et al
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(2001) showed that NKCC1 possesses a motif in its N-terminus that is a binding site
for PP1 (RVxFxD), which when mutated caused changes to the activation of the
cotransporter by intracellular CP concentration. Microcystin binds very strongly to
PP1 and has been used to isolate this phosphatase by affinity chromatography
(Moorhead et al, 1995). Microcystin-conjugated beads have been used to co-
precipitate PP1 and NKCC1 from HEK-293 cells (an action that was inhibited by
pre-incubation of samples with free microcystin) indicating that the phosphatase
interacts with the cotransporter. Matskevich et al (2005), using the same approach,
showed that the greater the amount of phosphorylation on NKCC the more
cotransporter was co-precipitated with PP1. However, Y-2-H experiments do not
provide evidence that NKCC1 and PP1 directly interact (Gagnon et al, 2007b).
Although false negatives are not unusual in Y-2-H, this issue requires further
investigation. PP2A has been immunoprecipitated with NKCC1 from an airway
epithelial cell line (Calu-3) and treatment of these cells with okadaic acid produced
around 4-fold increases in flux via the cotransporter (Liedtke et al, 2005). Calyculin
A did not produce any alteration to cotransport in these cells. Like the various
kinases, it would appear that phosphatase activity may be cell type specific.
1.5.3.6 - SPAK, OSR1 and WNKs
The greatest leap forward in understanding Na-K-Cl cotransport regulation came
with the discovery that the stress-related serine/threonine kinases, Ste20-related
proline-alanine rich kinase (SPAK) and oxidative-stress response 1 (OSR1),
interacted with the NKCCs. Y-2-H assays identified these proteins and their
interactions with the NKCCs were confirmed by GST pull-down and co-
immunoprecipitation experiments (Piechotta et al, 2002). SPAK and OSR1 are
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similar in structure with the highest amino acid identity within the catalytic domain.
The SPAK/OSR1 binding motif on the cotransporters was identified as (R/K)Fx(V/I)
followed by a further five residues which show no clear consensus but without which
the kinase did not bind in Y-2-H assays. In choroid plexus cells, both SPAK and
NKCC1 localise to apical membranes, whereas in salivary gland cells both proteins
were found to localise to basolateral membranes, as indicated by
immunohistochemistry (Piechotta et al, 2002). Further work by this group found that
expression ofNKCC1 with point mutations within or deletions of one or both
SPAK/OSR1 binding motifs (RFxV) in Xenopus oocytes did not affect 86Rb+ uptake
in response to hypertonicity and low [CP],-and the authors therefore suggested
another role for the SPAK/OSR1 interaction other than modulation of cotransporter
function via direct phosphorylation (Piechotta et al, 2003). From these data it was
inferred that SPAK may function as a scaffold to allow NKCC to interact with other
proteins. On the other hand, Dowd and Forbush (2003) show that overexpression of
a kinase-inactive dominant-negative SPAK mutant (referred to as PASK in this
paper) caused dramatic inhibition of human and shark NKCC1 activity expressed in
HEK-293 cells. A reduction of phosphorylation of Thr184 and Thr189 was also
observed on western blots using the R5 antibody. Some of these issues were
resolved with the discovery that SPAK and OSR1 require activation by other kinases
before they themselves can activate the cotransporter. It was discovered that people
with Gordon's syndrome (also known as Pseudohypoaldosteronism type II - a
disease characterised by high blood pressure and hyperkalaemia) had mutations in
genes that code for with-no-lysine kinases (WNK, K = lysine), in particular WNK1
and WNK4 (Wilson et al, 2001). These are large serine/threonine kinases without a
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lysine within subdomain II of the enzyme, which is considered vital for the binding
ofATP and catalysis in protein kinases. However, another lysine is located within
subdomain I and when mutated in WNK1 rendered the enzyme inactive (Xu et al,
2000). There are four known WNK isoforms (1-4) and are coded for on different
genes (Verissimo and Jordan, 2001). Piechotta et al (2003) showed that WNK4
interacted with SPAK. Vitari et al (2005) rationalised that these may be involved in
cell ion regulation due to the nature of the symptoms ofGordon's syndrome and
using anti-WNKl antibodies for co-IP experiments, followed by protein
identification with mass spectrometry, identified SPAK as an interacting protein.
WNK1 and WNK4 (overexpressed N-termini in HEK-293 cells and E. coli) were
able to phosphorylate SPAK and OSR1, whereas catalytically inactive mutants were
not. This group also demonstrated that expression ofWNK 1/4, SPAK or OSR1 and
the N-terminus ofNKCC1 in E. coli led to phosphorylation of the NKCC molecule,
whereas expression of these proteins individually (or kinase mutants) did not.
Moriguchi et al (2005) demonstrated by Y-2-H assays and immunoprecipitation that
SPAK could bind to WNK1. In vitro kinase assays showed that WNK1 was a direct
activator of SPAK and OSR1 and that this was by phosphorylation of the kinases, as
kinase dead WNK1 was ineffective at activating SPAK or OSR1. Gagnon et al
(2006a) provided further evidence that WNKs are involved in the activation of
SPAK and OSR1. Co-injection of OSR1 with WNK4 into Xenopus oocytes resulted
in increased cotransport via NKCC1, whereas injection of OSR1 alone produced no
^9
significant change. By measurement of P incorporation onto SPAK and the N-
terminal ofNKCC 1 in the presence of different pharmacological agents several other
features ofwere highlighted. K-252a and staurosporine both resulted in reduced
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phosphorylation on NKCC1 and SPAK, whereas NEM and diamide had little effect.
Arsenite had very little effect on phosphorylation even though this causes great
NKCC cotransport in the ferret erythrocyte (Flatman and Creanor, 1999b). SPAK
was also shown to be sensitive to changes in CP concentration, where a reduction of
cell CP resulted in more autophosphorylation on SPAK. Further Xenopus oocyte co-
injection experiments (Gagnon et al, 2006b) reinforced the fact that for NKCC
activation, the presence of catalytically active WNK and SPAK are required. Y-2-H
experiments showed that WNK4 and NKCC1 did not physically interact, placing
SPAK as an intermediate between the WNK kinase and NKCC1. How these
proteins interact with one another was investigated by Vitari et al (2006). In vitro
kinase assays, where active SPAK or OSR1 were combined with an N-terminal
fragment ofNKCC 1 (residues 1-260 from the shark protein), were conducted to
determine which residues on the cotransporter were phosphorylated by the kinases.
Trypsin digestion followed by liquid chromatography isolated those peptides that had
32P incorporated. Edman sequencing identified a doubly phosphorylated peptide and
a singly phosphorylated peptide, indicating phosphorylation on Thr175, Thr179 and
Thr184 (which correspond to threonines 203, 207 and 212 on human NKCC1 and 197,
201 and 206 on mouse NKCC1). Anselmo et al (2006) found that knock-down of
WNK1 or OSR1 (with inhibitory RNA) in HeLa cells substantially reduced NKCC
activity in sorbitol treated cells, as well as basal NKCC cotransport. They also found
that OSR1 did not catalyse the incorporation of phosphate onto WNK1, but that
WNK1 did phosphorylate OSR1 in vitro. These data again place the WNKs
upstream of SPAK/OSR1. This group also demonstrated that after activation with
WNK1, OSR1 could phosphorylate the N-terminus ofNKCC2. Zagorska et al
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(2007) found that WNK1 isolated from cells exposed to hyperosmotic stress would
phosphorylate OSR1 more than kinase isolated from untreated cells and that this
stimulation was dose dependent on the concentration of sorbitol, NaCl or KC1. Other
stimuli, including calyculin A, failed to induce the activation ofWNK1. Sorbitol
treatment also increased phosphorylation of other residues including WNK1 on
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Ser , which results in activation of the kinase. Phosphorylation of the kinase on
Ser1261, adjacent to the SPAK binding domain, prevented its interaction with SPAK
or OSR1. Using the same approach as Anselmo et al (2006), this group furthered the
work of siRNA ofWNK1 in HeLa cells. They found that the phosphorylation that is
normally found on SPAK and OSR1 upon treatment with sorbitol was markedly
reduced. They also observed that GFP-WNK1 had a striking relocalisation within
HEK-293 cells upon stimulation with sorbitol. Normally, it was dispersed
throughout the cytoplasm, but after treatment relocated to discrete intracellular
structures which contained clathrin, the transcription factor AP-1 and TGN46 (a
protein thought to regulate membrane traffic to and from the trans-Golgi network).
As mentioned, five sites for phosphorylation have been mapped in the N-terminus of
NKCC1. These are threonines 175, 179, 184, 189 and 202 (Darman and Forbush,
2002; Vitari et al, 2006). These correspond to 197, 201, 206, 211 and 224 on mouse
NKCC1 and each was mutated in turn in NKCC1 constructs. These were expressed
in Xenopus oocytes and the functional consequence of each mutation assessed
(Gagnon et al, 2007a). In vitro phosphorylation assays were conducted using wild-
type SPAK with each NKCC1 mutant. Mutation of Thr197 or Thr206 resulted in 33%
less phosphorylation on NKCC, with 66% less on the double mutant. Mutation of
Thr201 had no effect on NKCC phosphorylation, but in combination with Thr'97 and
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Thr206, 32P incorporation into NKCC was reduced by 95% in comparison to wild
type. Expression of NKCC 1 with T206A or T211A mutations in Xenopus oocytes
resulted in cotransporter that was non-functional. This study also investigated
whether or not SPAK binding to NKCC was required for activation of cotransport,
which follows on from their earlier work that suggested that binding was not required
in response to hypertonicity (Piechotta et al, 2003). Deletion of one SPAK binding
domain did not result in loss of cotransport. However, when both SPAK binding
motifs were removed from NKCC, cotransport was ablated in response to
hyperosmolarity. Point mutations (F79A and F135A) had the same effect on
cotransport and in vitro phosphorylation assays showed that this mutation resulted in
very little phosphorylation on NKCC. They concluded that only one motifwas
required for in vivo activation of cotransport by SPAK/WNK. There have been
suggestions that hydrophobic residues flanking the specific site of substrate
phosphorylation are important for NKCC and SPAK interaction. Gagnon et al
(2007a) demonstrated that mutation ofM212A (after Thr211 in mouse NKCC1) did
not alter the ability of the cotransporter to function in the presence of SPAK and
WNK4 (in Xenopus oocytes) or hyperosmotic conditions, whereas a F207A
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(following Thr ) mutation on NKCC1 resulted in a non-functional transporter. As
Thr211 is not a target of SPAK/OSR1, mutation did not affect the activity ofNKCC1
under these conditions. Villa et al (2007) provide structural information about the
interaction of SPAK/OSR1 with peptide containing the RFxV motif. Crystals of the
conserved C-terminal (CCT) domain of OSR1 bound to a peptide from WNK4
(GRFQVT) were formed and X-ray diffraction data was collected and modelled.












Figure 1.5 - SPOC Fold of OSR1
This diagram was constructed from information obtained from Villa ef al (2007) and
represents the novel SPOC fold observed in the conserved C-terminus of OSR1.
fold and was dubbed the SPOC fold (SPAK/OSR1 C terminus). It consists of four
anti-parallel P-sheets that are packed against two large alpha-helices and a third
smaller alpha-helical section (see figure 1.5 for a representation). The WNK4
peptide used possessed a terminal threonine residue, which when phosphorylated
prevented its binding to the CCT ofOSR1. The authors note that a serine or
threonine following the RFxV motif appear to be conserved across species and as
such the interaction between WNKs and SPAK/OSR1 substrates, such as NKCCs,
may be regulated by the phosphorylation of these residues. Figure 1.6 describes a








Figure 1.6 - Model of NKCC regulation via SPAK/OSR1 and theWNK kinases
SPAK/OSR1 docks on NKCC via one of its RFXV motifs. SPAK/OSR1 is phosphorylated by
WNK in the cytosol under hyperosmotic conditions resulting in dissociation of the molecules.
This allows active SPAK/OSR1 to bind and phosphorylate NKCC. Gagnon ef al propose that a
small proportion of NKCC binds active SPAK under isosmotic conditions which accounts for the
basal activity seen in many cell types. Although in panel A SPAK is found associated with
NKCC and free in the cytosol, Villa et al (panel B) propose that normally WNK and SPAK are
bound together until stimulation causes phosphorylation ofWNK (by an as yet unknown kinase)
and WNK phosphorylation of SPAK, inducing dissociation allowing free active SPAK to dock on
NKCC and activate it. This figure was compiled from models proposed by Gagnon ef al (2007a
- panel A) and Villa et al (2007 - panel B).





Gagnon et al (2007a) and Villa et al (2007). Y-2-H assays with SPAK as bait
(Piechotta et al, 2003) found proteins other than WNKs and NKCC. Apoptosis-
associated tyrosine kinase 1 (AATYK1) was one of these and has since been further
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investigated (Gagnon et al, 2007b). This protein contains two RFxV motifs and was
found to interact with both SPAK and protein phosphatase 1 (PP1) in Y-2-H
experiments. These proteins were also found to co-IP from HEK-293 cells
transfected with SPAK, PP1 and AATYK1. Through more Y-2-H experiments these
interactions were characterised further. NKCC1 did not interact with AATYK1 or
PP1, whereas SPAK and PP1 both interacted with the regulatory domain of
AATYK1. Mutation of the phenylalanine residue in either AATYK1 RFxV motif
prevented interaction with SPAK as did a VI175A mutation in PP1 stop interaction
with the tyrosine kinase. Xenopus oocyte co-injection experiments showed that
AATYK1 inhibited cotransport even when non-catalytic AATYK1 was used.
Mutations that prevent binding ofAATYK1 to SPAK or PP1 remove or reduce the
inhibitory effects of the kinase on cotransport and as such, the authors suggest that
expression ofAATYK1 acts to bind SPAK and PP1 removing them from acting
upon the cotransporter. Furthermore, they postulate that this is not purely due to
sequestration of these molecules, but that PP1 may actually dephosphorylate and
therefore deactivate SPAK. A model for the role ofAATYK1 is depicted in figure
1.7. As previously mentioned in section 1.5.3.3, there may be involvement of the
SAPKs and MAPKs in cotransport regulation. Finks have been made to several of
these proteins and either SPAK or WNKs. Johnston et al (2000) found that SPAK
was able to activate p38 kinase in rat pancreatic cells (catalytically inactive SPAK
did not result in p38 phosphorylation of the substrate AF-2 in vitro). More recently
(Piechotta et al, 2002), p38 MAPK has been found to co-IP with SPAK and NKCC1
from brain lysates. Zagorska et al (2007) found that sorbitol stimulated ERK1/2, p38
and JNK in HEK cells, a stimulus that activates NKCC cotransport. This study was
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investigating the activation ofWNK1. However, inhibition or activation of these
SAPKs and MAPKs had no effect on the activation of WNK1. Again, it seems that







Figure 1.7 - Model for Regulation of NKCC Cotransport by AATYK1
This diagram was reworked from Gagnon et al (2007b) and demonstrates the idea
that AATYK1 functions to scaffold SPAK/OSR1 and PP1. This model involves
AATYK1 acting as a negative regulator of NKCC activity by binding of SPAK/OSR1
and dephosphorylation of these kinases by PP1.
1.5.3.7 - Phosphorylation of NKCC2
Study of the regulatory phosphorylation of the NKCC2 isoform has been minimal
when compared to the wealth of studies that have been undertaken to understand
regulation ofNKCC 1. However, useful studies have been conducted and show that
some features of regulation may be common to both isoforms. NKCC2 has N-
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terminal threonine residues in common with those involved in regulatory
phosphorylation in the N-terminus ofNKCC1, including the three known
phosphoacceptor sites (shark NKCC1 T184, T189, and T202 correspond to rabbit
NKCC2 T99, T104, and Til 7). Indeed, activation ofmouse NKCC2 by the peptide
hormone vasopressin resulted in phosphorylation ofThr" and Thr104 residues, as
detected by the R5 antibody (Gimenez and Forbush, 2003). Further study showed
that mutations to any one of the three phosphoacceptor sites had no effect on NKCC2
activity when expressed in Xenopus oocytes (Gimenez and Forbush, 2005).
Cotransport in response to hypertonicity was only affected when all three residues
were mutated, but these mutations had little effect on cotransport under isotonic or
hypotonic conditions. Flux of 86Rb in NKCC2 mutants that lack the SPAK binding
site was not affected, suggesting that this kinase is not required for phosphorylation
ofNKCC2 or that it is not required to bind the cotransporter to phosphorylate.
WNK3 has been implicated in the regulation ofNKCC2 function. This kinase is
most abundantly expressed in the brain and kidney. Co-injection ofWNK3 with
NKCC2 resulted in a three-fold increase in ion cotransport (Rinehart et al, 2005).
Measurement of phosphorylation with the R5 antibody showed increases on NKCC2,
especially under hypertonic conditions. Kinase-dead WNK3 mutants did not
produce the same effects on NKCC2 phosphorylation. This may suggest that SPAK,
in conjunction with WNK3, is involved in NKCC2 phosphorylation. Recently, it has
been observed that AMP-activated protein kinase (AMPK) phosphorylates mouse
NKCC2 on Ser126 and that these two proteins co-IP from mouse macula densa-
derived cells (Fraser et al, 2007). This serine residue was phosphorylated under non-
stimulated conditions and appears to be responsible for the maintaining the basal
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activity ofNKCC2. This serine is conserved in NKCC1 and it may be of interest to
examine the involvement of this residue and AMPK in NKCC1 regulation.
1.5.4 - Current Understanding of NKCC Phosphorylation
In the last few years, a great number of studies have produced a wealth of data to
help us understand the regulation ofNKCC cotransport by protein phosphorylation.
These have highlighted several kinases that are required for activation of the
cotransporter under hyperosmotic stress. We know that active WNK phosphorylates
and activates SPAK and OSR1 kinases, which in turn can then phosphorylate and
activate NKCC. However, these actions do not account for all phosphorylation seen
on the cotransporter. Figure 1.8 demonstrates some of the knowledge acquired with
respect to NKCC phosphorylation. This also indicates that there is still much to be
identified. SPAK and OSR1 appear to only act upon certain residues. The kinases
that are responsible for phosphorylation of the other known threonines have not yet
Detected
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Figure 1.8 - Phosphorylation of NKCC at the N-terminal Regulatory Locus
This diagram summarises the information thus far obtained about phosphorylation at




been identified. Total 32P incorporation indicates phosphorylation on serine residues.
Only one known serine residue on NKCC2 has been uncovered, but there may be
others. Although a great deal of understanding has been made, there is still much to
decipher, particularly in the response ofNKCC to different cotransport stimuli.
1.6 - Implications to Health and Disease
1.6.1 - Loop Diuretics
Perhaps the most important link between NKCCs and medicine is through the use of
"loop" diuretics as treatment to reduce fluid volume in the body. The most well
known loop diuretics are furosemide, bumetanide and benzmetanide. They are used
commonly in the USA to treat hypertension and furosemide is given to those with
heart or renal failure (Padilla et al, 2007). Torasemide has been used to reduce the
oedema that is associated with chronic congestive heart failure, renal disease, hepatic
cirrhosis and for use in hypertension treatment (Dunn et al, 1995; Friedel and
Buckley, 1991). This drug appears to be longer lasting than the other loop diuretics
and lower doses are required. However, there are side effects associated with the use
of these drugs. Among these are hyponatremia, hypokalemia, dehydration, tinnitus,
hearing loss, and vertigo. Perhaps, with greater understanding of cotransport
regulation, more specific anti-cotransport drugs could be developed, perhaps with
fewer side effects.
1.6.2 - Bartter's syndrome
In the early 1960s, Bartter described a new syndrome characterised by hypokalaemia,
alkalosis, hyperaldosteronism, polyuria, polydipsia, hypercalciuria, juxtaglomerular
hyperplasia (on renal biopsy), and normal or low blood pressure (Bartter et al, 1998).
Gill and Bartter (1978) noted that this defect was due to poor chloride reabsorption in
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the loop ofHenle and the effects of furosemide also resemble the syndrome (Unwin
and Capasso, 2006). Healthy individuals who were administered furosemide showed
increased urine output and this contained greater than normal levels of chloride
(Kockerling et al, 1996). Like patients with Bartter's syndrome hyperaldosteronism
and hypercalciuria were observed. Though it was clear that renal ion transport was
likely to be involved in this disease, it wasn't until 1996 that Simon et al linked
mutations in the gene for NKCC2 with Bartter's syndrome. However, other
mutations that affect the ability of the TAL to absorb salts can also produce similar
phenotypes (Gamba, 2005). For example, the apical inward rectifying K+ channel
(ROMK) and the basolateral chloride channel CLC-KB also result in Bartter's
disease. Failure of K+ recycling and intracellular CI" extrusion all function to prevent
NKCC2 activity in the kidney, and thus mutations to ROMK and CLC-KB have the
same effect as an NKCC2 mutation. NKCC2 knockout mice, generated by
Takahashi et al (2000) were severely dehydrated and failed to thrive. However,
when mice were treated with indomethacin those that survived showed features of
the Bartter's phenotype such as polyuria, hypokalemia, metabolic alkalosis and
hypercalciuria. Thus far, Bartter's syndrome is the only known human disease where
a mutation ofNKCC has been directly linked to illness.
1.6.3 - Blood Pressure
Both isoforms may have a role to play in the regulation of blood pressure. We know
that inactivating mutations to NKCC2 can result in hypotension (from Bartter's
syndrome and mouse knock-outs) and the converse, where activity of the
cotransporter is increased, could feasibly contribute to hypertension (Gamba, 2005).
Gordon's syndrome (Gordon, 1986), also named pseudohypoaldosteronism type II
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(Schambelan et al, 1981), is characterised by hypertension, hyperkalemia, and
metabolic hyperchloremic acidosis with normal glomerular filtration rate. It was
suspected that Gordon's syndrome was due to a gain-of-function mutation to the
NCC cotransporter, particularly as thiazide diuretics have been successfully used to
treat this syndrome, but no mutations to this protein have been found in Gordon's
patients (Gamba, 2005). However, mutations to WNK1 and WNK4 have been
linked to the syndrome (Wilson et al, 2001). WNK4 is a negative regulator of NCC
function and thus inactivating mutations would allow unchecked activity ofNCC in
the kidney, whereas WNK1 inhibits WNK4 in the kidney and activating mutations to
this kinase would produce the same effect (Xie et al, 2006). Yang et al (2007)
produced a knockin mouse model possessing a WNK4 mutation found in human
Gordon's patients. These mice showed the characteristic symptoms of Gordon's
syndrome and increased expression ofNCC at the distal convoluted tubule was
observed. The authors also found increased phosphorylation on SPAK/OSR1 and
NCC and suggest that the pathogenesis observed is due to increased function ofNCC
via activation of this phosphorylation pathway. Stiefel et al (2000) made some
interesting observations about NKCC activity in a patient with Gordon's syndrome.
This group studied red blood cells rather than renal tubular cells and found increased
NKCC activity in Gordon's syndrome compared with patients with essential
hypertension. They suggest that kidney NKCC activity may be inferred from their
results and that increased activity of this transporter may contribute to the pathology
of the syndrome. Increased NKCC cotransport has also been observed in red cells
from spontaneous hypertensive rats and patients with essential hypertension (Orlov
et al, 1999; Righetti et al, 1995). Further studies have implicated NKCC1 activity
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with hypertension, particularly with relation to vascular tone. Treatment of rats with
bumetanide resulted in a decrease in blood pressure, an effect that was not affected
by clamping of renal arteries (Garg et al, 2007). This, and evidence that the effect
was not observed in NKCCl-null mice, suggest that the effects of bumetanide on
blood pressure was due to inhibition ofNKCC1. The contractile effect of
phenylephrine on mesenteric arteries was reduced in the presence of bumetanide and
the authors concluded that NKCC1 has a role on smooth muscle tone in resistance
vessels. Importantly, hypertension caused by chronic phenylephrine administration
was successfully treated with bumetanide in rats. Orlov (2007) suggests that a
specific NKCC1 inhibitor could be useful for the treatment of hypertension.
1.6.4 - Inflammation
A number of studies now suggest that increased NKCC1 activity may be involved in
the pathophysiology of inflammatory disorders. Levels ofNKCC1 mRNA in human
vascular endothelial cultured cells were raised in response to inflammatory cytokines
(IL-ip and TNF-a) and in vivo in lung and kidney after administration of the
bacterial endotoxin lipopolysaccharide (LPS) to mice (Topper et al, 1997). These
authors also demonstrate that NKCC1 was upregulated in vitro in response to fluid
mechanical stress. Using apparatus that mimics the type of environment that
endothelial cells would be exposed to in the vasculature (i.e. blood flow), they
identified that NKCC1 expression was highest under conditions of steady laminar
flow. Reducing the force of flow, or turbulent conditions, caused a decrease in
NKCC1 mRNA levels. These findings implicate the involvement of the
cotransporter in vascular homeostasis as well as inflammation. In addition to these
findings, other groups have implicated NKCC1 in specific inflammatory disorders.
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Eight-fold increases in NKCC1 expression have been found in bronchial biopsies
from asthmatic patients (Dolganov et al, 2001). Increased expression was confined to
goblet cells, as shown by immunohistochemistry. This, and the observation that
inhaled furosemide has beneficial effects in asthmatic patients (Niven and Argyros,
2003; Pendino et al, 1998), strongly suggest the involvement of the cotransporter in
this inflammatory condition. The expression ofNKCC1 in spinal sensory neurons
and dorsal root ganglion (DRG) was found to be altered in mice with either chronic
or acute arthritis (Morales-Aza et al, 2004). NKCC1 expression was reduced in
DRG and increased in spinal sensory neurons in both chronic and acute arthritis. The
authors suggest that this may result in neuronal excitability and that NKCC1 could be
a potential therapeutic target for inflammatory pain treatment. Bacterial pneumonia
in mice (by introduction of Klebsiella pneumoniae) can lead to sepsis and
hypothermia, effects which are not observed in NKCCl-null mice (Nguyen et al,
2007). It was observed that although the total neutrophils present in the lung were
not different from wild-type more of these cells were present in the alveolar spaces
ofmutant mice. Through evidence from further experiments, the authors propose
that loss ofNKCC1 results in altered trafficking of neutrophils to the site of
infection, reducing bacterial load and protection against the secondary effects of
sepsis and hypothermia. Interestingly, K. pneumonia-induced peritonitis showed the
same severity and progression as found in wild-type mice, suggesting that the effects
of blocking NKCC1 activity are only protective against lung infection.
1.6.5 - Ischaemia
NKCC1 has been implicated in cerebral ischaemic injury. NKCCl-null mice
showed less infarct volume and neuronal cell death after induced focal ischaemia
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(Chen et al, 2005). These neuroprotective effects were mimicked in wild-type mice
that were treated with bumetanide (O'Donnell et al, 2004). Pond et al (2006)
showed that oxygen-glucose deprivation, which is an in vitro model of ischemia,
induced CI" uptake into neurons in mouse hippocampal slices. Rises in [CP]/ were
observed during reoxygenation, along with increased phosphorylation on NKCC1.
Increased neuronal [CP], was shown to be necessary and sufficient for cell damage
after oxygen-glucose deprivation, an effect which was reduced by treatment with
bumetanide or furosemide. This is of clinical interest, where treatment of stroke
patients with a loop diuretic (or an as yet undiscovered NKCC1 inhibitor) could help
reduce the pathology associated with oedema.
1.7 - Experimental Approaches
1.7.1 - The red cell as a model
There are several reasons to use the red blood cell to study Na-K-Cl cotransport.
Apart from variability in age, cell populations are fairly homogeneous and have a
single compartment, making measurements of cotransporter activity simpler to
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understand. Radioactive rubidium ( Rb) is transported by NKCC in place of
potassium and is used to trace the movement of ions. They are easy to manipulate
pharmacologically in the test tube and are also easy to acquire and separate from
other cell types. Much of the early work into the features of cotransport was
conducted in avian red cells (Muzyamba et al, 1999; Lytle, 1997; Pewitt et al, 1990).
Ferret red blood cells offer the opportunity to examine NKCC from the mammalian
viewpoint. They show a thirty-fold higher rate of cotransport compared with those
from human, rat, and guinea pig (Lytle, 2003) and possess little, if any, Na+ pump
activity (Flatman, 1983). This allows study of cotransporter without the need for
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ouabain, and makes interpretation of flux results less complicated. Ferret red blood
cells are used in this work as the major source of NKCC. As red blood cells are
anuclear and do not possess the machinery capable of producing new protein, the
genetic component ofNKCC activity cannot be measured. In some ways this is a
disadvantage, but in others it is advantageous. We cannot decipher the components
involved with gene up-regulation and protein-trafficking that are features of
cotransporter regulation in other cell types. However, because these features are not
present in the red blood cell we are able to examine the effects that protein-protein
interactions and post-translational modifications may have on cotransport with less
complication.
As mentioned previously, it may be possible to use the red cell as an aid to diagnose
diseases, where cotransport in these cells may reflect cotransport in the kidney
(Righetti et al, 1995). If this is the case, then the red blood cell may offer a simpler
and more patient-friendly biopsy sample compared with the kidney.
1.7.2 - Rationale for Methods Used
The standard approach to investigating phosphorylation on a protein is to measure
• • ^9
the incorporation of radioactive P. This approach, coupled to phospho-labelled
peptide isolation and sequencing have identified residues that are phosphorylated on
the cotransporter. Another method is by the separation of proteins in two-
dimensions, based on their isoelectric point (pi) and molecular size, which should
allow resolution of proteins with different post-translational modifications such as
phosphorylation. The addition of a phosphate group to a protein adds only 80
Daltons, a change which is not likely to be detectable on standard SDS-PAGE (the
second dimension) (Mann et al, 2001). However, the change that addition of a
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phosphate brings to the pi of a protein is theoretically detectable in the first
dimension (isoelectric focussing). Along with the use of phospho-specific
antibodies, this thesis presents evidence that NKCC with different numbers of
phosphate groups is detectable with this method. Phosphorylation of
immunoprecipitated cotransporter is also investigated by the use of the same
phospho-specific antibodies, as well as those to total phosphothreonine. This allows
measurement of global changes in NKCC phosphorylation in response to a number
of different stimuli. To look for proteins that interact with NKCCs, perhaps in a
regulatory capacity, co-immunoprecipitation experiments were performed. In
conjunction with mass spectrometry and western blotting certain NKCC interacting
proteins identified in other cell types have been confirmed in the ferret erythrocyte.
Finally, molecular biological techniques were employed to verify the isoform present
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Chapter 2 - Materials and Methods
The majority of reagents commonly used throughout this project were sourced from
either Sigma-Aldrich (St. Louis, MO) or BDH Laboratory Supplies (from Merck,
Germany), choosing analytical grade options where available. A list of these
reagents and supplier information is given at the end of this chapter. Other reagents
and kits are given within the method descriptions. Unless otherwise stated, aqueous
solutions were made up with double glass-distilled water or ElixlO grade Millipore
water.
2.1 - General Methods
2.1.1 - Centrifugation
Several centrifuge instruments were used to provide all of the conditions required.
An Eppendorf MiniSpin Plus bench-top microfuge was used for most purposes. To
spin samples of larger volume, and those that required to be kept cool, a Sorvall RC
26 Plus with an SS34 fixed-angle rotor or Biofuge Stratos (Heraeus Instruments)
with fixed-angle (#3335) or swing-out (#8172) rotors were used. Both instruments
are refrigerated. High speed centrifugation was achieved using a Beckman TL-100,
which is capable of speeds up to 300,000 x g. The relative centrifugal field (RCF) or
g value is calculated using the following equation:
where r = the radius in centimetres from the centre of the rotor to the sample and
rpm = the speed of the rotor in revolutions per minute (Dawson et aU 1986).
g = RCF = 1.18 x 10 5 x r x rpm2
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2.1.2 - Spectrophotometry
An UltroSpec 2000 from Pharmacia Biotech was used for determining both protein
and nucleic acid content of samples. This is a UV/visible spectrophotometer,
allowing measurement ofwavelengths from 190-1 lOOnm. For protein assays,
absorbance at a specified wavelength was measured. Nucleic acid quantification is
measured using absorbance at 260nm. Absorbance (A) is defined by Beer's Law:
A = dc
where s = molar absorption coefficient with units of L mof1 cm"1, / = pathlength in
centimetres and c - the concentration of the solution in mol L"1 (Dawson et al, 1986).
In a 1cm pathlength, a solution ofDNA or RNA with an absorbance of 1.0 has a
concentration of 50 or 40pg/ml, respectively (Maniatis et al, 1982). These rules can
be applied to calculate a nucleic acid concentration from a measured absorbance.
Sample purity is assessed by the ratio of absorbance at 260nm (nucleic acid) to
absorbance at 280nm (protein). For pure DNA, the absorbance ratio is 1.8. For pure
RNA, this ratio is 2.0. In all cases, quartz cuvettes with a 1cm pathlength were used.
2.1.3 - Analysis of 1- and 2-Dimensional Gel Images
TotalLab and 2DEvolution software packages were used to analyse 1- and 2-
dimensional gel images and western blots. Both of these programs were developed
by Non-linear Dynamics, UK. For 1-D images, TotalLab software allowed
molecular weight estimation by log-linear interpolation from markers of known
mass. Optical density values were also obtained from this program. Molecular
weights were estimated on 2-D images using 2DEvolution software, which has since
been renamed Progenesis, in the same method as for 1-D images. Estimation of
isoelectric point for proteins on 2-D gel and western blot images was achieved by
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interpolation from the pH range of the first dimension gel strip, taking into account
those sections that are lost on the strip when cutting to fit the second dimension
sample well. Although the strip manufacturer states that separation occurs from pH
4-7, the actual measured range is pH 4.3-6.3 as calculated from data provided by the
strip manufacturer.
2.1.4 - Statistical Analysis
The GraphPad QuickCalcs online calculator (which is available from
www.graphpad.com/quickcalcs/ttestl.cfm) was used to conduct two-tailed unpaired t
tests. This program calculates the mean (X), standard deviation (<7) and standard
error of the mean (SEM) from two sets of data. It reports a p-value allowing
decisions to be made about any significant differences between the means of the two
sets of data. Where average molecular weights are shown in the results sections,
they are given as mass ± standard deviation. Unless otherwise stated in the text,
mean phosphorylation level (± standard deviation) refers to the mean
phosphorylation from (n) different animals where the phosphorylation level from any
one animal has been averaged from replicate determinations.
2.2 - Tissue and Membrane Preparation
2.2.1 - Blood
Human blood was drawn from the median cubital vein in the forearm. Rat blood was
obtained from animals after being Schedule 1 sacrificed. Ferret blood was obtained
by cardiac puncture after animals were given a lethal dose of Sagatal (pentobarbitone
sodium B.P. 130 mg kg"1, Rhone Merieux). Blood was immediately mixed with 4
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mM EDTA, to chelate divalent cations required for enzymes of the blood coagulation
cascade. All animal work was in accordance with Home Office guidelines.
2.2.2 - Preparation of Membranes from Ferret, Rat and Human Erythrocytes
Packed cells were diluted with ferret basic medium (FBM; 145 mM NaCl, 5 mM
KC1, 0.05 mM EGTA, 10 mM HEPES, pH 7.5 (neutralised with NaOH)) containing
11 mM D-glucose to give a cell suspension at approximately 10% haematocrit. The
suspensions were incubated at 38°C (ferret) or 37°C (rat and human) for 10 minutes,
with continuous gentle stirring. Pharmacological stimuli were applied after this time.
The different conditions used are described in Table 2.1. Cell suspensions were
transferred to test tubes and spun at 2,500 x g (4°C) for 5 minutes to separate the
Concentration Incubation period
Calyculin A 50 nM 15 minutes
Na Arsenite 1 mM 60 minutes
Untreated - 10-30 minutes
PP1 20 or 50 pM 30 minutes
Mg2+ free
2 mM Tris-EDTA (TE), 10 pM
A23187
TE 15 minutes, then A23187 15
minutes
Genistein 50 pM 20 minutes
Staurosporine 2 pM 20 minutes
Table 2.1 - Pharmacological Stimuli
Calyculin A is an inhibitor of protein phosphatases 1 and 2A. General kinase inhibition is
mediated by removal of Mg2+ by Tris-EDTA and the mobile ion-carrier A23187 (Flatman
and Lew, 1980). PP1, genistein and staurosporine are potent kinase inhibitors.
Staurosporine inhibits a wide number of kinases. Genistein is a tyrosine kinase inhibitor
and PP1 inhibits Src-family tyrosine kinases. In all cases, the solvents used to dissolve
the various compounds were found not to cause cell lysis or interfere with NKCC activity
and are described in papers by Flatman and Creanor (1999a and 1999b).
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cells from sample medium. Cells were cooled on ice before being passed through a
19 gauge needle into 20 volumes of ice-cold red blood cell lysis buffer (1 mM (3-
glycerophosphate, 10 mM HEPES, 2 mM EDTA, 2 mM Na pyrophosphate, 1 mM
Na vanadate, 2 mM NaF, pH 7.6), with 1% protease inhibitor cocktail III
(Calbiochem) and stirred continuously for 10 minutes. Sodium fluoride, P-
glycerophosphate, sodium pyrophosphate and sodium vanadate are all included as
protein phosphatase inhibitors (Jaumot and Hancock, 2001; Gordon, 1991). Lysates
were spun at 25,000 x g (4°C) for 10 minutes and supernatant discarded. Recovered
membranes were washed twice more by resuspension in ice-cold lysis buffer
(without protease inhibitors) and centrifugation (25,000 x g, 4°C). All of the
solutions during lysis and membrane recovery were kept ice-cold to ensure that the
membranes did not reseal (Wood, 1987). The final membrane pellet volume was
measured and protease inhibitor cocktail added to give 2% final concentration. All
samples were stored in liquid nitrogen until use. This protocol was adapted from
Flatman and Creanor (1999) and Matskevich et al (2005).
2.2.2.1 - Preparation of Sodium Vanadate
Stock solutions of 200 mM sodium vanadate (Na3V04) were prepared in the
following way. Na3V04 powder was dissolved in boiling water and allowed to cool.
The pH of the solution was measured and adjusted to pH 10 with HC1. This step
produces a colour change (to orange), which indicates the presence of decavanadate.
The solution was boiled again until colourless, and then allowed to cool. The pH
was measured and adjusted as before if necessary. The boiling, cooling and pH
adjustment steps were repeated until the solution was stable at pH 10 to ensure the
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presence ofmonovanadate (Gordon, 1991). Aliquots were stored frozen until
required for use.
2.2.3 - Deoxygenation of Erythrocytes
Ferret erythrocyte cells were deoxygenated according to Flatman (2005). Cells in
FBM/glucose (at 10% haematocrit) were incubated for 30 minutes at 38°C in a
tonometer (Eschweiler, Kiel, Germany) that had been gassed with water-saturated
argon. The final PO2, measured with a Clark polargraphic oxygen electrode with a
polypropylene membrane in thermostatic flow through cell and meter (Strathkelvin
Instruments, Scotland), was less than 3mm Hg. After this period, cells were taken
for membrane preparation as described in section 2.2.2. However, all solutions and
centrifuge tubes were purged of oxygen with argon gas prior to addition of any cells
or membranes. Cells were passed into cell lysis medium with a gas-tight syringe
(Hamilton, USA).
2.2.4 - Salivary Gland and Kidney Membrane Isolation
Salivary glands and kidneys were carefully removed and stored cold in phosphate
buffered saline (PBS; 137 mM NaCl, 10 mM Na2HP04,1.7 mM KH2P04, 2.7 mM
KC1, pH 7.4) until ready for dissection. Kidneys were dissected to isolate as much
medulla as possible, an area which is indicated in Figure 2.1. Following a protocol
adapted from Nielsen et al (1998), the separated tissues were homogenised with a
Powergen 125 homogenizer (Fisher Scientific, UK) in membrane isolation solution
(250 mM sucrose, 10 mM triethanolamine, 2% protease inhibitor cocktail).
Homogenates were spun at 1,000 x g for 10 minutes (4°C) and the supernatants
separated from the pellets. The pellet material was resuspended in membrane
isolation solution, and then spun again at 1,000 x g. The supernatants were pooled
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and spun at 17,000 x g for 20 minutes (4°C) to pellet the crude membrane fraction.
These were mixed with protease inhibitors (at 2% final concentration) and stored in
liquid nitrogen until required. This protocol was also used to recover cell
membranes from bone marrow cells.
Figure 2.1 - Kidney dissection
This indicates the area dissected from all kidney samples
for protein and nucleic acid isolation. As far as possible,




2.2.5 - Bone Marrow Preparation
Rat femurs were dissected from surrounding tissues and the knee and hip joints
removed. A needle was inserted into the bone and PBS was flushed through with a
needle (gauge varied depending on size of bone) and marrow collected. Any pieces
of bone were carefully removed and then the bone marrow-PBS mix was triturated
through a pipette tip several times to create a more uniform cell suspension.
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2.2.6 - Separation of Erythrocytes using a Percoll® Gradient
Whole blood was centrifuged at 2,500 x g for 5 minutes and the plasma removed.
The first few millilitres of cells which contain the most buoyant red cells and white
blood cell layer were recovered and set aside. The remaining blood was mixed and
spun again and the top few millilitres added to those cells recovered earlier. Percoll®
was prepared with NaCl to give a density of 1.090 g/ml in 0.15 M NaCl, following
If'. ] m "-t
White blood cells
Buoyant red blood cells
Mature red blood cells
Figure 2.2 - Percoll® Separation of Human Blood Cells
After centrifugation, cells separate into discrete bands. The
uppermost liquid and white cell layers were removed before
careful pipette removal of the buoyant red blood cell layer. Cells
can be separated from the Percoll® by washing in PBS and
collected by centrifugation for further study. Both white and
buoyant red blood cells were collected.
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instructions in the Pharmacia publication, Percoll®, Methodology and Application.
A gradient was prepared by spinning a tube of diluted Percoll18' at 20,000 x g for 20
minutes in a fixed angle rotor. After this time, the pooled cells were carefully
layered on top using a pipette, and spun in a swing-out rotor for 25 minutes at 1,000
x g. Figure 2.2 shows the separation of these cells. The most buoyant red cells and
white cells were carefully removed and washed by resuspension in 0.9% NaCl and
centrifugation at 200 x g for 10 minutes. The recovered cells were kept for RNA
extraction, which is described in section 2.9.2.
2.3 - Protein Estimation
Two different assays were used to estimate the protein content of samples. For most
situations, the Pierce BCA (bicinchoninic acid) assay was used. This is a
colorimetric assay where Cu+2 is reduced to Cu+1, with which the BCA forms a
complex. This complex is purple in colour and is detectable at 562 nm, using a
spectrophotometer. For samples containing substances that interfere with the BCA
assay (such as urea, detergents and reducing agents), the 2-D Quant Kit from GE
Healthcare Life Sciences (formerly Amersham Biosciences) was used. This assay
precipitates proteins, leaving interfering substances in solution for easy removal.
The protein is then resuspended in a copper-containing solution. As copper ions bind
to the peptide backbone of protein, any unbound ions are reacted with a colorimetric
agent, and measured at 480 nm. Protein concentrations were estimated by
interpolation of standard curves drawn from known protein standards, using
GraphPad Prism 4.00 software. Examples of these curves are given in figure 2.3.
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Standard Curve for BCA Standard Curve For 2D Quant
P9/ni BSA ng BSA
Figure 2.3 - Standard curves obtained from known protein standards for BCA and 2D
Quant protein assays
From these curves, the absorbance of test samples can be related to an amount of protein or
a protein concentration (usually bovine serum albumin, BSA). This is calculated
automatically by the GraphPad Prism software using linear regression for 2D Quant standard
curves and non-linear regression for BCA standard curves. The r2 values show the
correlation between the regression line the real data points (where r2 = 1.0 is a perfect fit).
2.4- One-Dimensional Electrophoresis and Protein Detection
Electrophoresis is the term used to describe the movement of charged particles in an
electric field. In this project, various different electrophoretic techniques were used
for the separation of proteins and are described here.
2.4.1 - Sodium Dodecyl Sulphate-Polyacrylamide Gel Electrophoresis (SDS-
PAGE)
This process involves heat-denaturing proteins and coating them with SDS (or LDS;
lithium dodecyl sulphate) molecules. This overrides any inherent charge that a
protein may have. When an electric field is applied, the negatively charged
molecules move towards the anode through a gel matrix. This allows separation of
proteins based on their molecular mass. In most circumstances, pre-cast NuPAGE™
gels (8cm x 8cm, 1mm thick) were used with the XCell SureLock™Mini-cell
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electrophoresis module from Invitrogen. NuPAGE™ 4-12% Bis-Tris or, for better
separation of larger proteins, 3-8% Tris-Acetate gels were used. Samples were
prepared for electrophoresis by heating at 70°C for 10 minutes with LDS sample
buffer (Invitrogen) and 100 mM DTT. LDS is preferred, as it protects proteins from
peptide bond cleavage that may occur when samples are boiled with SDS (Kubo,
1995). The different gel types required different running conditions and these are
listed in Table 2.2. Large home-cast gels were prepared, and run, using the SE 600
Ruby standard dual cooled gel electrophoresis unit (Amersham Biosciences) and the
Gel type Buffer Running parameters
3-8% Tris-acetate Tris acetate SDS running buffer 150V constant for 1 hour
4-12% Bis-tris MES SDS running buffer 200V constant for 35 minutes
4-12% Bis-tris MOPS SDS running buffer 200V constant for 50 minutes
Table 2.2 - Denaturing SDS-PAGE running conditions using NuPAGE gels
Hoefer SG 100 gradient maker. The composition of these gels was 4-12%
acrylamide (using a 40% acrylamide/N,N'-methylenbisacrylamide solution from
Bio-rad), 0.1% SDS, 375 mM Tris-HCl (pH 8.8) and polymerised with 0.1%
ammonium persulphate (APS) and 0.04% TEMED. Stacking gels (4% acrylamide)
were prepared in the same way, but with Tris-HCl at pH 6.8.
2.4.2 - Staining
To visualise protein on gels, several stains were used. For low abundance protein
detection either the PlusOne Silver Staining Kit (Amersham) or the fluorescent
SYPRO® Ruby stain (Bio-rad) were used. In most other cases, the colloidal
Coomassie stain GelCode Blue (Pierce) was used. A home-prepared Coomassie
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stain was also used. For this, gels were fixed (35% isopropanol, 10% acetic acid for
1 hour) and then stained with 0.15% Coomassie blue R-250 in fixative (Sigma-
Aldrich) for 15 minutes. To visualise the proteins, the gels were incubated for 15
minutes in 50% ethanol, 7.5% acetic acid, 5% glycerol. To give the best image,
three further 20 minute washes were conducted using 5% ethanol, 7.5% acetic acid,
5% glycerol (protocol adapted from Hartinger et al, 1996). Images were captured on
an Epson Perfection 3200 Photo scanner in transmission mode, except for SYPRO®
Ruby stained gels, in which case the Typhoon™ variable mode imager (GE
Healthcare) or with the Gene Genius Bio Imaging System (Syngene, Ltd.) using the
transilluminator mode were used.
2.4.3 - Protein Molecular Weight Estimation
To assist in molecular weight estimation, protein standard markers were run
alongside samples during electrophoresis. The HiMark™ protein standard was used
for Tris-acetate SDS-PAGE only, and allows more reliable calculation of higher
molecular weight proteins. Markl2™ and SeeBlue® Plus2 were used on Bis-tris
gels, using either MES or MOPS buffers. Figure 2.4 demonstrates how these
markers look after staining. TotalLab software (Nonlinear Dynamics, UK) was used
to calculate molecular mass of sample proteins, by interpolation ofRf values
compared with standards. Log-linear interpolation was used for each, except when
HiMark was used to estimate molecular weight. In these cases the Invitrogen
HiMark MW calculator was used (Excel file downloadable from
www. invitrogen.com).
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Figure 2.4 -MolecularWeight Standards for SDS-PAGE Gels
The left panel demonstrates the separation of molecular weight markers using 4-12% Bis-tris
gels (SeeBlue® Plus2 and Mark12™) or 3-8% Tris-acetate NuPAGE™ gels (HiMark™) and
are shown after staining with GelCode Blue (Pierce). The right panel shows an example of a
log-linear curve fit to the SeeBlue® Plus2 protein ladder obtained using TotalLab software.
2.4.4 - Western Blotting
Western blotting (or immunoblotting) involves transferring proteins from a gel
matrix onto an inert platform such as nitrocellulose or polyvinylidene fluoride
(PVDF). After this, antibodies are used to detect proteins of interest. With the use of
chemiluminescent reagents, specific proteins can be detected by exposure of
photographic film to these light producing chemicals. The general protocol for
blotting is described, with a list of antibodies used given in Table 2.3. Proteins
separated by SDS-PAGE were transferred onto 0.45pm pore size Invitrogen
nitrocellulose or PVDF, using the XCell II™ Blot Module in the XCell SureLock™
electrophoresis module from Invitrogen. Transfer was conducted at 30V (constant)
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for 1.5 hours with Invitrogen transfer buffer, containing a proprietary antioxidant and
0.05% SDS. After transfer, membranes were blocked for 1 hour with 5% non¬
specific protein in Tris-buffered saline (40 mM Tris base, 270 mM NaCl, pH 7.6)
with 0.1% Tween 20 (TBS-T). In most cases, the protein used was milk (Marvel).
However, some antibodies will not bind their targets in this mix and so bovine serum
albumin (BSA, fraction V, Merck) would be used in these instances. Primary
antibody was added and the blots were incubated at room temperature for 1 hour or
overnight at 4°C, with gentle rocking. These were washed three times in TBS-T,
before an hour-long incubation with horseradish peroxidase-conjugated secondary
antibody (in 5% protein, TBS-T). After final washes, the blots were treated with
Enhanced Chemiluminescence (ECL) or ECLplus reagents (GE Healthcare Life
Sciences). Amersham Hyperfilm™ ECL™ (GE Healthcare Life Sciences) was
placed onto the membranes in a light-proof cassette and then developed in the
Konica SRX-101A X-ray processor. In order to estimate molecular mass of proteins
on western blots, special protein standards are required. The Biotinylated Protein
Ladder from Cell Signalling Technology and MagicMark™ XP Western Protein
Standard from Invitrogen were used. Figure 2.5 shows how these markers look on a
photographic film after chemiluminescent detection.
2.4.5 - Western blot analysis
Photographic images were scanned on transparency mode using the Epson Perfection
3200 Photo scanner and analysed using TotalLab image analysis software (Nonlinear
Dynamics, UK). This software allows calculation ofmolecular mass (by
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extrapolation from protein standards) as
quantitation of detected bands.
Materials and Methods
as background subtraction and
Figure 2.5 - Molecular weight standards used for western blotting
The left panel shows chemiluminescent detection of a biotinylated protein ladder (BPL)
from Cell Signaling Technology and the MagicMark™ XP ladder from Invitrogen (XP)
separated on 3-8% Tris-acetate gels. The right panel shows an example of curve
fitting using TotalLab software to the BPL molecular weight standards after separation
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Antibody Name Target Source Block Immunoblot
Dilution
T4
NKCC1 and NKCC2 C-
terminus Hybridoma Bank 5% milk
1 in 4000
N1 NKCC1 N-terminus CovalAb 5% milk 1 in 4000




5% milk 1 in 4000
IVF12
Band 3 erythrocyte anion
exchanger Hybridoma Bank








10% milk 1 in 100
Anti-PP1 Protein phosphatase 1 UpstateBiotechnology


























5% BSA 1 in 500
NKCC-P
NKCC phosphorylated
on T203, T207 and T212
Gifted from Alessi,
Dundee
10% milk 1 in 300
R5
NKCC phosphorylated
on T212 and T217
Gifted from
Forbush, USA
5% milk 1 in 5000




5% milk 1 in 10000




5% milk 1 in 10000
Goat anti-sheep Sheep IgG UpstateBiotechnology
5% milk 1 in 1500
Table 2.3 - Antibodies used in western blot
Primary and secondary antibodies are shown here, with their western blot dilutions. Block refers to the
solution the antibody and blot membrane are incubated in during the procedure. Threonine phosphorylated
residues are numbered from human NKCC1.
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2.5 - Two-Dimensional Electrophoresis (2-DE)
Two-dimensional electrophoresis involves separation of proteins by one method,
then a second separation using another. The most common approach is to first
separate proteins based on their isoelectric point (pi) by isoelectric focusing (IEF),
and then to separate these by size, using SDS-PAGE. Often, sample fractionation
procedures can greatly improve the final picture, by reducing sample complexity.
Liquid-phase IEF can be performed using the Invitrogen ZOOM® IEF Fractionator,
and allows collection of proteins within a given pH range. Another approach is to
separate protein complexes by native PAGE. Followed by SDS-PAGE, the
individual proteins within these complexes can be resolved. These different methods
are described individually.
2.5.1 - IEF and SDS-PAGE
An IEF/SDS-PAGE 2-DE protocol was already developed in our laboratory derived
from "2-D Electrophoresis using immobilized pH gradients: Principles and
Methods", which is an Amersham Biosciences publication. The starting protocol is
given, with adaptations listed in Table 2.4. The adaptations made to this protocol are
described in chapter 3.
2.5.1.1 - Sample Preparation
Erythrocyte membrane samples were spun at 100,000 x g for 15 minutes (at 4°C) in
order to pellet membranes from any solution. After removal of supernatant, the
pellet was resuspended in 140pl rehydration solution (7 M urea, 2 M thiourea, 1%
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IPG buffer (Immobilised pH Gradient; Amersham), 0.5% ASB 16, 4% CHAPS, 1%
NP 40, 1 mM EDTA, and trace bromophenol blue) containing 5 mM iodoacetamide
and 2% protease inhibitor cocktail III in order to block the actions of proteases.
Proteins were solubilised by 30 minute incubation at room temperature. DTT was
Change to Protocol Rationale
Reduced IEF sample volume from 140fil
to 125jxl
Protocol exceeded maximum volume capacity
of IPG strip
Reduced protein content of IEF sample
to maximum of 100jxg
Maximum protein recommended for 7cm IPG
strip
Protein overload can cause precipitation in IPG
strip
Altered detergent composition of
solubilisation/rehydration solution
To improve solubilisation of membrane
proteins
Addition of Tris base to IEF sample
solution
For full range protein solubilisation
ZOOM® fractionation (liquid phase IEF)
of sample prior to 2-DE
To concentrate and simplify protein sample to
allow better chance of finding Na-K-2CI
cotransporter
Table 2.4 - Adaptations to Isoelectric Focusing Protocol
These changes were made to the standard IEF protocol given and then the resultant 2D
picture compared to the original.
added to give a final concentration of 160 mM and incubated at room temperature for
68
Chapter 2 Materials and Methods
a further 60 minutes. Remaining insoluble material was removed by centrifugation
at 14,000 x g for 10 minutes and the supernatant taken for isoelectric focusing.
2.5.1.2 - First Dimension Isoelectric Focusing
Samples were loaded onto ceramic strip holders (Amersham) and any bubbles
removed. Amersham pH 4-7 Immobiline DryStrips were gently placed on top of the
protein samples and then covered with Immobiline DryStrip cover fluid (Amersham).
IEF was performed with the IPGphor unit (Pharmacia Biotech) using the following
parameters: 30 minutes with no voltage (rehydration), 50V step for 12 hours (active
rehydration), the voltage was then increased to 2000V over 4 hours, and then stepped
up to 4000V step for 6 hours. The first 12.5 hours are to allow sample entry to the
strip, and are conducted at low voltage to prevent aggregation. The first gradient
allows a more gentle start to the focusing process, which is followed by the step-and-
hold high voltage. This allows the proteins to reach their isoelectric point and
prevents diffusion from this.
2.5.1.3 - Equilibration
At the end of the isoelectric focussing period, strips were carefully removed from
their holders and immersed in equilibration buffer (6 M urea, 4% SDS, 30% glycerol,
50 mM Tris-HCl pH 6.8) to remove the DryStrip cover fluid, and gently rocked at
room temperature in equilibration buffer containing 50 mM DTT for 45 minutes (to
reduce cysteine residues). This step was repeated with fresh buffer and DTT for 30
minutes. The strips were then washed in equilibration buffer with 150 mM
iodoacetamide by gentle rocking for 15 minutes (to alkylate reduced cysteine
residues). The equilibration buffer was pre-warmed (60°C) before adding the strips
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and then allowed to cool to room temperature during the various incubations. Strips
were cut to fit the second dimension gel loading well.









Figure 2.6 - Diagram representing the layout of the second dimension SDS gel
The IEF gel (or native gel) is placed into the sample well and gently pushed down to
make contact with the SDS gel at all points. The presence of the running buffer allows
easier movement of the gel strip. Gentle pushing onto the top of the gel helps to
remove bubbles. This ensures the current flows through properly and gives a greater
chance that the proteins in the strip enter the SDS gel. Strips were always loaded with
the high MW or high pH end next to the marker lane to allow easier comparison of
gels.
2.5.1.4 - Second Dimension SDS-PAGE
Equilibrated IEF strips were loaded onto NuPAGE™ mini-gels or home-cast 14 x
14cm gels, as depicted in Figure 2.6. Running buffer appropriate to the NuPAGE™
gel used (see Table 2.2) was then added to the anode tank and molecular weight
markers were loaded. Only then was the cathode tank filled. Regardless of the gel
type, electrophoresis was conducted at 20mA for 20 minutes, then at 40mA until the
dye front had reached the bottom of the gel. The lower voltage at the start of the run
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was to assist in the transition of proteins from the IEF strip to the separating gel.
After electrophoresis, the gels would be stained or processed for western blot.
2.5.2-ZOOM® IEF
This involves fractionation of protein samples using liquid-phase isoelectric
focusing, which allows separation of proteins into a discrete pH range and maximises
the amount of total protein that can be applied to narrow range IPG strips (Zuo and
Speicher, 2000). Membrane protein samples were prepared by solubilisation (30
minutes, RT) in IEF denaturant (7 M urea, 2 M thiourea, 3% CHAPS, 1% NP-40, 1%
ASB-16, 1 mM EDTA), 2% protease inhibitor cocktail, 20 mM DTT and 10 mM
Tris (all concentrations are for the final mix). The detergent concentrations for this
protocol were adapted from information supplied with the kit and as such differ
slightly from the IEF solubilisation buffer presented in section 2.5.1.1. N,N-
Dimethylacrylamide (DMA) was added (to give approximately 50% final
concentration) and incubated at room temperature for 30 minutes. To quench, DTT
(20 mM final concentration) was added and the sample incubated for 5 minutes (RT).
The reduced and alkylated lysate was centrifuged at 14,000 x g for 20 minutes (RT)
and an aliquot of the supernatant removed for protein concentration determination.
The remaining supernatant could then be prepared for ZOOM fractionation, by
addition ofDTT (10 mM), ZOOM® Carrier Ampholytes, pH 3-10 (Invitrogen) and
dH20. A trace amount of bromophenol blue was also added. Five samples were
prepared, giving one for each sample chamber. Figure 2.7 shows a representation of
the ZOOM® IEF Fractionator kit. Fractionation was at 100V for 20 minutes, 200V
for 80 minutes and then 600V for 80 minutes, as recommended by the manufacturer
(Invitrogen). Samples were easily collected from the chambers for further study. By
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addition of the appropriate IPG buffer (Amersham) these can be used directly for gel
based IEF, which was conducted using 7cm Immobiline DryStrips of single pH units
(e.g. pH 5.3-6.3). For one-dimensional SDS-PAGE and immunoblot applications,
the proteins were first precipitated from the mix (using the SDS-PAGE Clean-Up Kit


























Figure 2.7 - Representation of the ZOOM IEF Fractionator
Solubilised protein samples are added to the sample chambers, which are separated by
pH disks. When the current is applied the proteins migrate through the chambers until
they reach their isoelectric point. They then will not pass beyond a particular pH cut-off.
After electrophoresis, the samples can be recovered and used in downstream
applications.
2.5.3 - Blue-Native Polyacrylamide Gel Electrophoresis (BN-PAGE)
This form of electrophoresis maintains the native state of proteins allowing
separation of non-denatured proteins and the complexes they may be in with other
proteins. Coomassie G-250 is used to bind and charge the proteins for
electrophoresis. The Invitrogen NativePAGE™ system was used which was adapted
from work by Schagger and von Jagow (1991). There are several advantages to
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using this system. Firstly, gels are bought pre-cast which reduces user error.
Secondly, the gels are Bis-tris rather than Tris-glycine. This allows the experiment
to be conducted at near neutral pH, which increases protein complex stability and
resolution (Invitrogen, 2006). Erythroctye cell membranes (200pg) were gently
mixed with NativePAGE™ sample buffer (Invitrogen) and 2% dodecylmaltoside
(Fluka) and incubated on ice for 15 minutes. After centrifugation at 20,000 x g for
30 minutes (4°C), the soluble protein supernatant was mixed with NativePAGE™ G-
250 sample additive (Invitrogen) to give a final G-250 concentration of 0.5%. Pre¬
cast 3-12% NativePAGE™ Bis-tris gels were loaded with sample, alongside High
MW Calibration Kit for Native Electrophoresis (Amersham) standards. The cathode
chamber was filled with NativePAGE™ running buffer that was mixed
NativePAGE™ Cathode additive. This gives a buffer with 0.02% G-250 included.
The anode chamber was filled with NativePAGE™ running buffer with no G-250
added. Electrophoresis was at 150V constant. Once the dye front had run into the
first third of the gel, the cathode buffer was exchanged for buffer that contained only
0.002% G-250. Electrophoresis then continued until the free dye had run off the
bottom of the gel. Bands were excised and digested with Promega sequencing grade
trypsin (for HPLC-MS as described in section 2.7.2), western blotting was conducted
(described in section 2.4.1) or entire lanes were excised and prepared for second
dimension SDS-PAGE. This was achieved by several incubations at room
temperature. Sample reduction was by 20 minute incubation in Invitrogen LDS
sample buffer plus 50 mM DTT. Alkylation was as above but with LDS sample
buffer plus 50 mM DMA. Finally, this reaction was quenched by 15 minute
incubation in LDS buffer, 20% ethanol and 5 mM DTT. Sample lanes were layered
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onto the sample well of an SDS gel (see figure 2.6) and electrophoresis was
conducted as relevant to the composition of the gel and buffer type (e.g. Tris-acetate
or Bis-tris; see Table 2.2).
2.6 - Immunoprecipitation
To isolate the cotransporter for further study, protein was immunoprecipitated using
T4 and N1 antibodies. Two variations of the same protocol were used, which was
followed from Matskevich et al (2005). SDS-denaturation of samples was required
when using T4 monoclonal antibody (Hybridoma Bank, Iowa) as the antibody was
raised to denatured antigen (Lytle et al, 1995). N1 does not require this step. This
antibody was raised in rabbits for us by CovalAb (France) and the testing of the
efficacy of this antibody in western blot and immunoprecipitation experiments is
described in Chapter 3. Membrane samples (150pg) were incubated at 60°C for 20
minutes in the presence of 1% SDS (only when T4 antibody used). Samples were
diluted 5-fold with IP buffer (150 mM NaCl, 20 mM HEPES, 1 mM EDTA, 2 mM
Na pyrophosphate) with 0.5% ASB-16, 1% Triton X-100, 1 mM Na vanadate, 1 pM
Microcystin-LR and 2% protease inhibitor cocktail and incubated at 4°C for 1 hour,
with end-over-end mixing. Insoluble material was removed by centrifugation
(14,000 x g, 10 min) and the supernatant pre-cleared with 20pi 50% Protein G-
sepharose 4 Fast Flow (Amersham) for 1 hour at 4°C. The protein G-sepharose was
prepared by 1:1 dilution with IP buffer, plus 0.5% ASB-16 and 1% Triton X-100.
Pre-cleared supernatants were incubated with antibody for 1 hour at 4°C, then
incubated (1 hour, 4°C) with lOpl 50% Protein G-sepharose in a fresh sample tube.
Beads were spun out and washed three times with IP wash buffer. Proteins were
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eluted by incubating beads at 70°C with LDS sample buffer (Invitrogen) and 100
mM DTT. The supernatants were removed for SDS-PAGE (as in section 2.4.1).
2.7 - Mass Spectrometry
After electrophoretic separation and protein detection, by staining or western
blotting, mass spectrometric methods were used for identification and/or verification
of protein species. This involves proteolytic digestion, mass spectrometry to
generate a peptide spectrum and database searching to match these peptides against
theoretical digests of known proteins. This process is called peptide mass
fingerprinting. Alternatively, sequence data may be obtained by tandem mass
spectrometry which can be used to match known proteins to the sample. Two
different mass spectrometric methods were used during this project and are described
separately.
2.7.1 - Matrix-Assisted Laser Desorption lonisation Time-of-Flight (MALDI-
TOF) Mass Spectrometry
MALDI involves the ionisation of peptides from a matrix platform after
bombardment with a laser. These are accelerated by high voltage, and then allowed
to travel along a flight tube. Smaller peptides travel faster than larger ones, and the
time taken to fly is measured by a high speed detector. The steps involved in this
method are described separately.
2.7.1.1 - Trypsin Digestion
Following a protocol provided by the Edinburgh Protein Interaction Centre (EPIC,
www.epic.ed.ac.uk), bands (from 1-D gels) or spots (from 2-D gels) were excised
from gels using a sterile scalpel and transferred to autoclaved 1.5ml microfuge tubes.
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Gel pieces were incubated at 30°C with 200 mM ammonium bicarbonate (ABC)/50%
acetonitrile (ACN; Rathburn) for 30 minutes. This step was repeated twice more
with fresh solutions, with the liquid being drawn off by pipette between steps.
Reduction, by 60 minutes at 30°C in 20 mM DTT/200 mM ABC/50% ACN, was
followed by three wash steps in 200 mM ABC/50% ACN. Alkylation of cysteine
residues was achieved by incubation for 20 minutes (RT) in 50 mM
iodoacetamide/200 mM ABC/50% ACN. The samples were wrapped in foil at this
stage to ensure the reaction occurred in the dark. Gel chips were washed three times
with 20 mM ABC/50% ACN and then cut into smaller pieces using a sterile scalpel.
Any remaining liquid was removed by pipette after 2 minutes centrifugation at
13,000 x g. Gel pieces were covered with ACN, left for a few minutes to turn white
in colour, after which time the ACN was removed and the samples air dried for 5
minutes under a light source. The gel chips were rehydrated with 50 mM ABC
containing sequencing grade modified trypsin (Promega; 1U per gel piece) for 30
minutes at 4°C, after which time more enzyme solution was added if required
(enough to cover gel). All tubes were wrapped in Parafilm (Pechiney Plastic
Packaging) and incubated for 16-24 hours at 32°C, to allow digestion of proteins to
occur. Gel spots from 2-dimensional gels were prepared in the same way, with the
alkylation and reduction steps omitted, as this is conducted during IEF strip
equilibration prior to SDS-PAGE. Spots from silver stained gels were first covered
with a solution of 30 mM potassium ferricyanide and 100 mM sodium thiosulphate
until the gel pieces were clear (according to Gharahdaghi et al, 1999). These were
washed in 200 mM ABC and then treated like other samples. Before spotting onto
the MALDI target, samples were desalted and concentrated using Cis ZipTip®
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pipette tips (Millipore). The specifications of these are: resin - silica, 15 pm, 200 A
pore size, and volume - lOpl pipette tip with 0.6pl resin bed volume. ZipTips act
like chromatography columns, allowing trapping of peptides, washing to desalt, and
then elution in a solvent that is compatible with MALDI-TOF.
2.7.1.2 - Matrix Preparation
Approximately lmg of a-cyano-4-hydroxy-cinnaminic acid was added to a
microfuge tube and mixed with the following: 400pl 0.1% TFA in H2O, lOOpl 3%
TFA in H2O, and finally 500pl 0.1% TFA in ACN. After each addition, the sample
was vortexed for 1 minute and finally centrifuged for 2 minutes at 14,000 x g. A
visible yellow matrix pellet was always seen and indicated a desirable saturated
solution.
2.7.1.3 - Preparation of MALDI Plate
A 96 well x2 MALDI target plate (PerSeptive Biosystems) was used. A small
amount of trypsin digest sample (0.5pl) was spotted onto the plate and then 0.5pl of
saturated matrix solution was gently spotted on top of this. All samples on the plate
were left to dry before analysis.
2.7.1.4-MALDI-TOF
The Voyager™-DE STR Biospectrometry™ Workstation (PerSeptive Biosystems,
Inc, Framingham, MA, USA) was controlled via computer using the Voyager
Instrument Control Panel. The instrument settings were as follows: reflective mode,
manual instrument mode, acceleration voltage 20,000V, and spectrum acquisition
delay of 150-225nsec. The laser intensity was around 2100V (but was varied to
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improve spectra when necessary) and was set to fire 300 (also variable) laser shots.
Data was collected within the 800-3500Da mass range.
2.7.1.5- Spectrum Processing and Database Interrogation
Applied Biosystem's Data Explorer software was used to prepare the mass spectra
for database interrogation. This involves advanced baseline correction, noise
filtering, de-isotoping and mass calibration to an internal standard. Mass calibration
was achieved by using the auto-digested peptide masses of trypsin. Mass lists
generated from this program were used to search both MASCOT and MS-FIT
peptide mass fingerprinting search engines (www.matrixscience.com and
prospector.ucsf.edu respectively).
2.7.2 - High Performance Liquid Chromatography (HPLC) on-line with
Electrospray lonisation (ESI) Ion Trap Mass Spectrometry
HPLC collects peptides, desalts and concentrates them, before eluting them directly
to a mass spectrometer. In this case, an electrospray-ion trap mass spectrometer was
used. The HPLC passes the eluted peptides to the mass spectrometer via the
electrospray needle, which has a charge applied to it. A fine spray of highly charged
droplets (at the same polarity as the needle) is forced from the needle to the mass
spectrometer inlet. Dry gas (N2) and heat cause the solvent droplets to evaporate and
as they lose size, the surface tension can no longer withstand the charge. The
droplets then "explode" to form smaller droplets and multiply charged analyte
molecules. The analytes enter the mass spectrometer and are trapped by a 3-D
electric field. The voltages across these are variable creating a field within that traps
the ions in a stable oscillating trajectory. Changing these fields causes the ions to
eject in order of increasing mass/charge ratio, which are detected to produce a mass
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spectrum (Mann et al, 2001). The ion trap MS allows multiple stages ofmass
spectrometry, giving sequence detail about the analytes. The HPLC system consists
of a FAMOS™ well plate autosampler, Switchos™ II advanced microcolumn
switching unit for automated sample preparation, and the UltiMate™ integrated
micro-, capillary-, and nano-HPLC. This is coupled to a Finnigan LCQ Deca ion
trap mass spectrometer (Thermo Electron Corporation). Figure 2.8 shows the
experimental set-up used in this project. Peptide samples (prepared as for MALDI-
TOF) were spun (16,000 x g) through a Microcon centrifugal filter unit (0.22pm)
(Millipore, USA) to ensure no particulate matter remained in the sample, and the
resulting liquid added to a loading vial on the autosampler. The HPLC is controlled
by Chromeleon software (Dionex) and is fully automated. Briefly, the enzymatic
peptides are drawn up by a needle in the Famos unit, desalted and concentrated on a
trapping column in the Switchos module (flow rate of 0.030ml/min), and then eluted
onto a PepMAP C18 reverse phase column (3pm particle size; 75pm internal
diameter x 15cm length; LC Packings), at a flow rate of 0.200pl/min. The peptides
are loaded in the high aqueous phase (solution A - 0.1% formic acid in H2O) and
eluted with a linear gradient of 0-90% solvent B (0.09% formic acid in 100%
acetonitrile) over 45 minutes. Peptide elution from the column is monitored by
absorbance at 214nm by the UltiMate UV detector. Ionisation and mass
measurement is performed by the ESI-MS and the RAW data files managed by
Xcalibur software (Thermo Electron Corporation). These are converted to DTA
mass list files (using Sequest, distributed by Thermo Finnigan) and compiled before










Figure 2.8 -The HPLC-MS Station and Depiction of Sample Flow During High
Performance Liquid Chromatography
The upper panel shows the equipment used and the lower panel describes the flow of
samples through the LC unit, comprising of the autosampler, the switching unit and the
chromatography column.
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2.8 - Deglycosylation of Proteins
The cotransporter band appears as a fairly broad smear on a western blot. NKCC
proteins are potentially glycosylated, which may be the cause of this phenomenon.
To test this, red blood cell membranes were heated at 60°C for 20 minutes with SDS
at 1%, then diluted to give 0.2% SDS with the following mix: deglycosylation buffer
(150 mM NaCl, 20 mM HEPES, 1 mM EDTA, pH 7.44), 1% CHAPS, 1% Triton X-
100, 10 mM EDTA and 2% protease inhibitor cocktail, with 1% (3-mercaptoethanol.
An hour-long incubation at 4°C, with end-over-end mixing, prepared the samples for
deglycosylation. Recombinant N-glycosidase F (Roche) was added and the samples
incubated at 37°C overnight. SDS-denaturation was required to expose the sites for
the enzyme to act upon. It did need to be diluted, however, so as not to denature the
enzyme itself. Aliquots were removed and prepared for SDS-PAGE using the
NuPAGE™ system, then transferred to nitrocellulose for western blotting.
2.9 - Reverse-Transcription Polymerase Chain Reaction (RT-PCR)
This technique allows amplification ofmessenger ribonucleic acid (mRNA) by use
of a reverse transcription reaction followed by polymerase chain reaction. First,
complementary deoxyribonucleic acid (cDNA) is generated from mRNA using
deoxynucleotide triphosphates (dNTPs) and a reverse transcriptase enzyme. This
cDNA is used as a template in the PCR, where specific DNA fragments are amplified
using the appropriate DNA primers and the thermostable enzyme, Taq polymerase.
2.9.1 - Primer Design
Rat, human and mouse NKCC1 and NKCC2 cDNA (from mRNA) sequences were
obtained from the Entrez nucleotide database from the National Center for
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Biotechnology (NCBI) website (www.ncbi.nlm.nih.gov). Accession numbers are
shown in the table 2.5. The cDNA sequences were aligned using ClustalW, a
multiple sequence alignment tool, obtained from the European Bioinformatics
Institute (EBI) website (www.ebi.ac.uk). A list of non-identical regions (exclusion
list) was generated. Primer 3, a tool that picks primers from a given DNA sequence
(http://frodo.wi.mit.edu/cgi-bin/primer3/primer3_www.cgi), was used to generate
primer sets. The exclusion list was included to ensure that the chosen primers would
only detect regions common to the three species (human, rat and mouse in this case).
Species NKCC1 NKCC2
Rat (Rattus norvegicus) NM_031798 NM_019134
Human (Homo sapiens) U30246 NM_000338
Mouse (Mus musculus) NM_009194 U20973
Table 2.5 - Accession numbers from NCBI database used for PCR primer design
Primer sets were chosen (see Table 2.6) for both NKCC1 and 2 and produced by
Invitrogen on request. Nucleotide-nucleotide BLAST searches (using tool from
www.ncbi.nlm.nih.gov/BLAST) revealed that the primers chosen matched sequence
in cDNA from a number ofmammalian species, suggesting that these would be good
candidates for detection ofNKCC isoforms in different animal species. The
sequences that are amplified by these primers are shown in Appendix I, with details
of exon-exon boundaries. Primers were also generated for human and rat p-actin
using the Invitrogen OligoPerfect™ Designer application available from
www.invitrogen.com and shown alongside the NKCC1 and 2 primers in table 2.6.
2.9.2 - RNA Isolation
Two different kits were used to isolate RNA, with similar results. The Qiagen
RNeasy® kit and Invitrogen's PureLink™Micro-to-Midi Total RNA Purification
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System were used following the protocols supplied. Both kits use spin-cup columns,
containing silica membranes that bind RNA. Cell or tissue lysates were added to
these, washed and the RNA eluted with nuclease-free water (supplied with kits). The
absorbance ratio (A260/A280) was determined to assess sample purity and yield as
described in section 2.1.2.














p-actin rat forward GTCGTACCACTGGCATTGTG
181
p-actin rat reverse CTCTCAGCTGTGGTGAA
Table 2.6 - NKCC 1, NKCC2 and p-actin primer sequences
2.9.3 - Reverse Transcription
ImProm™-II reverse transcriptase was used to generate cDNA from RNA, following
the instructions given by the manufacturer (Promega). Up to 1 pg of total RNA was
present in each first-strand reaction. Oligo dTs (15 thymine bases; Promega) were
used to act as primers for the poly-adenine tails found on mRNA molecules.
2.9.4 - PCR
Promega Master Mix was chosen for PCR, as it contains all the necessary
components at optimal conditions for production of DNA products up to 2kb in size
(Taq polymerase, dNTPs, buffer, and MgCB) except primers and DNA template.
This allows easier sample preparation and reduces the risk of sample contamination,
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due to reduced pipetting steps. The GeneAmp® PCR System 9700 (Applied
Biosystems) thermal cycler was used in all cases. The conditions for the different
primer sets are shown in table 2.7.
NKCC1 and NKCC2 P-actin




Final extension 72°C 10min
-35 cycles




Final extension 72°C 10min
-35 cycles
Table 2.7 - Polymerase Chain Reaction Conditions to Amplify NKCC and Actin
Products
The cDNA templates are denatured to separate the strands, the temperature lowered to
allow the primers to anneal to the templates and then increased again to allow DNA
polymerisation (extension).
2.9.5 - DNA Gel Electrophoresis
PCR products were run on 1% agarose (in TBE; 89 mM Tris, 89 mM Boric acid, 1
mM EDTA in Milli-Q water) gels containing SYBR® Safe DNA gel stain
(Invitrogen). DNA was mixed with loading dye (Fermentas) and electrophoresis was
for 30 minutes at 180V. Base pair markers were run alongside (GeneRuler1M lOObp
DNA ladder, Fermentas). Gels were visualised with the Gene Genius Bio Imaging
System (Syngene, Ltd.). TotalLab software was used to interpolate PCR product
size, by comparison to the base pair markers.
84
Chapter 2 Materials and Methods
2.10 - Materials
The following comprises supplier details for all materials not already stated in the
previous methods sections.
Sigma-Aldrich
Common name or abbreviation Alternative Name
ABC Ammonium bicarbonate
Arsenite Sodium arsenite
Brilliant Blue G-250 Acid blue 90
Brilliant Blue R-250 Acid Blue 83
Cinnaminic acid a-cyano-4-hydroxy-cinnaminic acid
EDTA Ethylenediaminetetraacetic acid
Genistein 4,5,7-T rihydroxyisoflavone
HEPES 4-(2-hydroxyethyl)-1 -piperazineethanesulfonic acid
Glycine Aminoacetic acid
B-glycerophosphate Glycerol 2-phosphate
Tris base/Trizma base 2-Amino-2-(hydroxymethyl)-1,3-propanediol
triethanolamine 2,2',2"-Nitrilotriethanol
Triton X-100 t-Octylphenoxypolyethoxyethanol




















Glacial acetic acid Ethanoic acid
glycerol
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HCI Hydrochloric acid
k2hpo4 Di-potassium hydrogen orthophosphate
kh2po4 Potassium dihydrogen orthophosphate
NaCI Sodium chloride
isopropanol propan-2-ol
SDS Sodium dodecyl sulphate
Sucrose
Alexis Biochemicals








Common name/abbreviation Alternative Name
A23187 Calcimycin
ASB- 16 Amidosulfobetaine 16
C12E8 Octaethyleneglycol mono-n-dodecyl ether
CHAPS 3-[(3-Cholamidopropyl)dimethylammonio]-1-
propanesulfonate
ASB - C60 4-n-Hexylbenzoylamido-propyl-
dimethylammoniosulfobetaine
ASB - C8<t> 4-n-Octylbenzoylamido-propyl-
dimethylammoniosulfobetaine
ASB - C7BzO 3-(4-Heptyl)phenyl-3-hydroxy-propyl-
dimethylammonio- sulfobetaine
Protease Inhibitor Cocktail Set III
AEBSF, hydrochloride (100 mM), Aprotinin (80
pM), Bestatin (5 mM), E-64 (1.5 mM), Leupeptin,
hemisulfate (2 mM), Pepstatin A (1 mM)
GE Healthcare/Amersham
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Chapter 3: Using Proteomic Tools to Study the Na-K-2CI
Cotransporter
In order to obtain more information about phosphorylation on the cotransporter, 2-
dimensional electrophoresis (2-DE) techniques were employed. Standardly, 2-DE is
used to look at proteomes, but using isoelectric focussing (IEF) as a first dimension
separation, differently phosphorylated cotransporter species should focus at distinct
isoelectric points (pi); so-called "phosphorylation trains" (Carter et al, 2004). IEF
followed by denaturing SDS-PAGE, allows visualisation of these different species.
Coupled with mass spectrometry, this approach allows identification of the specific
parts of the protein that are phosphorylated. There are difficulties in obtaining good
separation and representation ofmembrane proteins on 2-DE gels, mainly due to issues
with solubility in the media used for isoelectric focussing (Santoni et al, 2000).
Improvements in the representation of membrane proteins on 2-D gels have been made,
particularly with the inclusion of thiourea (Rabilloud, 1998) and using a variety of
zwitterionic detergents (Chevallet et al, 1998), but there is still room for improvement.
Alternative methods for protein separation include native-PAGE coupled with SDS-
PAGE. Native-PAGE allows separation of protein complexes and following this with
SDS-PAGE could help identify proteins that NKCC interacts with. Both methods are
described in this chapter.
3.1 - 2D - IEF/SDS-PAGE
A protocol was devised, in the Flatman laboratory, to maximise cotransporter signal in
western blot using the T4 antibody. Large sample loads were required in order to
achieve this and as figure 3.1 shows this results in obscured visualisation of spots in the
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upper ranges of the 2-D gel. Using this method as a start point, several features of this
protocol were adapted and tested, with the aim of improving the representation and
pH7 4 * pH4 pH7 4 ► pH4
Silver Stain T4 Western Blot
Figure 3.1 - Two-Dimensional Electrophoresis of Ferret Erythrocyte Membrane Proteins
Ferret red blood cell membrane proteins were first separated by IEF (pH 4-7, 7cm strip) and then
SDS-PAGE using 3-8% Tris-acetate NuPAGE™ gels. Some molecular weights are shown for
reference and were interpolated from a biotinylated protein ladder (Cell Signaling Technology).
Some estimated pi values are also shown.
separation of membrane proteins on 2D gels and to finally identify the cotransporter by
mass spectrometry. Following the protocol, silver stained 3-8% tris-acetate mini
NuPAGE gels showed fairly good separation of moderate to low molecular weight
proteins (Fig 3.1). However, streaking of poorly focussed proteins masks areas of the
gel where higher molecular weight species would separate. Western blotting of 2-DE
separated proteins with T4 antibody showed cotransporter protein in several areas. The
isoelectric points of human NKCC1 and rat NKCC1 are 5.98 (131 kDa) and 6.08 (130
kDa) respectively (based on the amino acid sequence using the Compute pI/Mw tool
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from Expasy.org). Post-translational modifications such as phosphorylation make the
isoelectric point of a protein more acidic and may explain why the T4 detected spots are
at more acidic isoelectric points than we may predict for the cotransporter. Using the
Scansite molecular weight and isoelectric point calculator (available from
scansite.mit.edu/calc_mw_pi.html) changes to protein pi can be estimated after
theoretical addition of any number of phosphate groups. Based on the human NKCC1
sequence, at least 10 phosphates would need to be added to achieve a pi of 5.5. This
suggests that there are other modifications present that are responsible for the shifts in
pi found, such as glycosylation. Spots are present at higher molecular weights than
predicted, based on the amino acid sequence. This could be explained to some extent
by variable glycosylation, but may also represent the cotransporter bound to another
protein(s). None of the spots detected by the T4 antibody corresponded clearly with
visible spots on the stained gel. Much of this was due to problems distinguishing
individual spots within these regions. 2DEvolution software finds it difficult to
distinguish spots from areas of high background and streaking. An example of the
capabilities of the spot detection is shown in figure 3.2. Panel A shows the area where
T4 detects NKCC protein. The software indicates that there are many spots in this area,
but closer examination shows that these are streaks and not defined spots. Hence, in
order to use two-dimensional electrophoretic techniques for NKCC detection,
improvements would be necessary to allow detection of higher molecular weight
proteins. Several different adaptations and investigations into the original protocol were
made and are described.
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Figure 3.2 - 2DEvolution Spot Detection of 2-D Separated Ferret Membrane Proteins
2DEvolution software (Nonlinear Dynamics, UK) was used to detect the spots from the silver
stained image shown in figure 4.1. Panel A shows an area of streaking where protein spot
detection is difficult. Panel B shows an area where protein density is lower and spot detection
is more successful.
3.1.1 - Sample preparation
To ensure that the method of sample preparation was not selectively reducing the
amount ofNKCC present, western blot of the different sample fractions was carried out.
Prior to IEF, erythrocyte cell membranes were separated by ultracentrifugation and then
the resultant pellet material resuspended in a solubilisation buffer compatible with IEF.
Figure 3.3 demonstrates that the majority of T4 immunoreactivity resides in the
membrane pellet and that no T4 immunoreactivity is found in the supernatant material
that is discarded. Although reduced from the starting sample, it is clear that
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cotransporter is present in the solubilised IEF sample. In order that a western blot could
be performed an SDS-PAGE Clean-Up Kit was used (GE Healthcare) to precipitate the
proteins from the IEF sample buffer. These were then resuspended in buffer more
compatible with SDS-PAGE. This step may well account for the reduction ofNKCC as
Crude membrane SN 1EF sample IEF sample pellet BPL
Figure 3.3 - T4Western Blot Analysis of NKCC in 2DE Sample Preparations
The various stages of membrane sample preparation for isoelectric focussing are tested
for the presence of NKCC. Crude membrane samples are prepared in the ultracentrifuge
at 100,000 x g (4°C) and the supernatant (SN) separated from the membrane pellet.
These membranes are resuspended for IEF before a final spin (14,000 x g) and the
supernatant loaded for the first dimension. Any remaining pellet material (IEF sample
pellet) is discarded. To obtain equal loading of total protein in each sample lane, protein
from SN and IEF samples was precipitated using SDS-PAGE Clean-Up Kit (Amersham)
before preparation of the samples for SDS-PAGE. The 140 kDa biotinylated protein ladder
(BPL) marker is shown for molecular weight reference.
precipitated membrane proteins are often difficult to resuspend. There is no visible
evidence for the presence ofNKCC in the residual pellet material that is not soluble
after incubation with the IEF buffer. This demonstrates that the use of
ultracentrifugation to concentrate the membranes (and resultant protein) provides a
simple enrichment step with minimal NKCC loss.
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3.1.2 - Reduced Sample Volume and Protein Load
Revisiting the recommendations made by the immobilised pH gradient (IPG) strip
manufacturer revealed that the starting protocol exceeded strip volume and protein
capacity during the first dimension (Berkelman and Stendstedt, 1998). Reduction of
sample volume and protein in the IEF step results in improved second dimension
resolution. Silver staining of the SDS-PAGE gel shows that the issue of smearing is
Reduced Protein Content Reduced Sample Volume
Figure 3.4 - Reduced Protein and Sample Volume Improves Gel Appearance
According to 2-D Electrophoresis using immobilized pH gradients: Principles and Methods
(Amersham Biosciences) there is a maximal protein and volume set for each strip size. Starting
sample protein content in the left panel was 30pg and sample volume of 140|jl. The right panel
had a start sample protein content of 50pg and sample volume not exceeding 125(jl. Silver
stained 3-8% Tris-acetate NuPAGE™ gels are shown. Guide molecular masses were
interpolated from the Invitrogen HiMark™ marker set.
largely resolved (Fig 3.4). This improves the spot detection by 2DE analysis software
(Fig 3.5). Flowever, larger molecular weight proteins are mostly absent from these gels.
This may be as a result of protein precipitation in the IPG strip. This is a particular
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problem with integral membrane proteins, which often possess many hydrophobic
transmembrane spanning regions. Their solubility is reduced as they become
concentrated at their pi, causing aggregation. It is possible that altering the detergent
and ionic strength composition of rehydration/solubilisation buffer could reduce this
problem. A number of experiments were conducted to address this issue.
Figure 3.5- Improved 2DEvolution Spot Detection by Reducing IEF Sample Volume
This figure shows the result of spot detection on a 2D gel where IEF sample volume was
reduced. A silver stained 3-8% Tris-acetate NuPAGE™ gel is shown. Guide molecular
masses were obtained from the Invitrogen HiMark™ marker set.
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3.1.3 - Tris Base Inclusion
Pasquali et al (1997) suggest that tris base improves the solubilisation of hydrophobic
membrane proteins, many of which are optimally soluble at a higher pH. The addition
of 20mM tris base to the sample buffer increases the amount ofmaterial seen at the mid
to high molecular weight range (figure 3.6). There is a drawback in that much of this
protein is poorly focussed as may be expected by the addition of a charged chemical to
the first dimension. However, it does greatly increase the amount of protein on gels and
is a useful addition to the protocol.
pH7 -4 ► pH4 pH7 < ► pH4
No added Tris 20 mM Tris
Figure 3.6 - Inclusion of Tris in IEF Sample Buffer Increases Protein Content on 2D Gels
Samples of (30pg) protein were prepared for IEF/SDS-PAGE with or without Tris added to the
solubilisation buffer during sample preparation. Silver stained 3-8% Tris-acetate NuPAGE™
gels are shown. Guide molecular masses were taken from the Invitrogen HiMark™ marker set.
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3.1.4 - Increased Ampholyte Concentration
Increased concentration of IPG buffer can help to increase protein solubility (Shaw and
Riederer, 2003). The starting protocol already had IPG buffer at 1%, with 0.5% being
the standard, according to the strip manufacturer's instructions. Figure 3.7 shows the
results of increasing IPG buffer concentration from 1% to 2%. Although there is little
visible difference between the gels there was difficulty in achieving the appropriate
voltage during IEF. In conclusion, this does not greatly improve the outcome of the
experiment and as such was not used again.
Figure 3.7 - Increased Ampholyte Concentration During IEF
IPG buffer (pH4-7) was added to the so|ubilisation solution at either 1 or 2% concentration.
Amersham pH 4-7 IPG strips were used. Silver stained 3-8% Tris-acetate NuPAGE™ gels are
shown. Guide molecular masses were taken from the Invitrogen HiMark™ marker set.
3.1.5 - Use of Different Detergents for Membrane Protein Solubilisation
The best detergents for the solubilisation ofmembrane proteins are generally charged
(i.e. SDS) and therefore not suitable for use during IEF. A panel of newer zwitterionic
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detergents have shown to be efficient at solubilisation ofmembrane proteins, allowing
-> pH4 pH7 •+- -> pH4
1 % C60 1 % C80
Figure 3.8-2DE Separation of Membrane Proteins Solubilised with Zwitterionic Detergents
Ferret erythrocyte membrane proteins (100pg) were solubilised in IEF buffer with 4% CHAPS, 1%
Triton X-100, 1% NP40 and each of the detergents named above (see chapter 2 for full details of
solubilisation buffer). Silver stained NuPAGE™ 3-8% Tris-acetate gels are shown, with proteins
separated on pH 4-7, 7cm IPG strips. Molecular masses were obtained from the Invitrogen
HiMark™ marker set. Red circles surround spots that are not well represented on each of the other
gels.
0.5% ASB 16 1 % C7BzO
pH7<« ► pH4 pH7 < » pH4
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identification of a greater number of membrane proteins on 2D gels (Chevallet et al,
1998). The amidosulfobetaines have been shown to be effective at solubilisation and
are compatible with high concentrations of urea and thiourea (Shaw and Riederer,
2003). One of these, ASB-16, is the detergent used in the original protocol, along with
CHAPS, Triton X-100 and NP-40. A variety of other detergents were tested and their
effects on the 2D map observed (figure 3.8). Structures of these detergents are shown in
figure 3.23. With spot detection software, and the naked eye, you can clearly observe
extra spots on the gel using the C80 detergent, which are marked with a red circle in
figure 3.8. Other changes are not clear due to the streaking on the gels. Both the C80
and the C60 detergents give cleaner looking gels with less overall streaking. However,
the ASB-16 gels do have areas where spots are present that are not well represented on
other gels (red circles on figure 3.8). Though not investigated further, the use of
different detergents could be a useful area to explore in improving the 2-D separation of
erythrocyte membrane samples.
3.1.6 - ZOOM® Fractionation
This method involves liquid-phase isoelectric focussing of protein samples, which can
then be separated by gel-based isoelectric focussing and SDS-PAGE. Figure 3.9 shows
that it is possible to separate the cotransporter into a particular fraction, which ranges
from pH 5.4-6.2. However, as figure 3.10 demonstrates, attempts to separate these
proteins using 2-DE were disappointing. T4 western blots of these gels showed no
evidence ofNKCC present (data not shown). This method should provide the best
separation of any modified forms of the cotransporter by reducing sample complexity
and allowing separation of proteins within a single pH unit. However, several
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modifications and attempts to improve this protocol were made but the proteins were
never well resolved and there was generally very little protein where the cotransporter
would separate on a gel. As such, this protocol was not further investigated.
ZOOM pH fractions
r ^ "v




Figure 3.9-T4 Detection of Ferret Erythrocyte NKCC after ZOOM® Fractionation
Equal amounts of protein were loaded per lane (2.5pg) and separated on 3-8% Tris-
acetate gels. After transfer to nitrocellulose, the membrane was probed with T4
antibody to detect NKCC. The masses shown are from a biotinylated protein ladder
(BPL).
3.1.7-Studying NKCC
All investigative work to this protocol was performed using 3-8% tris-acetate NuPAGE
gels for the second dimension separation. The rationale for this was that they give
greater separation ofmid to large molecular weight proteins which are generally
underrepresented on 2-D gels. However, using 4-12% bis-tris NuPAGE gels gives
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greater separation of proteins within the range we are looking for the cotransporter, as
well as improving separation of smaller proteins. Figure 3.11 shows a 2-D separation of
ferret erythrocyte membranes using a pH 4-7 IPG strip and a 4-12% bis-tris NuPAGE
gel with Coomassie stained proteins. This stain shows far fewer proteins but is
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Figure 3.10 - ZOOM Fractionation and 2-D Separation of Erythrocyte Proteins
This shows a representative image of a 2-D separated pH 5.2-6.4 fraction on a
single pH unit IPG strip and an 3-8% Tris-acetate SDS-PAGE gel. Proteins were
silver stained and the guide masses shown were taken from Invitrogen HiMark™
markers.
compatible with mass spectrometry. A few protein identifications were made and
mostly represent cytoskeletal proteins, with the only certain red blood cell membrane
protein being band 4.1. Although the samples used should contain predominantly
membrane proteins, there will be residual haemoglobin and cytoskeletal proteins present
due to the gentle method ofmembrane preparation. Band 3, the most abundant red
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Figure 3.11 - Identification of Proteins from Ferret Erythrocyte Samples by MALDI-TOF
Proteins were separated by IEF on pH 4-7 IPG strips, followed by SDS-PAGE on 4-12% Bis-
tris gels. Guide molecular masses are shown and were taken from the Invitrogen Mark12™
marker set. The gel was stained with GelCode Blue (Pierce) and visible spots excised,
digested and subjected to MALDI-TOF mass spectrometry. Proteins were identified using the
MASCOT peptide mass fingerprinting utility.
blood cell membrane protein, is conspicuously absent. The isoelectric point for this
protein (approximately pH 5, based on the amino acid sequence) means that it should be
detectable using pH 4-7 IPG strips. Figure 3.12a shows a 2-D separation of ferret
erythrocyte membranes under the same conditions as for figure 3.11, but with silver
staining of the proteins. 2DEvolution software detected 334 spots (figure 3.12b).
However, only 9 proteins were identified. This may be due to incomplete removal of
silver ions, which can result in poor quality mass spectra (Gharahdaghi et al, 1999). It
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Figure 3.12a- Identification of Proteins from Ferret Erythrocyte Samples by MALDI-TOF
The gel was stained with PlusOne Silver Stain (Amersham) and spots excised, digested and
subjected to MALDI-TOF mass spectrometry. Proteins were identified using the MASCOT peptide
mass fingerprinting utility. The areas indicated in red are where cotransporter and band 3 are
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pH7« ► pH4
Figure 3.12b - Identification of Proteins from Ferret Erythrocyte Samples by MALDI-TOF
The gel was stained with PlusOne Silver Stain (Amersham) and spots excised, digested and
subjected to MALDI-TOF mass spectrometry. Proteins were identified using the MASCOT peptide
mass fingerprinting utility. The areas indicated in red are where cotransporter and band 3 are
likely to separate. From over 300 proteins on this gel (marked in blue; detected by 2DEvolution
software) only 9 identifications were made. The mass markers were taken from a biotinylated
protein ladder.
may also be due to the small amounts of protein present in each spot which are
detectable with silver stain but perhaps not by the MALDI-TOF. Figure 3.13 shows the
separation of proteins using pH 3-10 IPG strips and the proteins here are stained with
SYPRO Ruby stain. This stain has similar sensitivity to silver stain, but is compatible
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Figure 3.13 - MALDI-TOF ID of Erythrocyte Proteins Separated on pH 3-10 IPG Strip
Proteins were separated on a 13cm pH 3-10 IPG strip and 4-12% Tris-glycine home-cast
gel. The proteins were stained SYPRO Ruby (BioRad) and the circled spots excised and
digested with trypsin and subjected to MALDI-TOF mass spectrometry. Proteins were
identified using the MASCOT peptide mass fingerprinting utility. Only those proteins that
were identified are labelled. The other circled spots were not identified. Molecular mass
markers were taken from the SeeBlue® Plus2 marker set from Invitrogen.
with mass spectrometry. Again, we see poor coverage ofmembrane proteins.
However, band 3 is detected with this method, but it is at the wrong molecular weight
approximately 45 kDa and not 90-100 kDa) and isoelectric point (pH 9 and not pH 6).
This may represent a proteolytic cleavage product of band 3 which is not normally seen
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when using pH 4-7 IPG strips. Using the method that gave the most clearly resolved gel
images, western blots were obtained and probed with T4, R5 and NKCC-P antibodies.
Figure 3.14 shows NKCC spots from control ferret erythrocyte membrane samples
using the T4 antibody and unlike the blot shown in figure 3.1, there is significantly
more cotransporter found at the monomer weight. The estimated pi values are very
-> pH4
Figure 3.14 -T4 Detection of NKCC after 2-DE Separation of RBC Membranes
Gels were prepared on 7cm pH 4-7 IPG strips and 4-12% Bis-tris NuPAGE gels and
transferred to nitrocellulose and probed with T4 antibody. Isoelectric points (marked
with arrows) and molecular masses (shown with circles) were estimated using
2DEvolution software.
similar, with each differing by 0.1 of a pH unit. Figure 3.15 shows spots detected by
phospho-specific NKCC antibodies. The spots identified by T4 are also identified by
R5 and NKCC-P antibodies. Three R5 spots are seen and correspond to the major spots
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seen on T4 blots at the molecular weight of approximately 150kDa. The NKCC-P
antibody detects spots only at a pi of 5.3, but at several molecular weights. These sizes
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Figure 3.15 - Detection of Phosphorylated NKCC after 2-DE Separation
Gels were prepared on 7cm pH 4-7 IPG strips and 4-12% Bis-tris NuPAGE gels, then
transferred to nitrocellulose. Blots were probed with either the R5 antibody or NKCC-P
antibody and the spots detected with ECLplus. Isolectric points ( marked with arrows) were
estimated using 2DEvolution software and the molecular masses (marked with circles) were
interpolated from a biotinylated protein ladder.
As far as improving the overall picture of 2-DE separated erythrocyte membrane
samples this has been best achieved by reduction of sample volume, sample protein
content, inclusion of tris base in the IEF solubilisation buffer and by separating proteins
on 4-12% Bis-tris gels. Overall, this method has improved but as the mass spectrometry
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data shows still operates at the limits of the technology as far as membrane protein
identification is concerned.
3.2 - Blue-Native/SDS-PAGE
Blue-native polyacrylamide gel electrophoresis (BN-PAGE) allows the separation of










Figure 3.16 - Native-PAGE of Ferret Erythrocyte Membrane Proteins
Ferret red blood cell membranes were separated by native-PAGE and
stained with Coomassie R-250. High Molecular Weight native markers
(Amersham Biosciences) are shown with the molecular masses marked.
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Coomassie blue is used to "label" protein with a non-denaturing negative charge
allowing native proteins to run towards the positive electrode during electrophoresis.
Comparing samples that have been given treatments to increase or decrease cotransport
may identify proteins that are involved in the regulation of this activity. Home-cast and
pre-cast gels were used to separate erythrocyte membrane protein complexes for either
LC-MS/MS or for a second dimension separation of SDS-PAGE, followed by MALDI-
TOF MS or transfer to nitrocellulose for western blotting. BN-PAGE on mini-gels
separated proteins into five major complexes (Fig 3.16). There were no detectable
differences in the number or pattern of complex separation between the different
samples tested. Figure 3.17 shows identification ofproteins from these complexes
using liquid chromatography and tandem mass spectrometry (see Appendix for
supplementary data). This method allows identification of proteins from more complex
samples such as these. Unfortunately, no cotransporter was identified in these samples.
Figure 3.18 shows western blot detection ofNKCC on BN-PAGE gels using the T4
antibody. Again there are no obvious differences between the samples in terms of T4
immunoreactivity. The cotransporter appears as two major bands with some material at
higher positions, but the masses of these were not able to be estimated due to lack of
suitable markers for both BN-PAGE and western blotting. Based on the size and
position of these bands it does appear that they correspond to the complexes at around
250 kDa and 440 kDa (see figure 3.16). Two-dimensional separation followed by T4
western blotting, as in figure 3.19, shows cotransporter at several positions in the gels.
T4 immunoreactivity is still present in the native gel after 2-D separation showing that
not all of the cotransporter manages to exit the first dimension gel. The protein that
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Figure 3.17 - LC-MSMS Identification of Proteins from Native-PAGE Gels
Identification of proteins was based on raw MS/MS data from one or more peptides using
the MASCOT MSMS Ion search tool and confirmed with the Phenyx search tool.
does leave this gel into the second dimension separates at approximately 150 kDa and at
around 250-300 kDa. From the two original protein complexes, only one has the higher
molecular mass form of 250-300 kDa. Figure 3.20 shows identification of proteins by
MALDI-TOF after 2-DE separation. The first dimension is shown at the top of the gel
to aid understanding ofwhich complexes the proteins come from. As with LC-MSMS
of the complexes themselves, MALDI-TOF of the separated proteins provides
complementary evidence for the presence of band 3 in the largest protein complex.
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Figure 3.18 -T4 Detection of NKCC after Native-PAGE Separation
of Ferret Erythrocyte Proteins
Native gels were equilibrated in western blotting transfer buffer and then
proteins were transferred to nitrocellulose and proteins detected with
ECL reagents. Molecular weight estimation was not performed as
suitable mass markers were not available for western blotting from
native-PAGE gels.
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Native-PAGE








Figure 3.19 -Western Blot of Ferret Erythrocyte Proteins Separated by Two-
Dimensional Native-PAGE and Denaturing SDS-PAGE
The two gels were transferred together onto nitrocellulose after 4-12% Bis-tris SDS-
PAGE. T4 antibody was used to detect NKCC proteins. The masses shown were
estimated using TotalLab software and were interpolated from a biotinylated protein
ladder.
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Figure 3.20 - 2D Native-PAGE and SDS-PAGE of Ferret Erythrocyte Membranes
Protein identifications were made from MALDI-TOF generated mass spectra and the
MASCOT peptide mass fingerprint utility. The first dimension is shown at the top of
the image. The molecular weights shown were interpolated from the SeeBlue® Plus2
marker set from Invitrogen.
Based on these separations, it would appear that the cotransporter is in complex with
haemoglobin, peroxiredoxin-2, band 3, spectrin and ankyrin in red blood cell
membranes. To substantiate this, mass spectrometric identification of the cotransporter
from the native complexes or from a spot on a 2-DE gel would be of benefit. Figure
3.21 shows the output from Mascot for a significant hit and figure 3.22 shows the mass
spectrum for this hit, which is typical of data from 2-DE separated samples. This
example was for a BN-PAGE/SDS-PAGE spot and shows a hit for peroxiredoxin-2.
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3.3 - Discussion of Results
As the results in this chapter demonstrate, it is extremely difficult to achieve good
separation and representation ofmembrane proteins using a 2-DE protocol featuring
IEF and SDS-PAGE. Although improvements were made to the overall appearance of
the protein map, no identification of the cotransporter or other large membrane proteins
was made by mass spectrometric methods. It would be of use to repeat these
experiments with parallel western blotting ofmore abundant erythrocyte membrane
proteins such as band 3, to track any improvements in the representation ofmembrane
proteins on 2D gels. Rabilloud et al (1999) first tested many of the detergents used in
this thesis on erythrocyte membrane preparations and were able to identify band 3 on 2-
DE gels but only using the more sensitive LC-MSMS method. Olivieri et al (2001)
identified many of the same proteins that are presented in this thesis, but were also able
to identify band 3 by MALDI-TOF. However, in both of these studies large first
dimension gels were used (18 cm or more), which allows both better separation of
proteins and larger protein loads. In this thesis, due to reduced sample availability, only
7 cm and occasionally 13 cm IPG strips were used. Churchward et al (2005) claim that
inclusion of detergent-like phospholipids in IEF samples increased the amount of band
3 on 2-DE gels, but show no western blot or mass spectrometric evidence for this. As
with the other proteomic studies cited here the SDS-PAGE separation that these authors
used was for resolution of proteins not much larger than band 3. As such, it is not clear
if this method is useful for resolution of larger proteins, including the cotransporter.
Similar attempts to those made in this thesis to improve the representation ofmembrane
proteins using the standard 2-DE protocol were investigated by Klein et al (2005) when
studying the membrane proteome of Halobacterium salinarum. The authors of this
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paper also performed a number of fractionation steps to improve their chances of
obtaining membrane protein identification. They showed that by fluorescent labelling
ofmembrane protein preparations that most were precipitating within the strip and were
unable to leave this into the second dimension. They concluded that a gel-based IEF
step along with SDS-PAGE is not a suitable method for identification of integral
membrane proteins. This paper also suggests that digestion of integral membrane
proteins with trypsin creates difficulties for their identification due to the size of
peptides. Theoretical digest of human NKCC1 with trypsin using the Expasy
PeptideCutter tool generates 98 peptides from a protein sequence 1212 amino acids
long. A large number of these are smaller than the cut-off for mass spectral
identification (around 800 Daltons) and others are larger (above 4000 Daltons). This
means that peptide coverage may be poor and significant scores and identifications not
be obtained from peptide mass fingerprinting. Overexpression of ferret NKCC1 in
HEK-293 cells, gel separation, trypsin digestion and MALDI-TOF mass spectrometry
did reveal the cotransporter using a peptide mass fingerprint tool (unpublished,
Hannemann). In a natural situation, such as the ferret erythrocyte, it is unlikely that the
amount of protein present is sufficient to generate enough peptide in the measured mass
range to obtain protein identification. However, as lower levels of protein are required
for detection on western blots 2-DE separation can provide some information about
differently phosphorylated version of the cotransporter, although it is unlikely that
enough protein will be present on 2-D gels to identify specific phosphorylated residues
by mass spectrometry. The Scansite molecular weight and isoelectric point calculator
suggests that changes of approximately 0.05 pH units will occur with the addition of
each phosphate to human NKCC1. However, other modifications such as glycosylation
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could affect the shift. This could explain why changes of 0.1 pH units are observed.
Using phospho-specific antibodies we see a difference in the spot pattern. Western
blots of control membrane samples with the R5 antibody show three distinct spots. This
antibody detects a portion of the N-terminus ofNKCC1 that has phosphate on Thr206,
911 •
Thr or both (numbering from mouse sequence). As three spots are detected, it
suggests that in addition to detecting NKCC singly phosphorylated on Thr206 or Thr211
and doubly phosphorylated on both, a third moiety exists that is phosphorylated on
these residues but also at another position on the cotransporter. This results in a shift in
pi, making it more acidic but still allows detection by the R5 antibody. The NKCC-P
antibody was raised against a section ofNKCC 1 that was phosphorylated on three
threonine residues (Thr197, Thr201 and Thr206). Spots detected with this antibody all have
a pi of 5.3, but show different molecular weights. It is not known if this antibody
detects only the triply phosphorylated section of the cotransporter or could bind NKCC
with one or more of the residues phosphorylated. Based on this evidence, it would seem
that under control conditions only one species exists but is in complex with other
molecules. Comparison of these spots in erythrocyte samples that have been exposed to
different cotransport stimuli may yield extra information about differences in
phosphorylation on the cotransporter.
ZOOM fractionation could be used as a method for pre-fractionation of samples prior to
SDS-PAGE on large format gels. This would give greater concentration ofNKCC
within a sample and reduce the number of total proteins present. Separating the fraction
on large SDS-PAGE gels may give enough separation to allow visualisation of the
cotransporter. This method would also avoid the need for a gel-based first dimension
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separation which generally results in the loss of membrane proteins. This is an area that
could be investigated in the future.
Blue-native SDS-PAGE is an alternative method for two-dimensional separation of
proteins. Using this to look for proteins that may be in complex with cotransporter
suggested an interaction with band 3, ankyrin, spectrin, peroxiredoxin-2 and
haemoglobin. It should be noted that the levels of haemoglobin and cytoskeletal
proteins may vary depending on the stringency of the membrane sample preparation. A
link between the trout erythrocyte anion exchanger 1 and the endogenous NKCC in
Xenopus oocytes was made by Guizouarn et al (2004). Expression of the anion
exchanger resulted in increased Rb influx in oocytes. This was found not to be
dependent on the ion transport capability of the exchanger, but on a possible C-terminal
interaction with NKCC. Band 3 is known to interact with many other proteins
including ankyrin, band 4.1 and 4.2, deoxyhaemoglobin and many glycolytic enzymes
(Campanella et al, 2005; Zhang et al, 2000). The interaction between band 3 and
ankyrin provides a direct link for the membrane and the underlying cytoskeleton
including spectrin (Ding et al, 1996). The presence of ankyrin in these samples may
simply be due to its interaction with band 3. However, Michaely and Bennett (1995)
have reported that ankyrin is able to bind multiple types of membrane proteins and it is
therefore possible that NKCC directly interacts with this molecule. Haemoglobin also
interacts with the C-terminal domain of band 3, with deoxyhaemoglobin binding with
greater affinity than oxyhaemoglobin (Chetrite and Cassoly, 1985). Band 3 and NKCC
show different oxygen sensitivities. Band 3 is stimulated by oxygenation whereas
NKCC is stimulated by deoxygenation (Flatman, 2005; Drew et al, 2004). It has been
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suggested that there may be a common oxygen sensor which could coordinate the
activity of these transporters (Drew et al, 2004). Perhaps the interactions of the
cotransporter and band 3 are a part of the regulatory control of ion transport in response
to oxygen tension. Peroxiredoxin-2 was also present, a protein involved in antioxidant
defence in cells including erythrocytes (Low et al, 2007). This protein has been shown
to prevent the formation ofmethaemoglobin and is found to interact with haemoglobin
via the haem group (Stuhlmeier et al, 2003). This may be in the complex purely due to
its association with haemoglobin, but its function could be required to protect the
cotransporter and other proteins in the cell from damage by reactive oxygen species.
Figure 3.19 shows the 2-D separation of cotransporter. Assuming that these proteins
come from the larger complexes of 440 and 250 kDa (on figure 3.16), it would seem
that there is some difference to the cotransporter that is within these. T4
immunoreactivity from the 440 kDa complex separates at approximately 154 and 247
kDa, whereas the protein from the 250 kDa complex is found at 175 kDa. The proteins
found at 175 and 247 kDa may be bound to other protein(s) that shift the molecular
weight on the gel. The 154 kDa protein is likely to represent monomeric cotransporter.
These differences may reflect variability of cotransporter and its binding partners in the
erythrocyte membrane.
The BN-PAGE method has room for alteration of sample preparation, particularly with
respect to detergents used. It can tolerate different detergents, including non-ionic and
zwitterionic detergents (Krause, 2006). The non-ionic detergent dodecylmaltoside was
used in the experiments shown here but others could be used, such as those used in the
IEF/SDS-PAGE approach (CHAPS or ASB-16). This may improve the resolution of
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the complexes and result in clearer data. Pre-labelling of samples with fluorescent dyes
may allow analysis of different samples (e.g. control versus deoxygenated) within the
same 2-DE separation (Granvogl et al, 2006). This would provide direct comparison
for any differences in sample protein complex content and is of interest for future work.
Other methods of 2-DE could be used in the future to study the erythrocyte proteome.
Two SDS-PAGE steps, such as a 10% acrylamide/6 M urea tricine-SDS step followed
by a 16% acrylamide tricine-SDS step, can also resolve more proteins than either one
alone (Rais et al, 2004). This method was able to separate highly hydrophobic proteins
but was limited to those proteins smaller than 100 kDa. The cotransporter is larger than
this, meaning that it is unlikely that we would achieve good resolution ofNKCC using
this approach. 16-BAC/SDS-PAGE uses the cationic detergent benzyl-rc-
hexadecylammonium chloride in the first dimension separation, followed by standard
denaturing SDS-PAGE for the second dimension. The BAC-PAGE separates proteins,
like SDS-PAGE, according to their molecular weight (Hartinger et al, 1996). This
method has been shown to resolve hydrophobic and integral membrane proteins,
including proteins with 12 transmembrane domains (Zahedi et al, 2005). This method
is one worth investigating as it gives better resolution of either 1-D method alone, with
the benefit of not having the same protein losses as standard 2-DE does. This could be
used to compare global changes to proteins present in or at the erythrocyte membrane.
Comparison of samples with different levels of cotransport could perhaps implicate
proteins in NKCC regulation.
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{science} Mascot Search Results
User : Karen Hegney
Email : karen.hegney@ed.ac.uk
Search title : BHPAGE band dl
Database : NCBInr 20071130 <3678402 sequences; 1961803296 residues)
Taxonomy : Mammalia (mammals) <672434 sequences)
Tlnestang : 10 Dec 2007 at 13:11:33 GMT
Top Score : 78 Tor gi|119604714, peroxiredoxin 2, isoCorm CRA_a [Homo sapiens]
Probability Based Mows? Score
Protein score is -10*Log(P), where P is the probability that the observed match is a random event.
Protein scores greater than 71 are signiEcant (p<0.05).
Figure 3.21 - Example of Mascot Identification of Protein from a 2-DE Gel Separation
The example shown here is for the peroxiredoxin-2 spot shown in figure 3.20 from a two-
dimensional BN-PAGE and SDS-PAGE experiment. Scores over the threshold are
indicated in red outside the green shaded area and are considered to be significant.
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Voyajtr Spec II MC->AdvBC(15^.5,0.1 )->NF0.7->DI«>MC(BP * 1853.1,80367]
Figure 3.22 - Example of MALDI-TOF Mass Spectrum
This spectrum shown was that generated by digestion of the spot labelled peroxiredoxin-2 on
figure 3.20. The spectrum was processed using Data Explorer software. The red circled peaks
are the trypsin peaks that all other masses were calibrated to. All masses over a certain
percentage intensity are submitted to a search engine for peptide mass fingerprinting. This
spectrum generated the result shown in figure 3.21.
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Figure 3.23 - Structures of Detergents Tested in 2-D Electrophoresis
All images were obtained from www.merckbiosciences.co.uk
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Chapter 4 - Characterisation and use of new N-terminal
NKCC1 antibody for western blot and immunoprecipitation
T4 monoclonal antibody (Lytle et al, 1995) has been used successfully in western
blot, immunoprecipitation and immunohistochemical applications (Matskevich et al,
2005; Marty et al, 2002; Alvarez-Leefmans et al, 2001; Bildin et al, 2001; Maglova
et al, 1998; Crouch et al, 1997). This antibody is specific for regions in the C-
terminal portion of both NKCC isoforms. Although raised against human
cotransporter, due to the homology that exists in these regions, it also recognises
NKCC from many other animal species. However, T4 antibody is specific only for
SDS-denatured cotransporter and therefore limits its use. In order to gain more
specific information about the basolateral or housekeeping isoform, NKCC1, it
would be advantageous to have an effective antibody to this isoform only. An
antibody raised against two sequences in the N-terminal portion of human NKCC1
was custom-made (dubbed Nl) and tested in western blot and IP applications.
4.1 - N1 Antibody Information
Rabbits were immunised with peptide sequences from the N-terminus of human
NKCC1. These regions are P71- F84 (PLGPTPSQSRFQVD) and R240 - F255
(RPSLAELHDELEKEPF). These peptides were synthesised with a terminal
cysteine residue to allow coupling to a carrier protein and/or sepharose beads via
sulfhydryl linkage. Covalab, France, (www.covalab.fr) prepared the peptides,
immunised the animals and supplied us with pre-immune and immune sera. They
also supplied immobilised peptides on a gel matrix to allow peptide-purification of
the Nl polyclonal antibodies.
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4.2 - Western Blotting Using N1 Antibody
Ferret erythrocyte membrane proteins (approximately 5pg total membrane protein)
were separated by SDS-PAGE. After transfer onto nitrocellulose or PVDF, NKCC
protein was probed for with T4 monoclonal antibody (1 in 4000 dilution; 18.5pg
total Ig in 20ml total volume), N1 peptide-purified antibody (1 in 2500 dilution;
7.2pg peptide-pure antibody in 20ml total volume) and N1 immune-serum. Figure
4.1 shows a comparison of a western blot using T4 as primary antibody, with that of
N1 peptide-purified antibody. These both show strong bands of immunoreactivity
with a molecular weight of around 146kDa, as calculated using TotalLab software.
Measurements from experiments on five different samples gave a mean value of 146
± 4 kDa (X ± (7) for N1 and 146 ± 2 kDa for T4. An unpaired t test reports that these
means are not significantly different (p = 0.9550). Commonly, bands of apparent
molecular masses above 200 kDa are seen using both antibodies. The presence of
these varies, but the band of "monomer" mass is always present and strong. The
larger bands will be discussed in later chapters of this thesis. The use of immune
serum was also tested for immunoblotting. Sera from two rabbits, bled 81 days after
immunisation, were tested. Several dilutions were used to assess the optimal usage
of the serum. Figure 4.2 shows that NKCC could be detected on blots of ferret
erythrocytes using sera diluted 200 or 1000 fold. By visual comparison of figures
4.1 and 4.2, it is clear that using peptide-purified antibody results in stronger western
blot immunoreactivity from the same amount of starting protein. Also, with the use
of serum, there is always the possibility of cross-reactivity of the secondary antibody
to other rabbit proteins present and as such, the peptide-pure antibody gives a cleaner
result. The predicted mass for human NKCC1 is calculated at 132 kDa (protein
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Figure 4.1 -Western blot detection of NKCC using T4 and N1 antibodies
Ferret red blood cell (RBC) membranes (5pg per lane) were separated by SDS-
PAGE and transferred to nitrocellulose. T4 monoclonal antibody and peptide-
purified N1 antibody were used to detect NKCC protein. Some guide molecular
masses are shown and were taken from a biotinylated protein ladder.
sequence NP_001037 from NCBI protein database) using the Compute pI/MW tool
from the Expasy tools website (www.expasy.ch/cgi-bin/pi_tool). The apparent
molecular mass on SDS-PAGE gels may vary from the predicted mass due to
glycosylation. Figure 4.3 shows an example of three experiments, where ferret red
blood cell membranes were treated with N-glycosidase F and the molecular masses
then calculated. Treatment reduced the apparent molecular mass of the cotransporter
from 147 ± 3 kDa to 135 ± 4 kDa (2) ± (7), which correlates with the predicted mass
for human NKCC1. A two-tailed unpaired t test implies that these means are
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significantly different (p = 0.0129). This gives further weight to the conclusion that
the protein detected by N1 antibody in ferret samples is indeed NKCC1.
1 in 200 1 in 1000
Figure 4.2 -Western blot detection of NKCC using N1
immune serum
SDS-PAGE separated ferret RBC membrane proteins (5pg per
iane) were transferred to nitrocellulose and the blots probed with
immune serum at dilutions of 1 in 200 and 1 in 1000. A guide
molecular mass is shown which was taken from a biotinylated
protein ladder.
4.3 - N1 Westerns on Various Tissues from Different Animal Species
Although the antibody was raised to sequences from human NKCC1, figures 4.1 and
4.2 clearly show detection ofNKCC 1 from ferret red blood cells. BLAST of the
peptide sequences shows their presence in a variety of animal species with 100%
sequence identity (shown in table 4.1). Recent work from our laboratory indicates
that both peptides are present in the ferret cotransporter sequence (Hannemann,
unpublished). For comparison, western blot experiments were carried out on various
tissues from ferret and on rat erythrocytes (figure 4.4). Although kidney expresses
high levels of the NKCC2 isoform, there is also expression ofNKCC 1 (Delpire et al,
1996). Salivary glands and testes are known to express NKCC1 (Flemmer et al,
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2002; Delpire et al, 1994; Xu et al, 1994), and although there are no published
immunohistochemical or western blot data for rat erythrocytes, there is strong
evidence from cotransport studies to suggest that NKCC is present (Hannaert et al,
2002; Mairbaurl et al, 2000; Alvarez-Guerra et al, 1998). All samples show a band
of immunoreactivity at positions between 130-176 kDa, except for the bacterial cell
lysate (donated by Heather McLafferty) which was included as a negative control.
The variability of these apparent molecular masses may be due to the cotransporter
being differently glycosylated from the various tissues. Also, there may be species













Figure 4.3 - Deglycosylation of ferret erythrocyte NKCC
Recombinant N-glycosidase F was used to deglycosylate
ferret erythrocyte membranes. T4 antibody was used to
detect NKCC protein. Apparent molecular mass was
measured using TotalLab software by comparison to a
biotinylated protein ladder (BPL).
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Figure 4.4 - Detection of NKCC1 from different tissues and species
using N1 peptide-purified antibody
Isolated cell membrane (or bacterial cell lysate in the case of the negative
control) proteins were separated by SDS-PAGE and transferred to

















Table 4.1 - Proteins with N1 antibody sequence determinants present
A non-redundant database search using Blastp (protein-protein) reveals the
presence of the sequences used to create the N1 antibody in NKCC1 of all
mammalian species recorded. Blastp can be found at
www.ncbi.nlm.nih.gov/BLAST.
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4.4 - N1 Immunodetection of Phosphorylated NKCC1
The Na-K-2C1 cotransporter has previously been shown to be phosphorylated on






Figure 4.5 - N1 antibody binding is not affected by the phosphorylation
state of the cotransporter
Ferret erythrocyte membrane samples (n=3) of differing NKCC
phosphorylation state were prepared for SDS-PAGE according to total protein
content (10pg). Optical densities for each band were obtained using TotalLab
software. These values were normalised to the density of a sample of known
protein content (from a molecular weight marker reference). This allowed the
optical densities to be corrected for slight variations in sample protein
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peptide sequences used to create the N1 antibody contain serine residues and peptide
P71- F84 contains one threonine. Although it is not known whether or not these
residues could be phosphorylated on the cotransporter, it is important to test whether
or not NKCC phosphorylation could cause altered N1 antibody binding. Ferret
erythrocyte membranes, isolated from cells that had first been exposed to conditions
that increase or reduce phosphorylation on the cotransporter, were prepared for SDS-
PAGE and transferred to nitrocellulose. Deoxygenation or treatment of cells with
calyculin A results in increased cotransporter activity (Matskevich et al, 2005;
Flatman, 2005) and as shown in chapter 5, increased cotransporter phosphorylation.
The removal of cell magnesium results in the inhibition of kinases and reduces
phosphorylation and cotransporter activity (Matskevich et al, 2005). N1 peptide-
purified antibody was then used to detect NKCC1 and the blots were analysed using
TotalLab software. Figure 4.5 demonstrates that, regardless of cotransporter
phosphorylation, N1 antibody binds to NKCC1.
4.5 - Immunoprecipitation Using N1 Antibody
This set of experiments was to determine whether the N1 antibody could effectively
immunoprecipitate NKCC protein. Ferret membrane samples were prepared for
immunoprecipitation. A number of different control and test conditions were
examined and are described in table 4.2 and demonstrated in figure 4.6. A major
band is detected at ~150kDa after IP with either T4 or N1 antibody, which is not
present in the negative control samples (lanes 4 and 5). Using pre-immune serum
(denoted NlPi in figure 4.6) does not result in the presence of the major band. The
band was not present in the absence of erythrocyte membrane protein. These tests
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Table 4.2 - N1 Immunoprecipitation Test Samples
The upper section of the table describes the samples shown in figure 4.6 (left panel) and
the lower section represents figure 4.6 (right panel). Y = yes N = no GAM = goat anti-
mouse antibody GAR = goat anti-nabbit antibody ddH20 = double glass distilled water
confirm several important features. Firstly, inoculation with NKCC1 specific
peptides is responsible for the immunoreactive antibodies found in the rabbit serum.
Also, when sample was not included bands were not found at NKCC1 monomer
molecular weight. This shows that those detected in lanes 1-3 are likely to be
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SDS + + - - + -
IP antibody T4 N1 N1 N1 Pi N1 T4 T4
RBC + + + + + +
Figure 4.6 - Immunodetection of NKCC after immunoprecipitation of ferret
erythrocyte membrane proteins using T4 and N1 antibodies
T4 (left panel) and N1 (right panel) immune serum antibodies were used to
detect NKCC protein. Some guide molecular weights are shown and were
calculated from a biotinylated protein ladder that was run on the gels alongside
the samples.
specific to the ferret sample and not any cross-reactivity with proteins in the immune
serum or to the T4 ascites. Lane 1 shows a number of additional bands. The IP
antibody here was T4 monoclonal mouse IgG. The western blot detection antibody
was also T4 and as such the secondary antibody (goat anti-mouse) will detect the IP
antibody. Results of further investigations of this are shown in figures 4.7 and 4.8.
This experiment also demonstrates that there is no requirement for SDS-denaturation
of the membrane sample prior to immunoprecipitation with N1 antibody, as
demonstrated in lanes 2 and 3 in fig 4.6. On the other hand, lanes 6 and 7 highlight
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how necessary it is for NKCC to be SDS-denatured before immunoprecipitation with




T4 IP N1 IP N1 IP T4 IP
Figure 4.7 - Secondary antibody probe of IP samples
After IP of ferret membrane proteins, SDS-PAGE and transfer to
nitrocellulose, proteins were detected using only secondary antibodies
as probes. The left panel shows the results of a western blot using
goat anti-mouse (GAM) antibody. The right panel shows the results of
a western blot using goat anti-rabbit (GAR) antibody. Some guide
molecular masses are shown and were taken from a biotinylated
protein ladder run alongside the samples.
immunoreactivity is present in comparison to the sample where our standard protocol
is used (see chapter 2 for details of protocol). As mentioned, experiments were
conducted to assess any cross-reactivity ofwestern blot secondary antibodies to those
used in immunoprecipitation and the results are shown in figures 4.7 and 4.8. In both
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figures, no bands are visible at the expected cotransporter monomer molecular
weight position of 140-160kDa, showing that the secondary antibodies used
throughout do not cross-react with NKCC. The left panel of figure 4.7 shows several
bands of GAM reactivity to T4 antibody. This is not surprising as T4 was raised in
mouse. However, there are bands other than the expected heavy and light chains
(approximately 55kDa and 25kDa respectively) and show the same pattern as those
in figure 4.6 lane 1. Although T4 is a monoclonal antibody, it comes as ascites fluid
and there may be other antibodies/proteins from the mouse that GAM reacts with.
Importantly, there is no reactivity ofGAM to N1 antibody. The right panel shows
that GAR does not react with T4 antibody. GAR only appears to detect the heavy
chain of the N1 antibody.
Figure 4.8 shows that when these antibodies are run as the protein sample and probed
with secondary antibody on a western blot several bands are visible. Again, most are
likely to correspond to antibody heavy and light chains. Several different amounts of
T4 antibody were prepared to determine if the extra bands found were present in the
ascites fluid, or pulled out from the ferret sample during immunoprecipitation. More
bands appear with increasing antibody amount and are marked with asterisks on the
figure and appear correspond to those found on figure 4.6 lane 1. This confirms that
this reactivity is inherent to the T4 antibody ascites fluid /GAM interaction and not to
GAM showing cross-species immunoreactivity to ferret proteins. This experiment
also confirms that shown in figure 4.7, namely, that GAM does not detect ferret or
rabbit protein and that GAR does not detect ferret or mouse protein.
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Figure 4.8 - Immunoreactivity of secondary antibodies to T4 and N1
The left panel shows a western blot using only goat anti-mouse (GAM)
secondary antibody as the probe. Different amounts of T4 antibody were
used to highlight the increase in number of bands present that are
detected by GAM. The right panel shows a western blot using only goat
anti-rabbit (GAR) secondary antibody as the probe.
4.6 - Using the N1 Antibody in Co-lmmunoprecipitation Experiments
4.6.1 -Western Blotting
Other studies have shown that the SPAK and OSR1 kinases directly interact with the
cotransporter (Gagnon et al, 2007a; Piechotta et al, 2002). Using antibodies gifted
by the Alessi group (Dundee), the interaction of these kinases with the cotransporter
from ferret erythrocytes was examined by western blots ofNl-immunoprecipitates.
Figure 4.9 shows bands at expected molecular masses for SPAK (approximately 66
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kDa) based on the migration of this on SDS-PAGE gels in other animal species
(Ushiro et al, 1998). Phosphorylated SPAK is also present in immunoprecipitates.
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Figure 4.9 - N1 Immunoprecipitation of SPAK with NKCC
Ferret erythrocyte membranes (150 pg total protein) were
immunoprecipitated with N1 peptide-purified antibody and
protein G-sepharose. Western blots were performed using
total and phospho-SPAK antibodies. Molecular weights were
taken from a biotinylated protein ladder.
Other bands are visible at an estimated molecular mass of 75 kDa when using the
total SPAK antibody. This antibody was raised to peptide that is present in both
SPAK and OSR1. However, OSR1 has been shown to migrate at around 58 kDa on
SDS-PAGE gels (Chen et al, 2004) and it unlikely that this is what is present at this
higher position on the western blot. Unfortunately, as figure 4.10 shows, SPAK is
also present in negative control samples and so we cannot make any assumptions
about the relative amounts found in the N1 immunoprecipitates shown in figure 4.9.
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Figure 4.10 - Co-lmmunoprecipitation with NKCC1
Control and deoxygenated ferret erythrocyte membrane
samples (150pg total protein) were mixed N1 peptide-
purified antibody and protein G-sepharose beads.
Immunoprecipitates were run on SDS-PAGE gels and
western blots probed with various antibodies. Samples
mixed with beads and no antibody are included as
negative controls. Molecular weights were interpolated
from a biotinylated protein ladder.
Figure 4.10 also shows that protein phosphatase 1 (PP1) is present in N1 and bead
negative control samples. Even though PP1 has been shown to co-precipitate with
the cotransporter in previous studies (Darman et al, 2001) and that cotransporter also
is pulled down with PP1 using microcystin-sepharose (Matskevich et al, 2005), we
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cannot infer anything from these experiments due to the presence of PP1 in the
negative controls. However, these experiments do demonstrate the presence of these
regulatory proteins in the ferret erythrocyte and they may therefore be involved in
cotransport regulation. Using an antibody to the erythrocyte anion exchanger, band
3, we see the presence of this in N1 immunoprecipitates, but not in negative controls.
This is suggestive ofNKCC1 interaction with band 3 in the ferret erythrocyte
membrane.
4.6.2 - N1 Immunoprecipitation, SDS-PAGE and Mass Spectrometry
Attempts were made to isolate proteins interacting with NKCC1 by larger scale
immunoprecipitation and separation of resulting proteins by SDS-PAGE. Figure
4.11 shows an example of a gel with ferret erythrocyte membrane proteins after N1
or bead only IP experiments. The only different bands between test and control
samples were the IP antibody heavy and light chains, which were identified as rabbit
IgG by MALDI-TOF mass spectrometry. Pre-clearance of the samples with protein
G-sepharose results in the loss ofmost bands on the gel, as shown in figure 4.12.
Again, apart from the heavy and light chains of the N1 antibody itself, there is little
that is distinct between the test and control samples. However, a very faint band of
approximately 150 kDa is present in the test samples and not in the negative control.
This band was excised and digested with trypsin and a mass spectrum generated
using MALDI-TOF. Peptide mass fingerprinting revealed no positive significant
identification for this protein. Using a shotgun approach, N1 antibody
immunoprecipitates were subjected to LC-MS/MS and subsequent Mascot MSMS
ions search revealed the presence of malate dehydrogenase and heat shock 70 kDa
protein 8 as well as antibody fragments, which are to be expected. Peptides for band
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3 were also present but not enough peptides were present to make the score for this
















Figure 4.11 - Large Scale N1 Immunoprecipitation
Ferret erythrocyte membranes (500 pg total protein) were
prepared for immunoprecipitation with N1 antibody.
Samples were pre-cleared with protein G-sepharose and this
was also used as a control for comparison with the sample
including antibody. The molecular masses were interpolated
from the SeeBlue® Plus2 marker set from Invitrogen.
This is a common problem when conducting work of this type and is often difficult
to avoid. Due to their abundance they can mask less common peptides during the
liquid chromatography and mass spectrometry steps and could account for the non-
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significant score for band 3. These peptide matches were also observed using the
Phenyx search tool (see Appendix for supplementary data). However, at no point
were peptides for the cotransporter observed and thus any proteins identified from
these experiments cannot truly be suggestive of protein interactions with NKCC.
Figure 4.12 - N1 IP of a 150 kDa Protein from Ferret Erythrocytes
Pre-cleared samples (500 pg total starting protein) were mixed with
N1 and protein G-sepharose beads or beads alone and the resultant
precipitated proteins separated by SDS-PAGE. Molecular weights
shown are from the HiMark™ marker set made by Invitrogen.
4.7 - Discussion of results
Overall, these experiments indicate that the custom-made N1 antibody is effective at
western blot detection and immunoprecipitation of a protein that is consistent with
the Na-K-2C1 cotransporter. The previously characterised T4 monoclonal antibody
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is commonly used as the 'gold standard' in NKCC antibodies. N1 immuno-detects
protein that migrates on SDS-PAGE gels at the same position as T4 detects.
Deglycosylation of the cotransporter reduces the apparent molecular mass to that
similar to the predicted molecular mass for human NKCC1, to which the N1
antibody was raised. This, along with the evidence from known NKCC 1 expressing
tissues, is suggestive that N1 does indeed detect NKCC1. Also, this interaction is not
inhibited by the phosphorylation state of the cotransporter. This antibody does not
detect protein from a bacterial cell lysate, which serves as a useful negative control.
Although an uncharacterised homologue is found in cyanobacterium Synechococcus
species (Park and Saier, 1996), NKCCs are generally not found in bacteria. What is
not tested is whether or not the N1 antibody detects NKCC2. As mentioned, kidney
is cited as the only source ofNKCC2, but it also expresses NKCC1. Without a pure
source ofNKCC2 protein this aspect of the N1 antibody must go uncharacterised.
N1 is also effective for use as an immunoprecipitation antibody. Most importantly,
SDS-denaturation is not required for this interaction to occur. Unlike T4 antibody,
this allows the use of the N1 antibody for co-immunoprecipitation experiments.
Using the antibody for larger scale co-IP experiments had disappointing results. The
only protein observed on SDS-PAGE gels in test samples not found in control
samples was not able to be identified by MALDI-TOF mass spectrometry. This may
have been due to an issue with protein abundance as the bands were always very
faint. Due to the migration of this protein on SDS-PAGE gels at approximately 150
kDa it may even have been the cotransporter itself, but without positive mass
spectrometry identification this is only a speculation. Although ferret erythrocytes
possess greater amounts of cotransporter compared to red cells from other animal
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species it is still present at fairly low levels. This is reflected by the LC-MSMS data
ofN1 immunoprecipitates, where no NKCC was detected. This issue could be
further affected by the nature of the sample itself, where the fairly gentle method of
erythrocyte membrane preparation results in there being large amounts of remaining
haemoglobin and cytoskeletal proteins present. Perhaps this technique would be put
to better use in samples with higher levels of cotransporter expression, but still
represents a sensitive and useful technique for the detection of cotransporter
interacting proteins.
SPAK has been shown to interact with NKCC in yeast-2-hybrid assays and co-IP
experiments from brain lysates (Piechotta et al, 2002) and is known to be a
cotransporter kinase (Vitari et al, 2006). SPAK and OSR1 have been shown to
phosphorylate the cotransporter in response to hyperosmotic stress (Zagorska et al,
2007; Villa et al, 2007). Exposure of ferret erythrocytes to conditions that increase
or decrease cotransport activity, followed by membrane preparation and
immunoprecipitation with the N1 antibody allows investigation of any differences in
binding of proteins to the cotransporter. Western blotting ofN1 immunoprecipitates
showed the presence of SPAK and/or OSR1, as detected by an antibody that is
specific for regions present in both of these cotransporter kinases. However, the
presence of SPAK immunoreactivity in sepharose-bead (no IP antibody) negative
control samples prevents any comparison being made about the binding of SPAK
and phosphorylated SPAK (and therefore activated) to the cotransporter under any of
the conditions shown. The total SPAK antibody shows the presence of a band at an
unusual molecular weight of approximately 75 kDa. This does not correspond to any
published masses for either SPAK or OSR1. BLAST (Basic Local Alignment Search
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Tool) of the human SPAK amino acid sequence brings up a sequence for a putative
SPAK in dog, which is approximately 75 kDa in size. As dog and ferret are both
within the order of Carnivora and it is possible that ferret may have a kinase of
similar size which could account for the bands detected at this position on the
western blots. PP1 was also detected in the ferret red blood cell, but as with the
findings for SPAK, the phosphatase is also precipitated with protein G-sepharose.
As calyculin A stimulates increased cotransport and increased threonine
phosphorylation (as shown in chapter 5) it is strongly suggestive of a role for PP1 in
NKCC regulation. Unfortunately, the data presented in this chapter are unable to
provide further insight into the role of PP1 in cotransport regulation.
Band 3 is detected by antibody and mass spectrometry from N1 immunoprecipitates.
Other studies have looked at the interaction of this protein with the cotransporter. As
already mentioned in section 3.3, the trout erythrocyte anion exchanger has been
shown to change the activity of endogenous NKCC in Xenopus oocytes when
expressed in these cells (Guizouarn et al, 2004). The evidence from this paper, the
presence of band 3 in complex with the cotransporter (suggested in chapter 3 of this
thesis) and the co-IP of the protein with NKCC1 shown in this chapter do imply an
interaction of these two proteins. The presence of malate dehydrogenase may be due
to an interaction with band 3, as it is known to bind a number of glycolytic enzymes
under oxygenated conditions (Campanella et al, 2005). It would be of interest to see
if this protein is still detectable from N1 immunoprecitates from deoxygenated red
blood cell samples. The presence of a heat shock protein may present a direct
interaction with the cotransporter. Heat shock protein 90 has been shown to interact
with NKCC1 (Simard et al, 2004b), and so it may be feasible that HSP70 directly
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interacts with the cotransporter itself, rather than indirectly via Band 3 as is likely to
be the case with malate dehydrogenase. These proteins may represent the NKCC
environment under basal cotransport conditions. It will be of interest to study
interactions in stimulated cells, to identify further NKCC regulatory proteins. This
method and others could be used to achieve this. Using, for example, GST-NKCC
fusion proteins we could fish for interactions by using the affinity ofGST for
glutathione (on beads). Cell lysates would be mixed with the NKCC fusion protein
and beads and any interacting proteins could be pulled-down and identified by mass
spectrometric methods (Monti et al, 2005). This method will only reflect the in vitro
situation and may not help when assigning functional significance to interactions.
Cross-linking of proteins, and then capture of these with the N1 antibody, could
allow more meaningful identification of proteins interacting with NKCC. A method
described by Vasilescu et al (2004) involves treating samples with cell permeant
formaldehyde and immunocapture of desired protein complexes. Boiling of the
samples in SDS reverses the cross-links and allows separation of the individual
proteins again by SDS-PAGE. Mass spectrometry was used to identify individual
proteins. This method is useful in that it allows for more stable isolation of protein
complexes, which may otherwise dissociate during sample preparation. This could
uncover novel interacting partners for NKCC.
A method that shows far fewer non-specific protein interactions in complexes is
known as tandem affinity purification (TAP). This involves the expression of a
desired protein containing two affinity tags, protein A and calmodulin-binding
peptide, which are separated by a tobacco etch virus (TEV) protease cleavage site
(Puig et al, 2001). This allows affinity purification first by an IgG column and then
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cleavage of the complex with the TEV protease. This is then further purified using a
calmodulin column and elution is achieved by alteration of calcium concentration.
The eluents are analysed by mass spectrometric methods. This approach was
originally developed in a yeast expression system, but has now been developed for
examination of mammalian proteins (Knuesel et al, 2003). This allows more
appropriate expression of mammalian proteins of interest and importantly, they can
be expressed at near physiological levels meaning that any information obtained
from these experiments has more physiological relevance than systems where
proteins are over-expressed.
Changes to the LC-MSMS method itself could result in greater numbers of peptides
being found. The protocol used here was fairly short and it may be that many
peptides remained on the column after the run was complete. These simple
modifications could improve the method described in this thesis. Also, multi¬
dimensional liquid chromatography could be used. For example, strong cation
exchange chromatography could be used for the first dimension separation with
reverse-phase HPLC (performed in this thesis) as the second (Tomer, 2001). This
would allow improved resolution of these complex sample mixes and may help to
identify more proteins. This could also be used for the study of the blue-native
PAGE complexes described in chapter 3.
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Chapter 5: Phosphorylation of the Na-K-2CI Cotransporter
Phosphorylation of the Na-K-2C1 cotransporter is linked to its transport activity.
Lytle (1997) showed a proportionate increase in duck erythrocyte NKCC
phosphorylation in response to a variety of cotransport activating stimuli. Studies of
NKCC recovered from shark rectal gland have identified three key threonine
residues, in the cytoplasmic N-terminal region, that are phosphorylated when the
cotransporter is active (Darman & Forbush, 2002) and more recently, another two
residues have been mapped to this region (Vitari et al, 2006). However, there may
be other threonine or serine residues whose phosphorylation could modulate
cotransporter function. Indeed, activation ofNKCC in duck erythrocytes shows the
cotransporter to be phosphorylated at both threonine and serine sites, but not
phosphotyrosine, within the N- and C-termini (Lytle, 1997). This chapter includes
analysis of general threonine phosphorylation on the ferret erythrocyte cotransporter
and investigates threonine phosphorylation of the residues that are thought to be key
in NKCC regulation.
5.1 - NKCC Phosphorylation Using General Phospho-Antibodies
5.1.1 - Tyrosine phosphorylation
Phosphorylation of tyrosine residues on the cotransporter is not considered to occur
(Lytle, 1997). Western blot analysis of total phosphotyrosine was examined in T4
immunoprecipitates from ferret RBCs, after SDS-PAGE separation as shown in
figure 5.1. A number of sample conditions are shown. The left hand panel of figure
5.1 represents samples where cotransport rate was reduced by the effects of
inhibiting kinase activity, whereas the right hand panel shows those samples where
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cotransport activity was increased (as determined by Rb flux; Flatman and Creanor,
1999a and 1999b). No phosphotyrosine was observed on the cotransporter and this
did not change under any of the conditions used to modulate cotransport. This
provides further evidence that the activity ofNKCC is not modulated by addition of
phosphate to tyrosine residues.
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Figure 5.1 - Phosphotyrosine on T4 Immunoprecipitated NKCC from Ferret RBCs
All cells were incubated with 11 mM glucose in FBM for 10 minutes at 38° C to allow cells to
equilibrate, before treatment to inhibit or activate NKCC cotransport. The following additions
were made: none (control), 50 pM PP1 for 30 minutes, 2 pM staurosporine for 20 minutes, 2
mM Tris-EDTA plus 10 pM A23187 for 15 minutes (Mg2+free), 50 nM Calyculin A for 15
minutes, 1 mM Na+ arsenite for 60 minutes, 50 nM Calyculin A and 1 mM Na+ arsenite for
60 minutes (Cal/Asn). In each immunoprecipitation, 150 pg of total membrane protein was
included. The + control sample is a phosphotyrosine positive cell lysate (Zymed) and anti-
phosphotyrosine antibody was used as the primary antibody. A biotinylated protein ladder
(BPL) is shown alongside.
5.1.2 - Threonine phosphorylation
To show threonine phosphorylation of the cotransporter, T4 monoclonal antibody
was first used to precipitate protein from ferret erythrocyte cell membranes. The
immunoprecipitates were separated by denaturing SDS-PAGE and transferred to
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nitrocellulose for immunodetection with anti-phosphothreonine antibodies. This
method allows visualisation of total threonine phosphorylation (detectable by the
antibody), and also gives an easy method of comparison. As such, cell membranes
from ferret erythrocytes, treated with various compounds that affect cotransport rate,
are directly comparable on a single blot. Figure 5.2 shows a representative western
blot of anti-phosphothreonine on NKCC under unstimulated control conditions and
treatments where cotransporter activity is increased with pharmacological agents and
figure 5.4 shows the same, but with deoxygenated samples, a strong physiological
stimulus of cotransport (Flatman, 2005). An increase in threonine phosphorylation is
seen when cells are under stimulating conditions and lower levels of phosphorylation
are present on cells under normal conditions. The optical densities of each sample
were calculated using TotalLab software and normalised to the control within each
experiment. This allows comparison of phosphorylation between each sample.
Treating erythrocytes with a number of different compounds that inhibit protein
kinase activity reduces NKCC threonine phosphorylation, but does not abolish it
completely. Figure 5.3 shows this with phosphorylation levels relative to control
cells. In all cases, phosphorylation is reduced, but never completely lost. These
experiments show (see also Matskevich et al, 2005) that the overall trend in ferret
erythrocytes fits with that observed in other animal species, where inhibition of
phosphatases increases NKCC phosphorylation and inhibition of kinases reduces
NKCC phosphorylation. Arsenite, particularly in combination with Calyculin A,
produces the greatest increases in threonine phosphorylation. General kinase
inhibition by removal of cell magnesium and inhibition of serine/threonine kinases
with staurosporine results in an expected reduction of cotransporter phosphorylation.
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Although we do not observe tyrosine phosphorylation on the cotransporter, treatment
of cells with genistein and PPli (considered to be tyrosine kinase inhibitors) results
in reduced threonine phosphorylation. Table 5.1 summarises the changes in























Calyculin A Arsenite Cal/Asn Control
Figure 5.2 - Phosphothreonine on T4 immunoprecipitated NKCC
All cells were incubated with 11 mM glucose in FBM for 10 minutes at 38°C
to equilibrate. The following additions were then made: none (control), 50
nM Calyculin A for 15 minutes (Calyculin A), 1 mM Na+ arsenite for 60
minutes (Arsenite), 50 nM Calyculin A and 1 mM Na+ arsenite for 60
minutes (Cal/Asn). A guide molecular mass is shown and was interpolated
from a biotinylated protein ladder using TotalLab software. Error bars
show ± standard deviation. These data were compiled from replicate
experiments on samples from three different ferrets using a total
phosphothreonine antibody.
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Figure 5.3 -Kinase Inhibition Reduces NKCC Threonine Phosphorylation
All cells were incubated with 11 mM glucose in FBM for 10 minutes at 38°C to allow
cells to equilibrate, before treatment to inhibit or activate NKCC cotransport. The
following additions were made: none (control), 50 pM PP1 for 30 minutes, 2 pM
staurosporine for 20 minutes, 2 mM Tris-EDTA plus 10 pM A23187 for 15 minutes
(Mg2+ free), 50 pM genistein for 20 minutes. A guide molecular mass is shown and
was interpolated from a biotinylated protein ladder using TotalLab software. Error bars
show ± standard deviation. These data were compiled from replicate experiments on
samples from three different ferrets using a total phosphothreonine antibody.
Increased
Phosphorylation
Calyculin A Arsenite Calycutin A/Arsenite Deoxygenated
2.5 3.0 5.5 2.0
Decreased
Phosphorylation
PP1 Genistein Staurosporine Mg2+ free
0.55 0.5 0.45 0.55
Table 5.1 - Threonine Phosphorylation of NKCC as a Proportion of Control Levels
These data were compiled from replicate experiments from at least three different ferrets and
shows average levels of phosphorylation in comparison to control samples, apart from
deoxygenated samples where data from only two ferrets were available.
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Control Deoxygenated
140 kDa mk 41 i fe--
Figure 5.4- Deoxygenation Increases NKCC Threonine Phosphorylation
This shows a representative western blot using a total phosphothreonine
antibody from replicate experiments from two ferrets. Deoxygenation was
achieved according to Flatman (2005). A guide molecular mass is shown
which was taken from a biotinylated protein ladder.
5.2 - NKCC Phosphorylation Using NKCC-Specific Antibodies
5.2.1 - Membranes
Ferret red blood cell membranes were run on SDS-PAGE gels and probed with
antibodies that were raised against certain threonine phosphorylated residues of the
cotransporter itself. Figure 5.12 (and figure 1.8) shows which threonine residues
each of these antibodies detect. R5 was raised against a doubly phosphorylated
peptide (Thr206 and Thr211 in mouse) and NKCC-P was raised against a triply
phosphorylated peptide (Thr197, Thr201 and Thr206 in mouse). These antibodies
overlap by one of these phosphorylated threonine residues, all of which reside in the
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Figure 5.5 - Threonine Phosphorylation Using NKCC Specific Antibodies
Each lane of an SDS-PAGE gel was loaded with 10 pg of total protein. A western blot
using the N1 antibody is shown to demonstrate that changes in threonine
phosphorylation are not due to differences in the amount of NKCC present in the
sample. A guide molecular mass is shown, which was taken from a biotinylated protein
ladder. These images are representative of replicate experiments from one ferret only.
shows western blots ofmembranes from cells that were inhibited or activated for
cotransport. A blot using the N1 antibody shows that each sample has similar
amounts of cotransporter. Phosphorylation of residues 206 and 211, as detected by
the R5 antibody, is increased upon stimulation of cotransport with deoxygenation
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and calyculin A and reduced when cotransport is inhibited by removal of cell
3-i
Figure 5.6 - R5 Phosphorylation of Ferret Erythrocyte Membranes
Ferret erythrocytes were incubated with 11 mM glucose in FBM for 10 minutes at 38°C to
allow cells to equilibrate, before treatment to inhibit or activate NKCC cotransport.
Deoxygenation was achieved according to Flatman (2005) and all other treatments were
as previously described. Normalised phosphorylation is given as optical density relative to
control. R5 antibody was used as primary antibody and a guide molecular mass is shown
from a biotinylated protein ladder. These images are representative of replicate
experiments from one ferret only.
magnesium, as shown in figure 5.6. The relative levels of phosphorylation largely
follow those presented in table 5.1. However, the pattern of phosphorylation
observed when the NKCC-P antibody is used as a western probe shows some
differences (figure 5.7). Most obvious is the reduction of phosphorylation seen in the
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e 3-1
Figure 5.7 - NKCC-P Phosphorylation of Ferret Erythrocyte Membranes
Ferret erythrocytes were incubated with 11 mM glucose in FBM for 10 minutes at 38CC
to allow cells to equilibrate, before treatment to inhibit or activate NKCC cotransport.
Treatments were as previously described. Normalised phosphorylation is given as
optical density relative to control. NKCC-P antibody was used as primary antibody and
a guide molecular mass is shown from a biotinylated protein ladder. These images are
representative of replicate experiments from one ferret only.
deoxygenated samples. Although the overall trend is for an increase in threonine
phosphorylation on the cotransporter when red cells are deoxygenated (figure 5.4),
this antibody detects a visually obvious but not quite statistically significant
reduction (p = 0.0903). However, figures 5.6 and 5.7 were constructed from
replicate determinations of phosphorylation level, for each condition, from one
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animal only. The experiment must be repeated with blood from other animals to test
the significance of the findings. The other conditions follow the same trend as the
R5 and total threonine phosphorylation antibodies.
5.2.2 - Immunoprecipitated NKCC
In order to be able to compare phosphorylation using the R5 and NKCC-P antibodies
with total threonine phosphorylation on the cotransporter, immunoprecipitation
experiments were performed using both the N1 antibody described in chapter 4 and
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Figure 5.8 - Threonine Phosphorylation on Immunoprecipitated NKCC
N1 and T4 antibodies were used to immunoprecipitate NKCC from ferret erythrocyte
membranes that had been exposed to treatments that activate or inhibit cotransport. Each
sample contained 150 pg total ferret protein. Total phosphothreonine (PThr), R5 and NKCC-P
antibodies were used in western blots of immunoprecipitated protein. A guide molecular mass
is shown from a biotinylated protein ladder. Representative blots are shown from replicate
experiments from at least one ferret.
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the well characterised T4 antibody. Figure 5.8 shows western blots using the various
antibodies to detect phosphothreonine. Here we see that R5 antibody follows the
same pattern as total phosphothreonine, but that the NKCC-P antibody again differs.
When the N1 antibody, which is specific for the NKCC1 isoform, is used to
immunoprecipitate the cotransporter we see a reduction of phosphorylation when
cells are deoxygenated. When the T4 antibody is used, there is an increase in
phosphorylation observed that mimics the trend for total phosphothreonine. Figures
5.9-5.11 show the levels of phosphorylation compared with control samples for each
of the three antibodies used. Total phosphothreonine (figure 5.9) is comparable
between N1 and T4 immunoprecipitates. This is not the case for the NKCC-P
antibody, where a significant rise in phosphorylation was not detected in
deoxygenated samples (figure 5.10). In some cases a reduction of phosphorylation
was observed when using the N1 antibody to immunoprecipitate NKCC. However,
as the error bars show, there is overlap between this and the samples where T4 was
the immunoprecipitation antibody. There is an increase in phosphorylation detected
by the NKCC-P antibody, when cells are treated with calyculin A. There is only a
small decrease observed when cell magnesium is removed. Figure 5.11 shows a
comparison of phosphorylation on NKCC, detected by the R5 antibody. Although
the errors are greater, this antibody follows the same trend as that observed when
using the total phosphothreonine antibody. There is a doubling of phosphorylation
when cells are deoxygenated and a tripling of phosphorylation when cells are treated
with calyculin A. Like total phosphothreonine, reduction of cell magnesium results
in phosphorylation levels on the cotransporter being roughly half that of control.
Table 5.2 pools all of the normalised phosphorylation data which was used to
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construct figures 5.9-5.11 and compares this with levels of Na-K-2C1 cotransport, the
data for which was obtained from Matskevich et al (2005) and Flatman (2005). The
table reflects the general trend for increased phosphorylation with cotransport.
Figure 5.9 - Comparison of Total Phosphothreonine on Ferret NKCC
Normalised phosphorylation is given as optical density relative to control. This
data was compiled from replicate experiments from at least three ferrets.
Error bars show ± standard deviation.
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Figure 5.10 - Comparison of NKCC-P Phosphorylation on Ferret NKCC
Normalised phosphorylation is given as optical density relative to control.
This data was compiled from replicate experiments from at least three
ferrets. Error bars show ± standard deviation.
Figure 5.11 - Comparison of R5 Phosphorylation on Ferret NKCC
Normalised phosphorylation is given as optical density relative to control.
This data was compiled from replicate experiments from at least three
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5.3 - Discussion of Results
The data presented in this chapter shows that ferret erythrocytes behave similarly to
other cell types in that phosphorylation is increased under conditions that produce
greater cotransport activity and reduced when cotransport activity is less. Using
antibodies to specific threonine residues that have been previously shown to be
phosphorylated on the cotransporter and a total phosphothreonine antibody have
highlighted some interesting features. Firstly, there appears to be phosphorylation on
the cotransporter under resting conditions, which may correspond to the significant
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Figure 5.12 - Detection of NKCC Threonine Phosphorylation
The sites that should be detected by the various anti-phospho antibodies used in this
thesis are shown above in relation to a section of mouse NKCC1.
This is detectable with all three of the antibodies used. This could suggest
phosphorylation of threonine residue 206 (using mouse numbering; see figure 5.12)
under basal conditions and account for the levels of cotransport that are seen in
unstimulated ferret erythrocytes. However, there is still detectable phosphorylation
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on the cotransporter when kinases are inhibited and cotransporter activity is reduced,
which is about 60% of control cotransport and phosphorylation (Matskevich et al,
2005). The relative levels of phosphorylation are also similar between detection with
R5 and total phosphothreonine antibodies, even though the R5 antibody is only able
to detect phosphorylation on two threonines. These features highlight that although
using the total phosphothreonine antibody is a useful method for measuring relative
changes in phosphorylation on the cotransporter in response to various conditions the
same cannot be said for the NKCC phospho-specific antibodies. They can tell us that
certain residues are phosphorylated under different conditions, but the fact that the
antibodies are not specific for a single phosphothreonine makes interpretation of
these results difficult. In the case of the R5 antibody, at least, it also detects
phosphorylated NKCC2 (Gimenez and Forbush, 2003). The R5 antibody has been
shown to detect both mono- and di-phosphorylated forms of the cotransporter,
although it has the greatest affinity for cotransporter that is phosphorylated on both
threonines (Flemmer et al, 2002). However, there is no such information available
about the NKCC-P antibody other than it detects threonine residues that have been
found to be phosphorylated by SPAK and OSR1 (Vitari et al, 2006). This antibody
was raised to a triply phosphorylated peptide, but could potentially bind singly and
doubly phosphorylated protein. As such, there is a potential for the antibody to
detect seven different permutations. These would not be distinguishable under the
given experimental conditions. Like the R5 antibody, it may be the case that the
antibody can bind when phosphate is present on one or more of the three threonine
residues, but at a lower affinity. This could account for any reductions seen in
relative phosphorylation. If one or more of the three residues is not phosphorylated,
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then the antibody does not bind so strongly and gives a weaker signal. Despite this,
the use of this antibody does tell us that the ferret erythrocyte cotransporter is
phosphorylated by SPAK or OSR1. Based on these data, one could speculate that
these kinases are not responsible for the increase in cotransporter activity seen when
cells are deoxygenated. We could assume then that the rise in total threonine
phosphorylation, which is paralleled by the increase in R5 antibody signal, is as a
result of the actions of another kinase(s). We can also speculate from the
experiments in this thesis that there may be involvement of a tyrosine kinase in the
activation pathway for Na-K-2C1 cotransport. As mentioned in section 1.5.3.6 and
depicted in figure 1.7, Gagnon et al (2007b) have found that the apoptosis-associated
tyrosine kinase 1, AATYK1, is responsible for an inhibitory action on cotransport.
Although this protein is a tyrosine kinase and one might imagine that inhibition of its
catalytic activity could result in an increase in cotransporter activation (and
phosphorylation), it has been shown that a catalytically inactive version of this
tyrosine kinase is still able to exert its inhibitory effects on cotransport. As such, the
use of tyrosine kinase inhibitors would be unlikely to affect this part of the pathway.
However, there may be as yet unidentified tyrosine kinases whose catalytic activity is
required for cotransport activation. Although, as figure 5.1 shows, direct tyrosine
phosphorylation of the cotransporter is not present, the actions of these kinases could
be involved at stages of the activation pathway that are yet to be elucidated.
The data shown here suggests that the ferret red blood cell offers an interesting
source for study of cotransporter phosphorylation. The cotransporter follows some
of the trends that have already been observed in other cell types in response to
various stimuli. The response to deoxygenation is not clear and as it is a
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physiological stimulus that an erythrocyte is likely to encounter is one of great
interest. Although cotransporter activity is raised under deoxygenated conditions to
similar levels when cells are treated with calyculin A or arsenite, the threonine
phosphorylation is generally lower (Flatman, 2005). This offers an opportunity to
investigate modifications that affect cotransport that are not necessarily reliant on
threonine phosphorylation, but perhaps serine phosphorylation. As these
modifications will occur on the cytoplasmic N- and C-termini it would be of interest
to be able to isolate these for further analysis.
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Chapter 6 NKCC isoforms in the erythrocyte
Chapter 6 - NKCC Isoforms in the Erythrocyte
The erythrocyte has been used in many studies of ion cotransport (Lytle, 1997;
Flatman, 1991; Pewitt et al, 1990) and it has always been assumed that in the case of
Na-K-2C1 cotransport, NKCC1 is the isoform responsible for this activity (Lytle,
2003). However, this has never been properly investigated and thus far western blot
analysis of red blood cells has used the T4 antibody which detects both NKCC1 and
2 (Matskevich et al, 2005; Lytle et al, 1995). The isoform(s) present in the red cell
may have consequences for how cotransport data is interpreted and could have
implications when studying cotransport regulation in this cell type. As such, several
experiments were undertaken to try to clearly identify which isoform(s) are present
in erythrocytes.
6.1 - Western Blot Analysis of NKCC Isoforms in the Erythrocyte
6.1.1 - Ferret Erythrocytes
Ferret erythrocyte cell membranes were prepared for SDS-PAGE, and then probed
with NKCC1 and NKCC2 (C-terminal) specific antibodies. The monoclonal
antibody, T4, which detects both forms, was also used. Figure 6.1 shows the
presence ofNKCC isoforms in kidney, salivary gland tissue and red blood cell
membranes. Kidney tissue provides a source ofNKCC2 and to a lesser extent
NKCC1, whereas salivary gland is a source ofNKCC 1 only. There are several
observations to be made from this experiment. Immunoreactivity is present at the
expected "monomer" position, but also as several higher molecular weights. T4
antibody shows several bands in the red blood cell, which are also detected by the
NKCC1 specific N1 antibody. Interestingly, NKCC2 immunoreactivity is present in
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ferret red blood cell membranes, but at an apparent molecular weight of 240 kDa and
not at the monomer position observed in the kidney (-134 kDa). However, the
kidney sample does display NKCC2 immunoreactivity at a higher molecular weight
which is similar to that found in the ferret red blood cell. Importantly, the NKCC2
antibody does not detect anything in the salivary gland tissue sample, which is
considered to only express the NKCC1 isoform (Kurihara et al, 2002 and 1999).
6.1.2 - Rat Erythrocytes
As with the ferret erythrocyte, rat cells show NKCC2 immunoreactivity but at a mass
of 240 kDa and not at an expected monomer mass (figure 6.2). Also, T4 detects
bands of higher molecular weight in rat samples, as does the N1 antibody. The
detection of larger bands using N1 antibody was however more variable than is the
case in the ferret. Figure 6.2 demonstrates the detection of phosphorylated NKCC
isoforms using the R5 antibody. This detects NKCC at a monomer mass of 150 kDa
and a higher molecular weight of 220 kDa. Another negative control was included in
these experiments. Bacteria do not widely express NKCC and as such make a good
control for the possibility of non-specific antibody interactions. As was also shown
in figure 6.1, no NKCC2 is observed in salivary gland tissue. In comparison to the
ferret erythrocyte, NKCCs are present at lower levels. The same amount of total
erythrocyte membrane protein was loaded, including the ferret kidney and salivary
gland samples, in the rat experiments as the ferret experiments. Greater exposure
times were required to detect NKCCs in the rat erythrocytes. This results in over¬
exposure of the control tissue samples as is shown in figure 6.2. However, they still
allow overall comparison of tissues that are known to express the different isoforms,
with the rat red blood cells.
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Figure 6.1 - Immunodetection of NKCC Isoforms in Ferret Erythrocytes
Estimated molecular weights (in kDa) are shown for the bands present and
were interpolated from a biotinylated protein ladder using TotalLab software.
The images shown are representative of replicate experiments performed on
red blood cell samples from four different ferrets. Kidney and salivary gland
membrane samples are included as control tissues.
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Figure 6.2- Immunodetection of NKCC Isoforms in Rat Erythrocytes
This figure shows representative images of replicate experiments
performed on red blood cell samples from three different rats. Ferret
kidney and salivary gland membrane samples are shown as control
tissues. The negative control shown in this experiment is a bacterial cell
lysate pre-cleared with goat anti-rabbit and goat anti-mouse antibodies.
Some markers from a biotinylated protein ladder (BPL) are shown as a












Human red blood cells have low levels ofNa-K-2Cl cotransport and this is likely to
be reflected in the number of cotransporter molecules present in cell membranes
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(Lytle, 2003). In order to improve the chance of protein detection higher levels of
total protein were loaded onto gels. This was achieved by ultracentrifugation of
larger volumes of human red blood cell crude membrane preparations and
resuspension of the resultant pellet in SDS-PAGE sample buffer. As figure 6.3
shows, there is immunoreactivity present for all antibodies used, but that the detected
protein is poorly separated and resolved. This is often the case when loading large
amounts of protein, which then exceeds the capacity of the gel lane. HEK-293 cells
were used in these experiments as a human control tissue. These cell preparations
show clear bands present at monomer molecular weight (-150 kDa) when antibodies
that detect NKCC1 are used. No immunoreactivity is observed when an anti-
NKCC2 antibody is used. HEK cells have been previously shown to express only
NKCC1 (Isenring et al, 1998c). Like rat and ferret, immunoreactivity in red blood
cells is present for both NKCC isoforms. This, however, was so poorly resolved that
precise molecular weight estimations were not obtainable.
6.1.4- NKCC2 Immunodetection Using an Alternative Antibody
A second NKCC2 antibody was gifted from M. Knepper and was used in western
blots on ferret and rat erythrocyte samples, as shown in figure 6.4. This antibody
was raised against a different epitope from the commercially available anti-NKCC2
antibody used in figures 6.1-6.3. The Alpha Diagnostics antibody is raised to a 15
amino acid section of the C-terminal cytoplasmic domain ofNKCC2 (residues 859-
873), whereas the Knepper antibody is to 22 amino acids from the N-terminal
cytoplasmic domain (residues 109-129; Ecelbarger et al, 1996). This N-terminal
antibody only detects protein from kidney samples.
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Figure 6.3 - Immunodetection of NKCC Isoforms in Human Erythrocytes
Erythrocyte membranes were collected by ultracentrifugation (100,000 x g) and
resuspended in LDS sample buffer and 100 mM DTT and prepared for SDS-
PAGE. HEK cells are shown as a positive control for NKCC1 and a negative
control for NKCC2. The images shown are representative of replicate
experiments on samples from two human donors. Some markers from a
biotinylated protein ladder (BPL) are shown as a guide to protein molecular
mass (in kDa).
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red blood cell
Figure 6.4 - NKCC2 Detection with an N-terminal Antibody
Representative images are shown of rat and ferret western blots using an N-
terminal anti-NKCC2 (gifted by M. Knepper). Rat kidney is shown alongside rat
erythrocytes and ferret kidney is shown alongside ferret erythrocytes. In both
cases, ferret salivary gland tissue was used as a negative control tissue.
Another negative control is a bacterial cell lysate pre-cleared with goat anti-
rabbit and goat anti-mouse antibodies. Some molecular masses are shown (in
kDa) and are from a biotinylated protein ladder (BPL).
6.2 - Detection of NKCC1 and NKCC2 mRNA from Erythroid Cells
Another method for the examination of protein expression is reverse-transcription
polymerase chain reaction (RT-PCR). This process involves the generation of
complementary DNA from messenger RNA strands and then PCR using
oligonucleotide primers that are specific for regions within certain sections of a gene
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of a specific protein. Using sequences common to mouse, rat and human NKCC1
and NKCC2, primers were designed and used in PCR. In order to determine the
isoforms present in red blood cells, reticulocytes were isolated from whole blood




















Figure 6.5 - RT-PCR of Rat Erythrocytes and Leukocytes
Ferret kidney is included as a positive control for both isoforms. Ferret
salivary gland is included as a positive control for NKCC1 and a negative
control for NKCC2. White blood cells are included as a control for
expression of NKCC isoforms in the blood, p-actin is included as a positive
control for the PCR reaction, whereas the water sample acts as a negative
control. Base pair (bp) numbers are shown for each PCR product.
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the observation that these cells possess around 10% less haemoglobin than mature
red blood cells and are therefore more buoyant (Rapoport, 2000). Figure 6.5 shows
PCR products for NKCC1 and NKCC2 in kidney and red blood cells from rats. As
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Figure 6.6 - RT-PCR of Human Erythrocytes and Leukocytes
Ferret kidney acts as positive control for NKCC1 and NKCC2 expression,
whereas ferret salivary gland acts as a positive control for NKCC1 only. This
tissue does not express NKCC2 and provides a negative control for NKCC2
expression. White blood cells are included as a control for expression of NKCC
isoforms in the blood, p-actin is included as a positive control for the PCR
reaction, whereas the water sample acts as a negative control. Base pair (bp)
numbers are shown for each PCR product.
PCR product is present in white blood cell samples indicating that the product
present from red cell samples is not likely to be from contaminating leukocytes. The
same pattern ofNKCC expression is observed in human red and white blood cells, as
shown in figure 6.6. Bone marrow was isolated from rat femurs and RNA was
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extracted and reverse-transcribed. Figure 6.7 demonstrates that NKCC1 and NKCC2
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Figure 6.7 - RT-PCR of Rat Bone Marrow Cells
Rat and ferret kidney act as positive controls for NKCC1 and NKCC2
expression, whereas ferret salivary gland acts as a positive control for
NKCC1 only. This tissue does not express NKCC2 and provides a
negative control for NKCC2 expression, p-actin is included as a positive
control for the PCR reaction, whereas the water sample acts as a
negative control. Base pair (bp) numbers are shown for each PCR
product.
is the site of blood cell generation. Ferret kidney and salivary gland cDNA was
prepared for use as control tissue samples. In all cases, the PCR products were of the
expected size based on the sections ofDNA that are covered by the primer sets.
6.3 - Discussion of Results
These findings indicate that NKCC1 is the major isoform present in the red blood
cell. However, it would appear that there is some expression ofNKCC2. Western
175
Chapter 6 NKCC isoforms in the erythrocyte
blotting showed the presence of a protein detected by a C-terminal anti-peptide
NKCC2 antibody but at an unusual molecular mass. The N-terminal NKCC2
antibody was not able to detect this, or any other protein from red blood cell samples.
It is interesting that the C-terminal antibody detects cotransporter and the N-terminal
antibody does not. Perhaps the C-terminal antibody is binding to something in a
non-specific manner. However, the same pattern is observed from three different
animal species. Also, it does not detect any protein in the salivary gland negative
control tissue. Perhaps, the form ofNKCC2 present in the red cell is such that the N-
terminal antibody is unable to bind it. Or it may be the case that it is bound to
another protein at its N-terminus, making it both appear at a higher apparent
molecular weight and unable to be recognised by the Knepper antibody. Although
confirmation with the N-terminal antibody is lacking, nonetheless these findings are
interesting as NKCC2 is considered to be a kidney-specific isoform. To investigate
this further, the RT-PCR technique was employed. Although mature erythrocytes are
anuclear, younger red cells can still possess nucleic acid. Hoffman et al (2002) and
Stengelin and Hoffmann (1997) successfully performed experiments looking for
different isoforms ofNa+ pump in reticulocytes and earlier erythroid progenitor cells
and these studies inspired the experiments presented in this thesis. NKCC1 and
NKCC2 PCR products were observed from rat and human red blood cells. As there
is a difference between these and the expression of cotransporter from isolated white
blood cells, it is assumed that the presence ofNKCC2 is purely erythroid in nature.
The presence ofNKCC2 mRNA was also detected in rat bone marrow where
erythroid precursor cells reside. The RT-PCR and western blot data do indeed
strongly suggest the presence ofNKCC 1 in the red cell, but also that NKCC2 is
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present. The significance of this is unclear, but it may have consequences for the
interpretation of cotransport data. As mentioned in sections 1.2.2 and 1.4.2, NKCC2
has a number of splice isoforms that display different transport and ion binding
capacities. Also, the splice isoforms have been shown to have modulatory effects on
cotransport in the kidney (Gagnon et al, 2002; Plata et al, 2002; Plata et al, 1999).
Also, NKCC1 and NKCC2 may be able to interact with each other, as demonstrated
in yeast-two-hybrid experiments by Brunet et al (2005). If this is the case, then
NKCC2 could potentially influence the activity ofNKCC 1 in the red cell, and vice
versa. The splice isoforms differ at regions within the second transmembrane
domain (residues 204-237 in mouse) ofNKCC2. The primers used to amplify
NKCC2 in this project are for a region of the gene which is outwith the splice
cassette exon and as such do not differentiate between any of these splice variants.
1 *)(\
As mentioned in section 1.5.3.7, NKCC2 can be phosphorylated on Ser by AMP-
activated protein kinase (Fraser et al, 2007). The authors observed that this residue
was phosphorylated under non-stimulated conditions and suggested that it was
responsible for maintaining the basal activity ofNKCC2 in mouse macula densa-
derived cells. Ferret erythrocytes show high levels of basal cotransport activity and
perhaps a proportion of this is due to the presence ofNKCC2. However, in the
absence of data showing the presence and activity ofAMP kinase in erythrocytes and
the absolute quantities ofNKCC2 in the erythrocyte, this is purely speculative. The
literature has always quoted NKCC2 as being "kidney specific" and this data
contradicts this. As such, it would be prudent to further investigate the presence of
NKCC2 in erythrocytes. Several modifications could be made to the experiments
performed here that could provide more conclusive data. First of all, it would be
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prudent to formally identify the cells that the RNA is extracted from. As suggested,
the NKCC2 mRNA is not likely to come from white blood cells. The method of cell
separation used here, although cheap and easy to perform, does not ensure that there
will be no contamination of the samples with other cell types. Magnetic cell sorting
(MACS) or fluorescence-activated cell sorting (FACS) techniques could be
employed to obtain purer erythroid cell samples. Both of these techniques depend on
the expression of cell type-specific markers to isolate cells. CD34 has been used as a
marker for erythroid cell isolation (Hoffman et al, 2002) and could be used with
either cell sorting technique. However, these cells require culture with agents that
induce erythropoiesis in order to obtain pure samples of erythroid cells and their
progenitors, which is both an expense and time consuming. Another possibility
would be to inject animals with erythropoietin, to increase the numbers of circulating
erythroid progenitor cells found, making isolation via density gradients more fruitful.
These methods would provide purer cell samples or greater cell numbers in order to
obtain protein and RNA from. The generation of a new NKCC2 specific antibody
would also be of great use. A highly specific antibody, that was useful in not only
western blot but immunoprecipitation applications, would help to clear up the
disparity between the two antibodies used in the experiments presented here.
Finally, identification of the protein by mass spectrometry would lend further
support. As demonstrated in chapter 3, this is not easy to achieve. More
sophisticated separation methods, such as two-dimensional liquid chromatography,
and tandem mass spectrometry would be best employed if this was to be achieved.
Lu et al (2004), using visible isotope-coded affinity tags (VICAT), showed the
presence and relative abundance of human group V phospholipase A2 from lung
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macrophages, whereas their western blot data were inconclusive. This method uses a
biotinylated tag (the VICAT tag) which is able to attach to peptides via thiol linkage
of cysteine residues and a radioactively-labelled VICAT-tagged pure peptide from
the protein of interest. This pure peptide is mixed with the test sample and separated
on an IPG strip. The radioactive peptide will separate to the same position as peptide
from the test sample (if it is present in the mix) and as such provides a marker for
this in the strip. This can be isolated, the peptides eluted and then those bearing the
VICAT tag captured by streptavidin-agarose. The peptides can then be analysed by
mass spectrometry. The quantity of sample-derived peptide can be inferred from an
internal standard.
There is still a great deal to explore regarding the presence ofNKCC2 in the red





Chapter 7 - Discussion
7.1 - NKCC Interacting Proteins
Chapters 3 and 4 of this thesis suggest that several proteins may interact with the Na-
K-2C1 cotransporter in the ferret erythrocyte membrane. These are band 3,
haemoglobin, ankyrin, peroxiredoxin-2, alpha spectrin, heat shock protein 70 and
malate dehydrogenase. Some proteins were identified by only one method, whereas
others were identified using several (table 7.1). Band 3, the erythrocyte anion
exchanger, emerges as a strong candidate for an NKCC binding partner. As
mentioned, expression of a trout erythrocyte anion exchanger in Xenopus oocytes
Protein Methods of Separation Identified By
Band 3 N1 co-IP
N1 co-IP










Peroxiredoxin-2 BN/SDS-PAGE MALDI-TOF MS




HSP70 N1 co-IP LC-MSMS
Malate dehydrogenase N1 co-IP LC-MSMS
Alpha spectrin BN/SDS-PAGE MALDI-TOF MS
Table 7.1 - Potential Binding Partners of NKCC
produced increased endogenous Na-K-2C1 cotransport and was thought to involve an
interaction between these two proteins (Guizouarn et al, 2004). The evidence
presented here further implicates an interaction between NKCC and band 3, this time
in the mammalian erythrocyte. T4 western blotting places NKCC within one of the
native-PAGE complexes that contain band 3. Further experimentation should be
performed to validate these findings. As the cotransporter was not identified with
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mass spectrometry other methods would need to be employed. Multiplex western
blotting of native-PAGE gels, using antibodies for band 3, NKCC and fluorescently
labelled secondary antibodies, would allow us to identify if both proteins really are
present within the same complex on a gel. For example, secondary antibodies
labelled with Cy3 (green) and Cy 5 (red) dyes could be used and the western blots
scanned using a laser scanner. If the two proteins were at the same position on a blot
then the band would appear as yellow in overlaid images. The two bands observed
in the native-PAGE experiments that contain NKCC (as detected by western
blotting) are fairly broad and range from 225-290 kDa and 396-500 kDa. It is
possible that more than one protein complex exists within these bands. As such, it
may be that the proteins identified by mass spectrometry in this thesis may not all be
from the same complex. In the future, it would be prudent to perform cross-linking
of proteins and separate these by SDS-PAGE. Again, multiplex western blotting
could be performed with NKCC and band 3 antibodies. LC-MSMS could also be
used to analyse the proteins present in separated cross-linked complexes. Band 3
was found to co-immunoprecipitate with NKCC1 from ferret erythrocytes. An
important experiment to perform in the future would be to identify proteins that co-
immunoprecipitate with band 3 using the band 3 specific antibody. Western blot
detection ofNKCC using T4 or N1 antibodies from band 3 immunoprecipitates
would provide important complementary evidence.
What is the significance ofan interaction between these two proteins?
Band 3 interacts with many proteins, including haemoglobin and ankyrin. Ankyrin
links band 3 to the cytoskeleton and haemoglobin has been shown to interact with
peroxiredoxin-2. These proteins were also identified by mass spectrometry from
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native-PAGE experiments. The interactions of band 3 with the cytoskeleton are
important for maintaining the shape of erythrocytes (Wang, 1994). Perhaps this
interaction with the cytoskeleton via band 3 provides NKCC the means to physically
sense changes in cell volume, which also vary under different oxygen tensions.
However, changes in cell volume cannot explain the extent of activation by
deoxygenation, as volume changes under these conditions are minor in red cells
(Flatman, 2005). Band 3 has increased tyrosine phosphorylation and increased
interactions with the cytoskeleton under deoxygenating conditions (Barvitenko et al,
2005). Band 3 has been shown to bind to haemoglobin and this interaction
strengthens on deoxygenation (Chetrite and Cassoly, 1985). Deoxygenation is a
strong activator ofNa-K-2C1 cotransport in erythrocytes (Flatman, 2005; Muzyamba
et al, 1999). Perhaps under conditions of deoxygenation, the binding of
deoxyhaemoglobin to band 3 has a functional consequence for NKCC activity.
Indeed, haemoglobin may act as the oxygen sensor for NKCC activity within the red
blood cell. This may be directly through an interaction with the cotransporter itself,
or indirectly via band 3 (figure 7.1). If the interaction between band 3 and
deoxyhaemoglobin could be interrupted under deoxygenating conditions and the
activity ofNKCC measured we may be able to infer some relationship between these
proteins. Likewise, ifwe could interfere with the interaction between NKCC and
band 3 we could measure cotransport activity in response to a number of stimuli and
determine if their interaction is required for cotransport activation in all cases. It
would also be of interest to determine ifNKCC interacts with different anion
exchanger isoforms in other cell types, as their interaction may represent a part of
cotransport regulation that is not purely confined to the erythrocyte.
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Figure 7.1 - Possible Activation of Erythrocyte NKCC by Deoxygenation
The left hand section of this diagram involves indirect activiation of NKCC via
the increased binding of deoxyhaemoglobin (Hb) to band 3 when cells are
deoxygenated. The right hand section suggests that Hb may directly interact
with the cotransporter and activates it when oxygen levels are low.
The presence of peroxiredoxin-2 (PrxII) in native-PAGE complex with band 3 may
be simply due to its interaction with haemoglobin. As mentioned in chapter 3, this
protein is important in protection against oxidative stress by preventing the formation
ofmethaemoblobin (Stuhlmeier et al, 2003). The importance of this protein in the
red blood cell is demonstrated with a knockout mouse. These animals have
haemolytic anaemia, splenomegaly and increased haematopoiesis (Lee et al, 2003).
Peroxiredoxin proteins, ofwhich there are six in mammals, have also been shown to
interact with membrane proteins (Rhee et al, 2005). Peroxiredoxin-1 interacts with
and increases androgen receptor activation in response to hypoxia/reoxygenation in
prostate cancer cell lines (Park et al, 2007b) and the thromboxane receptor is
regulated by an interaction with peroxiredoxin-4 (Giguere et al, 2007). It is therefore
possible that peroxiredoxin-2 interacts directly with band 3 and/or NKCC. PrxII has
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been found to modulate the activity of JNK and p38, two kinases that have been
suggested to regulate cotransporter activity. In this case PrxII prevented TNF-a
induced H2O2 activation of JNK and p38 in HeLa cells (Kang et al, 2004). Not only
are the peroxiredoxins able to interact with integral membrane proteins and modulate
their activity, they are able to influence kinase activity due to their ability to remove
reactive oxygen species (ROS). Thus, PrxII present in the red cell may not only
function to protect proteins from ROS, but as a modulator of protein function. It
would be of interest to measure erythrocyte Na-K-2C1 cotransport in response to
different stimuli from the PrxII"7" knockout mouse produced by Lee et al (2003).
LC-MSMS identified heat shock protein 70 from N1 immunoprecipitated control
ferret erythrocyte material. This protein was also identified by MALDI-TOF mass
spectrometry from 2-DE separated control ferret erythrocyte membrane samples.
Malate dehydrogenase may also help to protect the cotransporter from damage within
the cell due to its reductive properties. However, this protein may also function as a
molecular chaperone. The expression of malate dehydrogenase was increased in E.
coli under conditions of heat shock and when, used as an expression partner for
heterologous protein expression in these bacteria, improved the solubility of proteins
which often aggregate (Park et al, 2007a). Interestingly, expression ofmalate
dehydrogenase is increased in TAL cells from the loop ofHenle in response to
hyperosmotic stress (Dihazi et al, 2005). In this work, increased expression of hsp70
and hsp90 were also observed. Simard et al (2004b) have shown that hsp90 interacts
with NKCC from HEK-293 cells. The authors indicate that this interaction is not
only relevant for the proper folding ofNKCC, but in regulating the activity of the
mature cotransporter. Geldanamycin (an inhibitor of hsp90) was found to inhibit Rb+
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influx in low chloride medium, a stimulus that normally increases activity ofNKCC.
A slight increase in NKCC activity was observed under normal conditions when
geldanamycin was present. Due to these findings, the authors speculate that hsp90 is
able to inhibit NKCC activity when [Cf], is normal, but activates cotransport when
[CI"], is low, perhaps by chaperoning a conformational change in the cotransporter
that allows optimal ion translocation. Hsp70 may be involved in NKCC regulation
in a similar manner, particularly as it is upregulated in response to hypertonicity
(Dihazi et al, 2005). However, low [CI"], is unlikely to be a stimulus in the red blood
cell as the levels of chloride are much higher than other cell types due to the actions
of band 3. Gagnon et al (1999) found that hyperosmotic stress increased hsp70
mRNA 8-fold in Madin-Derby canine kidney epithelial cells which translated to a
near doubling of protein expression (this mode of stimulation of hsp70 is not possible
in the RBC as they do not synthesise new protein). Hsp70 has been shown to be
involved in erythroid cell maturation, ensuring that a necessary transcription factor,
GATA-1, is protected from caspase cleavage (Ribeil et al, 2007). This protein may
help to protect NKCC in the mature erythrocyte from proteolysis or chaperone a
conformational change that allows cotransport activation. It will be of interest to
examine if hsp70 is present in N1 immunoprecipitates from ferret erythrocyte
membranes pre-treated with different cotransport activating stimuli as its interaction
with the cotransporter may represent a level of cotransport regulation.
7.2 - Phosphorylation of NKCC
Study of threonine phosphorylation of the ferret erythrocyte cotransporter under
different activation states has highlighted some interesting features and indicates
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areas of research that will be of interest in the future. Using total phosphothreonine
antibody it was observed that increased NKCC phosphorylation closely followed
increased Na-K-2C1 cotransport (Matskevich et al, 2005). It is shown in this thesis,
by experiments using antibodies that detect changes in phosphorylation on specific
NKCC threonine residues, that the SPAK/OSR1 kinases are not likely to be
responsible for the increased activity of the cotransporter in response to
deoxygenation even though their presence in the ferret red blood cell was shown by
western blot. A direct interaction of SPAK or phosphorylated SPAK with NKCC
was not able to be confirmed due to the presence of SPAK immunoreactivity in
sepharose-bead negative control samples in co-IP experiments. As such, the models,
proposed by Gagnon et al (2006a and 2006b) and Villa et al (2007) and summarised
in figure 1.6, regarding the activity and interactions of SPAK/OSR 1 with NKCC
cannot be confirmed in the ferret erythrocyte. This is also true for the involvement
of PP1 but as already discussed in chapter 4 there is strong evidence for it being a
regulatory phosphatase of the cotransporter. It may be possible in the future to apply
more thorough pre-clearance of samples with beads, or to use beads of a different
type that will reduce non-specific interactions of proteins. However, the fact that
increased phosphorylation is observed using the NKCC-P antibody when cells are
treated with calyculin A does implicate SPAK/OSR 1 as kinases (and PP1 as a
phosphatase) of the cotransporter in ferret erythrocytes. In vitro kinase assays using
SPAK/OSR1 isolated from deoxygenated red blood cells similar to those described
by Vitari et al (2006) may help define if this cotransport stimulus does result in
activation of these kinases. If a viable SPAK/OSR1 knockout animal could be
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produced, the activity of erythrocyte NKCC could be measured in response to
deoxygenation and the impact of the absence of these kinases observed.
The R5 antibody detects threonine phosphorylation on another NKCC threonine that
is not covered by the NKCC-P antibody (Thr211 as numbered in mouse NKCC1; see
figure 5.12). R5 phosphorylation was increased in response to treatment with
calyculin A and deoxygenation. It would appear that whatever kinase is responsible
for phosphorylation of this residue is active in the deoxygenated red cell. It will be
of importance now to map the different threonines, and perhaps serine residues, that
are phosphorylated on erythrocyte NKCC under the various different conditions that
inhibit or activate cotransport. It is important that both N- and C-termini are studied
to obtain a full picture of phosphorylation of the cotransporter. This may not be easy
to achieve, due to the low abundance of the protein, but is definitely worth
investigating.
7.3 - NKCC Isoforms
Western blot and RT-PCR data presented in this thesis suggest that the red blood cell
has both NKCC1 and NKCC2 isoforms present. This is the first time NKCC2 has
been observed outside the context of the kidney. However, some of the data in
chapter 3 of this thesis may appear to be contradictory. The theoretical pi for human
NKCC1 is 5.98 and 7.18 for NKCC2, and these are similar for other mammalian
NKCCs. Figure 3.9 shows an example of a T4 western blot of ZOOM fractions. T4
immunoreactivity was only present in fraction pH 5.4-6.2. This fits with the
theoretical pi for NKCC1, but immunoreactivity would also be expected in fractions
above pH 6.2 ifNKCC2 were present. A single ZOOM fractionation of ferret kidney
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membranes was conducted (data not shown) and T4 immunoreactivity was observed
in fractions pH 5.4-6.2 and pH 6.2-7.0. Although it is possible that the quantities of
NKCC2 present in red blood cells are lower than NKCC1 and therefore not visible in
the ZOOM fractionations above pH 6.2, it may also be the case that the red cell
isoform is sufficiently different as to have a more acidic pi placing it within the same
fraction as NKCC1. We observe NKCC2 immunoreactivity from ferret and rat
erythrocyte membranes at a molecular weight of approximately 240 kDa on western
blots. This is around 100-120 kDa larger than expected based on the amino acid
sequence of kidney NKCC2. Based on the size of the band, the most obvious
assumption to make would be that this is a dimer formed from two NKCC
monomers. It could also indicate heavy glycosylation of the protein. This would be
easily tested by the deglycosylation experiment demonstrated in figure 4.3, followed
by western blotting with the anti-NKCC2 antibody. It may also indicate that any
NKCC2 present in the red blood cell is different to that found in the kidney, based on
its estimated molecular mass and pi (if present in the same ZOOM fraction as
NKCC1). In order to understand this we may wish to purify the proteins for further
study. As shown in this thesis, 2-DE and IP yield disappointing results in red blood
cells. Another approach would be to sequence the whole cDNA for the cotransporter
isoforms present and infer protein sequence and molecular weight from this. This
may be more easily achieved in avian erythrocytes, which are nucleated. This would
allow isolation of better quality nucleic acid than was obtained using the methods
described in chapter 6 of this thesis.
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Why would the red blood cell possess NKCC2?
NKCC2 splice variants can interact with NKCC1 and may confer a level of
cotransport regulation (Brunet et al, 2005; Gagnon et al, 2002; Plata et al, 2002;
Plata et al, 1999). This may be particularly important in the red blood cell where
cotransport activity cannot be upregulated by increased expression of the cotransport
protein. The various isoforms and splice variants have different transport and ion
binding capacities. This panel of slightly different NKCC proteins may be required
for the cell to handle different needs for ion transport. In the absence of specific
inhibitors to each isoform, this idea is not currently able to be tested. It is of interest
though, to identify which of the various NKCC2 variants are present in the
erythrocyte and this could be achieved with splice isoform-specific PCR primers.
7.4 - Conclusions
There are three main findings from the research conducted for this thesis. Firstly,
band 3 and NKCC interact within the erythrocyte. Secondly, phosphorylation of the
cotransporter is increased or reduced when transport is increased or reduced and that
although the red blood cell expresses SPAK/OSR1 kinases these are not responsible
for the increase of phosphorylation and cotransport observed in response to
deoxygenation. Thirdly, for the first time evidence is provided that the RBC
expresses NKCC2.
A model is presented in figure 7.2 that suggests increased activity ofNKCC under
deoxygenating conditions and when plasma potassium concentration is high.
Physiologically, this situation is likely to occur in blood vessels associated with
exercising muscle. Here oxygen is rapidly consumed and potassium is released into
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Deoxygenation Low plasma [K1
High Plasma [K+] a
Figure 7.2 - Model for Function of NKCC in Ferret Red Blood Cells
Under deoxygenating conditions, or where plasma potassium is high, NKCC becomes active and drives
net influx of ions and acts as a sink for potassium. As NKCC is capable of bi-directional cotransport, it
can release stored potassium when necessary. At rest, NKCC cotransport is close to equilibrium. As
shown in this thesis, this activity is regulated via protein phosphorylation but the mechanisms for how
this occurs in response to deoxygenation is not yet understood. Other than via NKCC, the major route
for chloride ion transport is via band 3 (3). An interaction between band 3 and NKCC may offer a
further level of NKCC cotransport regulation. Ca-Na (CN) exchange driven by the Ca gradient created
by the Ca pump (C) help to extrude sodium from ferret red blood cells (Milanick, 1989).
the plasma. Hyperkalemia is an undesirable state which can result in abnormal heart
rhythms and in severe states can cause the heart to stop beating. The situation
present in the ferret red blood cell (and perhaps other animals) appears poised to take
up potassium from the blood. Flatman (1983) showed that by increasing the
potassium concentration of the medium, ferret erythrocytes increased uptake via
NKCC. Potassium content in ferret red blood cells is normally low at about 4 mM
(Flatman and Andrews, 1983) and extracellular changes above this level would result
in influx of ions via NKCC. The converse was true when medium initially
containing no potassium was used, indicating that ion cotransport is bi-directional
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and that potassium could be also released from the cell. As suggested in figure 7.2,
the red cell could take up potassium from the plasma effectively removing it from the
circulating blood and away from the heart. The cells could then release this
potassium when necessary in different sites within the body.
7.5 - Future Directions
The objective now will be to further understand the significance of the findings
presented in this thesis. This will again involve a multi-disciplinary approach.
7.5.1 - Protein-Protein Interactions
Other tissue types should be used to investigate the interactions ofNKCC and the
proteins identified by IP and native-PAGE experiments. The shotgun N1 IP LC-
MSMS method described in chapter 4 of this thesis could be explored using other
tissue samples, as well as the various 2-D electrophoresis techniques. We could then
investigate if any novel interactions uncovered from other cell types are of relevance
in the red blood cell using a standard co-IP and western blotting approach.
7.5.2 - Phosphorylation
It may be necessary to use other cell types for some of the research, due to the
difficulties in obtaining sufficient protein from red blood cells. This will be useful
for studying aspects of cotransport that are not red blood cell specific. For example,
using salivary gland or kidney tissue we may be better able to separate out differently
phosphorylated cotransporter molecules using the 2-DE approach used in this thesis,
in particular, the spots identified by the R5 and NKCC-P antibodies. This would
allow mass spectrometric identification of the phosphorylated residues of each
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individual species. Further experiments could include isolation of smaller fragments
ofNKCC, by immunoprecipitation with N1 and T4 antibodies after chemical
cleavage with formic acid, allowing a means to study phosphorylation on the N- and
C-termini. Figure 7.3 shows the hypothetical NKCC products of formic acid
hydrolysis and the epitopes that the N1 and T4 antibodies were raised against. Based
on this it is theoretically possible to isolate different sections of the cotransporter,
which may then be enzymatically digested and the peptides (and any phospho-
modifications) analysed by LC-MSMS. This, and perhaps more standard
^9 ...
phosphorylation experiments in this cell type, could be used to look at the residues
that are modified across the whole protein rather than just in the N-terminus as is
currently the focus. This may help to further understand how the cotransporter is
regulated and could help clear up which of the N-terminal residues are
phosphorylated under the conditions used in this thesis.
7.5.2 - Molecular Biology
It is important now to ensure that the products amplified by the NKCC 1 and 2
primers from red blood cells used in this project are actually from NKCC 1 and 2
mRNA. Sequencing of the PCR products would confirm or deny this. If these are
correct, then identification of which NKCC2 splice variants are present in the
erythrocyte will be important. The use of nucleated avian erythrocytes for RNA
interference experiments, or NKCC2 variant knockout animals, may be required in
order to decipher the functional significance of these proteins in the red blood cell.
Overall, the erythrocyte remains a powerful functional model for the study ofNa-K-
2C1 cotransport. As well as having unique features of regulation that are relevant to
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its own function it may help us to understand general cotransport regulation as
applicable to other systems.
Formic acid cleavage site <
N1 antibody T4 antibody
meprptapssgapglagvgetpsaaalaaarvelpgtavpsvpedaapasrdgggvr





















Figure 7.3 - Hypothetical Cleavage Products of Human NKCC1 by Formic Acid
Formic acid cleavage between an aspartate and proline residue results in three
segments based on the human NKCC1 sequence. N1 antibody was raised against
two peptide sequences (labelled in green) and the T4 antibody was raised to a section
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Appendix I - Supplementary Data
Examples of Mascot Ion Searches
The following tables show data from the Mascot ion searches for LC-MSMS data
from both Native-PAGE complexes and N1 immunoprecipitation experiments.
The native-PAGE complexes (numbered 1-5) refer to those observed commonly on
gels, as shown in figure 3.17.
Protein Identification Mascot Score Peptides Matched
Band 3 106 4
Ankyrin 47 but confirmed with Phenyx 2
Alpha haemoglobin 106 4
Beta haemoglobin 99 4
Gamma haemoglobin 70 3
Table A.1 - LC-MSMS Mascot Ion Search for Native-PAGE Complex 1
Scores greater than 52 indicate identity
Protein Identification Mascot Score Peptides Matched
Alpha haemoglobin 228 10
Beta haemoglobin 283 11
Gamma haemoglobin 101 4
Epsilon haemoglobin 89 6
Table A.2 - LC-MSMS Mascot Ion Search for Native-PAGE Complex 2
Scores greater than 52 indicate identity
Protein Identification Mascot Score Peptides Matched
Band 3 102 3
TER ATPase 269 10
Alpha haemoglobin 227 14
Beta haemoglobin 293 10
Gamma haemoglobin 113 4
Epsilon haemoglobin 77 3
Glucose transporter 54 2
Table A.3 - LC-MSMS Mascot Ion Search for Native-PAGE Complex 3
Scores greater than 52 indicate identity
218
Protein Identification Mascot Score Peptides Matched
Band 3 191 13
Alpha haemoglobin 278 17
Beta haemoglobin 309 14
Gamma haemoglobin 89 5
Epsilon haemoglobin 82 5
Table A.4 - LC-MSMS Mascot Ion Search for Native-PAGE Complex 4
Scores of 52 or more indicate identity.
Protein Identification Mascot Score Peptides Matched
Alpha haemoglobin 328 16
Beta haemoglobin 381 15
Gamma haemoglobin 122 5
Table A.5 - LC-MSMS Mascot Ion Search for Native-PAGE Complex 5
Scores of 52 or more indicate identity.
Protein Identification Mascot Score Peptides Matched
Malate dehydrogenase 88 4
Heat Shock Protein 70 46 3
Band 3 33 1
Table A.6 - LC-MSMS Mascot Ion Search for N1 Immunoprecipitated Proteins
Scores of 42 or more indicate identity. Where only one peptide is matched, scores are
lower. Keratin contamination of these samples was evident with scores of 191.
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][ = exon-exon boundary
»»> = forward primer with base number where primer starts in cDNA
sequence
««< = reverse primer with base number where primer ends in cDNA
sequence
The exon-exon boundaries were identified using the Human Blat Search Genome
function (http://genome.ucsc.edu/cgi-bin/hgBlat) after input of the amplified region
and examining where this is found within the genomic DNA sequence.
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Abstract
A method is described to measure threonine phosphorylation of the Na-K-2C1 cotransporter in ferret erythrocytes using readily available
antibodies. We show that most, if not all, cotransporter in these cells is NKCC1, and this was immunoprccipitated with T4. Cotransport rate,
measured as sf,Rb influx, correlates well with threonine phosphorylation of T4-immunoprecipitated protein. The cotransporter effects large
fluxes and is significantly phosphorylated in cells under control conditions. Transport and phosphorylation increase 2.5- to 3-fold when cells
are treated with calyculin A or Na+ arsenite. Both fall to 60% control when cell [Mg2+] is reduced below micromolar or when cells are treated
with the kinase inhibitors, 4-amino-5-(4-methylphenyl)-7-(/-butyl)pyrazolo[3,4-d]pyrimidine or staurosporine. Importantly, these latter
interventions do not abolish either phosphorylation or transport suggesting that a phosphorylated form of the cotransporter is responsible for
residual fluxes. Our experiments suggest protein phosphatase 1 (PrP-1) is extremely active in these cells and dephosphorylates key regulatory
threonine residues on the cotransporter. Examination of the effects of kinase inhibition after cells have been treated with high concentrations
of calyculin indicates that residual PrP-1 activity is capable of rapidly dephosphorylating the cotransporter. Experiments on cotransporter
precipitation with microcystin sepharose suggest that PrP-1 binds to a phosphorylated form of the cotransporter.
© 2005 Elsevier B.V. All rights reserved.
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1. Introduction
Na-K-2C1 cotransporters play key roles in regulating
cell K+ and Cl~ content and cell volume. In epithelia they
enable transepithelial fluxes by providing entry routes for
Na+ and CP, whereas in erythrocytes they are mainly
involved in regulating cell, and perhaps, plasma K4
concentration [1-5], Their activity is regulated by a variety
of stimuli including cell volume, hypoxia, hormones,
growth factors and cell CP concentration [1,2], The ability
of the transporter to respond to these signals is prevented by
treating cells with inhibitors of protein kinases or phospha¬
tases suggesting that changes in protein phosphorylation are
involved in the signal transduction pathway [6-8], It is now
* Corresponding author. Tel.: +44 131 650 3254; fax: +44 131 650 6527.
E-mail address: pcter.flatman@ed.ac.uk (P.W. Flatman).
clear that phosphorylation of the cotransporter itself is a
major determinant of transport rate [9-14], Initial studies
using 32P indicated that 5 or 6 threonine and serine (but not
tyrosine) residues are phosphorylated when the transporter
is maximally activated [9,15]. More recent work has
focused on the phosphorylation of three threonine residues
(l84Thr, 189Thr and 202Thr) in the N-tcrminus of the shark
cotransporter that arc particularly important in regulating
transport in response to changes in cell volume and CI
[14]. These three residues are well conserved in the cotrans¬
porter from a wide variety of animal species so their phos¬
phorylation is likely to be a common theme in cotransporter
regulation, with phosphorylation of lx9Thr (or its equi¬
valent) being the main determinant of activity, and phospho-
rylation of Thr and "Thr modulating the response [ 14].
Studies using inhibitors of protein phosphatase 1 (PrP-1)
suggest that this plays a major role in dephosphorylating and
thus inactivating the cotransportcr, and the recent demon-
0005-2736/$ - see front matter © 2005 Elsevier B.V. All rights reserved,
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26 I. Malskei'ich et al. / Biochimica et Biophysica Acta 1714 (2005) 25-34
stration that PrP-1 can bind to a motif on the cotransporter
close to the key threonine residues in the N-terminus
reinforces this idea [16]. However, the identity of the kinase,
or kinases, that phosphorylate the cotransporter remains
elusive [17-19],
Using ferret erythrocytes, a robust model for studying the
properties of the mammalian cotransporter, we have
explored the effects of inhibitors of kinases and phospha¬
tases on transport [20,21], Although the results indicate that
transport is stimulated by phosphorylation, they are not
consistent with the current view that cotransporter phos¬
phorylation is regulated by a single kinase and phosphatase
[15], It seems more likely that the cotransporter is
phosphorylated by several kinases and dephosphorylated
by several phosphatases [3,5,22], Transport is stimulated by
calyculin A suggesting protein phosphatase 1 is one of the
regulatory phosphatases [3,20], It is also stimulated by Na+
arsenite which is believed to activate a kinase [21],
However, treatment of cells in a variety of ways to inhibit
protein kinases, including reduction of cell Mg2+ concen¬
tration to below 1 pM, inhibits only about 40% of the
resting flux leaving a substantial residual flux [20], This
suggests that the cotransporter may exist in two forms, one
that is constitutively active (it does not require to be
phosphorylated) and one that is activated by phosphoryla¬
tion in the conventional way, or, these procedures may trap
the cotransporter in a partially phosphorylated, partially
active state [3], In order to resolve these issues and
understand how cotransporter phosphorylation affects trans¬
port in ferret erythrocytes we describe a method that allows
us to compare the extent to which the cotransporter is
phosphorylated on threonine with transport rate under a
variety of conditions. Some of these results have been
published in abstract form [23,24],
2. Materials and methods
2.1. Solutions and chemicals
All solutions were prepared in double-glass distilled
water with analytical grade reagents (BDH AnalaR, VWR
International, Lutterworth, UK). Calyculin A, microcystin-
LR and 4-amino-5-(4-methylphenyl)-7-(/-butyl)pyra-
zolo[3,4-d]pyrimidine (PP1) were obtained from Alexis
Biochemicals (Carlsbad, CA). Protease inhibitor cocktail set
III, A23187 and the detergents: ASB-16 (an amidosulfobe-
taine) and CHAPS were obtained from Calbiochem (VWR
International). EDTA, EGTA, HEPES, dithiothreitol (DTT),
Triton X-100, Tween 20, Na+ orthovanadate, Na+ |i-
glycerophosphate, glycine, genistein, staurosporine and Tris
base were obtained from Sigma (Poole, UK). Na+ (meta)-
arsenite was from Fluka Chemicals, (Gillingham, UK).
Protein G sepharose (Amersham Biosciences, Little Chal-
font, UK) was washed 3 times before use. Microcystin-
Sepharose was from Upstate (Charlottesville, VA), recombi¬
nant N-glycosidase F from Roche Diagnostics (Lewes, UK),
and anti-NKCCI from Alpha Diagnostics International (San
Antonio, TX). Bumetanide was a gift from Leo Laboratories
Ltd. (Aylesbury, UK).
Ferret basic medium (FBM) comprised (mM): 150 NaCl,
5 KC1, 0.05 EGTA, 10 HEPES, pH 7.5 al 38 °C, adjusted
with NaOH. Lysis buffer contained (mM): 10 HEPES, 2
EDTA, 2 Na+ pyrophosphate, 2 NaF, 1 Na" p-glycerophos-
phate, 1 Na+ vanadate, pH 7.6 at room temperature. Na+
vanadate was added from a 200 mM stock just prior to use.
The stock was prepared by dissolving Na' vanadate in
water, adjusting pH to 10 with HC1 and then boiling until
colourless and then readjusting the pH to 10 [25], It was
frozen until used. Immunoprecipitation buffer (IPB) con¬
tained (mM): 150 NaCl, 20 HEPES, 1 EDTA, 2 NaF, 1 Na+
(i-glycerophosphatc, pH adjusted to 7.6 at room temperature
with NaOH. Tris-buffered saline (TBS) contained (mM):
136 NaCl, 20 Tris base, pH 7.6 adjusted with HC1 at room
temperature.
2.2. Preparation of erythrocyte suspensions and flux
measurements
Blood was taken by cardiac puncture from adult ferrets
terminally anaesthetised with Na+ pentobarbitone (Sagatal,
Rhone Merieux, Harlow, UK, 120 mg kg-1) according to
guidance from the British Home Office. Cells were washed
four times by ccntrifugation and resuspension in FBM, care
being taken to remove all of the buffy coat. They were
stored at 5 °C in FBM containing 22 mM glucose until used
(normally within 3 days). All plastics used to handle cells
were sterile and all solutions were passed through a 0.2-pm
filter before use.
Washed erythrocytes at about 7% hematocrit were
incubated at 38 °C for the indicated times in FBM containing
11 mM glucose and the following additions: control (no
additions, 20 min), 20-50 nM calyculin A (15 min), 50 pM
PP1 (30 min), 2 pM staurosporine (20 min), 0.3 mM
genistein (20 min), 1 mM Na+ arsenite (60 min), 0.008-
0.03% gluteraldchyde (5 min), and various combinations
of these. Where necessary cell [Mg~+] was reduced to sub
micromolar levels by incubating the cells in FBM
containing 2 mM EDTA and 10 pM A23187 for 15 min
[26],
Cotransporter fluxes were determined by adding 8('Rb to
aliquots of these suspensions and then measuring the uptake
of 86Rb, with and without 10 pM bumetanide, a specific
cotransporter inhibitor, as described previously [20].
2.3. Preparation of erythrocyte membranes
Cells were spun out of solution, cooled on ice and then
injected into 20 volumes of ice-cold lysis buffer containing
1% protease inhibitor cocktail, and stirred for 10 min on ice.
Membranes were washed 3 times by centrifugation
(25,000 xg for 10 min) and resuspension in ice-cold lysis
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buffer. Membrane protein concentrations were measured
with Coomassie Plus protein assay reagent (Pierce Bio¬
technology, Rockford, IL) or 2-D Quant (Amersham
Biosciences). Samples were stored in liquid nitrogen after
adding 2% protease inhibitor cocktail.
Membranes were dcglycosylatcd by incubating them
with 1% SDS at 60 °C for 20 min. Samples were then
diluted 5-fold into deglycosylation buffer (in mM: 150
NaCl, 20 HEPES, 1 EDTA) containing 1% Triton X-100,
1% CHAPS and 2% protease inhibitor cocktail. Recombi¬
nant N-glycosidase F (80-160 units/ml) was added and the
tubes were incubated at 37 °C overnight. Inclusion of 2%
mercaptoethanol had no effect on results. Membranes were
dephosphorylated by treating them with alkaline phospha¬
tase (Proinega, Madison, WI) for 1 h at 37 °C.
2.4. Immunoprecipitation of the cotransporter
Cotransporter was immunoprecipitated with T4 (Deve¬
lopmental Studies Hybridoma Bank, University of Iowa), a
monoclonal antibody to the C-terminal of the cotransporter
[27], This antibody recognises both NKCC1 and NKCC2
isofomis of the cotransporter in the SDS-denatured state.
Membranes were therefore heated to 60 °C in the presence
of 1% SDS for 20 min and were then diluted 5-fold with
IPB with the following additions: 1 mM Na+ vanadate, 2%
protease inhibitor cocktail, 1 p,M microcystin L-R, 1%
Triton X-100 and 0.5% ASB-16. The mixture was incu¬
bated for 1 h at 4 °C followed by centrifugation al
14,000xg for 10 min to remove any precipitate. The
supernatant was pre-cleared with protein G sepharose, T4
ascites fluid was added and the tube was incubated at 4 °C
for 60 min. The immune complex was precipitated with
protein G sepharose and washed 3 times with IPB
containing 1% Triton X-100 and 0.5% ASB-16. Cotrans¬
porter was eluted by heating the beads to 70 °C for 20 min
in x4 NuPAGE LDS sample buffer (Invitrogen Corpora¬
tion, Carlsbad, CA) containing 166 mM DTT. The super¬
natant, diluted 4-fold and with [DTT] made up to 100 mM,
was subjected to SDS-PAGE.
2.5. Microcystin pull down assay
Membranes, solubilised in IPB containing 1 mM Na+
vanadate, 0.5% ASB-16, 1% Triton X-100 and 2% protease
inhibitors, were incubated with Microcystin-Sepharose for
1 h at 4 °C. The beads were washed 3 times with IPB
containing 0.5% ASB 16 and 0.1% Triton X-100. Proteins
were cluted from the beads as described above.
2.6. Gel electrophoresis and Western blotting
We used either 3-8% Tris-acetate or 4-12% bis-tris
NuPAGE gels (Invitrogen). Gels were calibrated against
Mark 12 and HiMark unstained molecular weight markers
(Invitrogen) and a biotinylated protein ladder (Cell Signal¬
ing). Membranes and protein samples were heated to 70 °C
for 10 min in LDS sample buffer (Invitrogen) containing
100 mM DTT then and centrifuged at 14,000 xg for 1 min
prior to electrophoresis. Protein bands were stained with
GclCode Blue, a colloidal Coomassie stain (Pierce).
Proteins were blotted to nitrocellulose in an Xcell II run at
30V for 90 min using a transfer buffer (in mM: 25 bicine, 25
bis-tris, 1 EDTA) containing 0.1% SDS and 10% methanol
(Invitrogen). Blots were blocked with TBS containing 0.1%
Tween 20 and either 5% dried milk powder, or 5% filtered
(0.2 pm) bovine serum albumin (fraction V, ICN Biomed¬
ical, Costa Mesa, CA) when phospho-specific antibodies
were used. They were then incubated at 4 °C with primary
antibodies diluted in blocking buffer, T4 1:5000 for 1 h or
rabbit anti-phosphothreonine (Cell Signaling Technology,
Beverly MA) 1:2000 overnight. After washing and re-
blocking, the blots were treated with horseradish perox-
idase-conjugated secondary antibodies (1:10,000, Jackson
ImmunoResearch Laboratories, West Grove, PA). Antibody
binding was quantified using ECL reagents and Hyperfilm
(Amersham Biosciences). Gels and blots were scanned and
the images analysed with TotalLab (Non Linear Dynamics,
Newcastle, UK).
Most data are expressed as means with standard errors
and the significance of differences between means is
assessed with two-tailed r-tests, the exact value of P being
stated. Rate constants are given with standard deviations.
Lines through data are fitted to specific models using non¬
linear regression analysis (Prism 4.03, GraphPad Software,
San Diego, CA). All experiments were repealed with the
blood from at least 3 ferrets. Representative blots are shown.
3. Results
3.1. Measurement of threonine phosphorylation of the
cotransporter
Our first aim was to establish a simple robust assay to
measure threonine phosphorylation of the cotransporter in
ferret erythrocytes using readily available antibodies.
Cotransporter was immunoprecipitated with the monoclonal
antibody T4 [27], The immunoprecipitate was then sepa¬
rated into components by SDS-PAGE. The proteins were
blotted to nitrocellulose, care being taken to ensure that
sufficient time was given for the complete transfer of large
proteins, and the presence of phosphorylated threonine
residues in the protein bands was detected with an anti-
phosphothrconine antibody (Fig. 1). A prominent band
covering molecular weights ranging from 140 to 160 kDa
was observed in all samples, precisely the place where we
would expect to find the cotransporter if its monomeric
glycosylated molecular weight is about 150 kDa (see later).
The relative intensity of this band depended on how the cells
had been treated prior to the preparation of membranes.
Treatments that activated cotransport, for instance, incuba-
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Fig. 1. Threonine phosphorylation ofT4 immunoprecipitates. T4 immuno-
precipitates were prepared from the membranes of ferret erythrocytes that
had been incubated at 38 °C in FBM containing 11 mM glucose and the
following additions: none for 30 min (Con), 50 pM PP1 for 30 min (PP1),
20 nM Calyculin A for 15 min (Cal) and 1 mM Na+ arsenite for 60 min
(Asn). Immunoprecipitates were run on a 3-8% Tris-acetate gel together
with a sample of control membranes (Mem). The gel was blotted and
probed with an antibody to phosphothreonine.
tion with calyculin A or Na+ arsenite, increased the intensity
compared to controls, whereas treatment with PP1,
decreased the intensity (Fig. 1). This is consistent with the
idea that calyculin or arsenite activate the cotransporter by
causing its phosphorylation, whereas PP1 inhibits by
reducing its phosphorylation. Usually a second band,
covering the range 300-320 kDa (Fig. 1), was also seen
in each lane. In some cases, the intensity of this band was
similar to the low molecular weight band, though in most it
was much lower, and it appeared to depend to some extent
on how membrane samples were treated prior to electro¬
phoresis (see later). Some faint bands at intermediate
weights were also sometimes visible. Shown on the same
blot (Fig. 1) is an example of a membrane sample, separated
by SDS-PAGE, and probed with the anti-phosphothreonine
antibody. Prominent bands were usually observed at 150,
250, 270 and 300 kDa.
In order to interpret these phosphorylation patterns, we
need to know the identity of the proteins immunoprecipi-
tated by T4 and the molecular weights of cotransporter
fomis found in the membrane or sample buffer.
3.2. Molecular weight of cotransporter complexes
In Western blots of ferret erythrocyte membranes the
cotransporter is detected by a variety of cotransporter
antibodies as a smear at 140-160 kDa together with high
molecular weight complexes, comprising a prominent smear
at about 300 kDa and often bands at 400-500 kDa (Fig.
2A). In addition, much sharper bands were seen at about
250 and 270 kDa (Fig. 2A). A similar pattern of bands is
seen when T4-immunoprecipitates prepared from erythro¬
cytes are run on SDS gels (Fig. 2B). There are prominent
broad bands centred at 150 and 300 kDa, but the bands al
250 and 270 kDa are less conspicuous.
All high molecular weight species were seen despite
heating the samples with SDS and reducing agents such as
100 mM DTT or 5 mM tris[2-carboxyethyl]phosphine
(TCEP) prior to running gels. The proportion of T4 staining
found at high molecular weights increased slowly with the
length of time cells were stored (4 °C) before the preparation
of membranes, and with the time that membranes were
stored frozen (—20 °C) before electrophoresis (data not
shown). A possible explanation for the bands at 300 and 500
kDa is that the cotransporter forms homodimers and (rimers
but we cannot rule out the possibility that it binds to other
proteins, and the bands at 250 and 270 kDa may provide
evidence for just such interactions. Importantly, SDS-
resistant high molecular weight forms of the cotransporter
assemble during storage, even in the cold. Variations were
minimised by preparing membranes from cells within 3
days of blood collection, and by storing membranes in
liquid nitrogen. Despite these precautions, bands at 250, 270
and 300 kDa could be detected even in the freshest samples,
suggesting that these forms may normally be present in the
membrane under physiological conditions. However,
because some of these complexes form during storage or
in sample buffer, it is difficult to assess the extent to which
the colransporter exists in these forms in the membrane. To
address this issue, we treated cells with low concentrations
of gluteraldehyde (0.008-0.03%) to cross-link proteins
prior to preparation of membranes. The procedure, which
has been used to fix erythrocyte ion transporters in their
active or inactive states [28], greatly increased the propor¬
tion of transporter found in the 300-kDa form (Fig. 2C),
supporting the idea that many cotransporter molecules in









Fig. 2. Cotransportcr bands in blots of erythrocyte membranes and T4-
immunoprecipitates. Samples were run on: 3-8% Tris-acetate gels (A D),
6% (E) or 9% (F) tris-glycinc gels and probed with T4 (A E) or an
NKCCl-specific antibody from Alpha Diagnostics International (F). A:
control membranes showing all the major cotransporter bands seen
commonly, B: T4-immunoprecipitate prepared from control membranes.
C: con—control membranes, glut—membranes from cells treated with
0.008% gluteraldehyde for 5 min, D: con—control membranes, glyc—
membranes treated overnight at 37 °C with N-glycosidase F, E and F:
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The appearance of the cotransporter as a broad, smeared
band has been reported for other cell types and species.
This smearing is usually attributed to variable N-linked
glycosylation of sites in the large extracellular loop of the
cotransporter [27,29], Wc examined this possibility by
treating ferret erythrocyte membranes overnight with
recombinant N-glycosidase F. Following treatment the
apparent mean molecular weight of the transporter fell by
about 25 kDa to 124 ± 1 (n= 4) kDa, close to the expected
weight of the cotransporter based on its sequence. Un¬
expectedly, the band remained very smeared (Fig. 2D).
Doubling the amount of glycanase did not cause any
further change in molecular weight and nor did dephos-
phorylating the cotransporter with alkaline phosphatase
(data not shown). Thus, variable glycosylation or phos¬
phorylation does not explain the wide range of molecular
weights the transporter displays. Densitometer scans of the
150-kDa band often showed two peaks suggesting that the
band may comprise two components, an idea supported by
the finding that it occasionally appeared as a distinct
doublet with weights centred on 140 and 160 kDa (e.g. Fig.
2E and F). Doublets have also been observed in T4-
immunoprecipitates from endothelial cells [30] and mem¬
branes from rat parotid gland [31], In the latter case, the
140-kDa band was attributed to an unphosphorylated,
immature form found in intracellular compartments. Such
compartments do not exist in ferret erythrocytes, and the
140-kDa form resides in the plasma membrane like the
160-kDa form. In addition, dephosphorylation (with alka¬
line phosphatase) made no difference to the apparent
molecular weight of the transporter in our studies (data
not shown).
T4 interacts with both the NKCC1 and NKCC2
isoforms of the cotransporter [27] which have slightly
different molecular weights [2], so a plausible explanation
for the doublet at 140-160 kDa is that ferret erythrocytes
express both isoforms. Membranes were therefore probed
with a variety of antibodies that are specific for NKCC1.
The results were similar to those with T4, and impor¬
tantly, the Alpha Diagnostics antibody (developed to a
peptide in the C-terminus) also revealed a doublet at
140-160 kDa (Fig. 2F). Antibodies specific for NKCC2
failed to identify proteins at molecular weights ranging
from 120 to 160 kDa, the expected monomeric weight of
this transporter (though occasionally there was staining at
240 kDa, data not shown). We also attempted to identify
the proteins immunoprecipitated with T4 by MALD1-TOF
mass spectroscopy following their digestion with trypsin.
Wc were unable to identify the proteins in the prominent
bands even at high yields. This is not an unusual problem
with very hydrophobic membrane proteins especially if
they have been treated with SDS [32,33] which is
necessary when using T4. This technical problem is very
disappointing as we had hoped to identify the components
of the high molecular weight complexes by mass
spectroscopy and thus establish whether the cotransporter
dimerizes or binds to other proteins. Thus, although we
cannot categorically rule out the possibility that some
NKCC2 is expressed in these cells, we can conclude that
the vast majority of bands detected by T4 contain
NKCC1.
3.3. Relationship between threonine phosphorylation of the
cotransporter and transport rate
Resting K+ fluxes through the cotransporter are high,
about 15 mmol 1 celP1 h-1 when ferret erythrocytes are
incubated under control conditions, and this is reduced to
about 0.5 mmol 1 cell-1 h-' in the presence of 10 pM
bumetanide, indicating that over 95% of resting K+ uptake
is via the cotransporter [34]. Fig. 5 shows that fluxes are
stimulated 2.6-fold by treating cells with calyculin A or
with Na+ arsenite, are reduced by about 40% when protein
kinases are inhibited with PP1, staurosporine, genistein or
by reducing cell Mg2+ content below 1 pM [20,21], Figs.
1, 4 and 5 show that these changes in transport rate are
paralleled by changes in phosphothreonine levels detected
in T4-immunoprecipitates prepared from erythrocyte
membranes.
It was necessary to establish a robust protocol to
quantify cotransporter phosphorylation. We have seen that
cotransporter molecules can be distributed amongst a
variety of forms with different molecular weights and that
heating samples with SDS and reducing agents do not
cause these complexes to break up. It is thus important to
include all relevant forms if cotransporter phosphorylation
is to be measured accurately. We therefore analysed how
normalised total phosphothreonine (all that found in a lane
above 140 kDa normalised to the value found in the same
region with control cells) correlated with the normalised
amount of phosphothreonine found in the bands centred at
150 or 300 kDa under a variety of conditions (Fig. 3). The
same relative changes in phosphorylation were found no
matter which method of analysis was used. Wc therefore
usually compared phosphorylation in the 150-kDa bands as
these were the most prominent. Adding in phosphorylation
from faint, ill-defined bands often simply increased the
error on the measurements without affecting the ratios. It
is also clear from these results that threonine phospho¬
rylation of the cotransporter does not affect the propensity
of the transporter to form or separate from the 300-kDa
complexes.
Phosphothreonine was clearly detected in T4-immuno-
precipitates prepared from all control membranes (e.g. Figs.
1, 4 and 6), consistent with the large resting fluxes found
under control conditions. Figs. 1 and 5 show that calyculin
increased cotransporter threonine phosphorylation 2.4-fold
(±0.3, n= 6 ferrets), consistent with PrP-1 being one of the
cotransporter's regulatory phosphatases, and Na+ arsenite
increased it 3.1-fold (±0.7, n= 5 ferrets). Kinase inhibition
by drugs or Mg2'-removal reduced it by about 40%, in line
with the changes in transport rate (Figs. 4 and 5).













Fig. 3. Similar changes in threonine phosphorylation are seen in both the
low and high molecular weight forms of the cotransporter. T4-immuno-
precipitates were prepared from the membranes of erythrocytes that had
been incubated at 38 °C in FBM containing 11 mM glucose and the
following additions: 50 pM PP1 (PP1) for 30 min, 20 nM calyculin A (Cal)
for 15 min, or 1 mM Na+ arsenite (Asn) for 60 min. Control cells were
incubated for 30 min in FBM with 11 mM glucose. Immunoprecipitates
were run on 3-8% Tris-acetate gels, blotted and probed with an antibody to
phosphothreonine. Signal intensity in the lanes at molecular weights above
140 kDa (Total), or in the bands centred on 150 kDa and 300 kDa were
measured and expressed as a ratio of the level seen in the same regions on
control lanes. Bars represent the mean ratios with their standard errors
(« = 5).
Imporlantly, cotransporter threonine phosphorylation was
not abolished by any of these procedures.
Stimulation of transport by calyculin A is prevented
when cells are pre-treated with PP1, staurosporine, genis-
tein or are Mg2+-depleted [20]. The simplest explanation is
that these treatments prevent phosphorylation of the
cotransportcr itself, though we could not rule out the
possibility that they prevented the phosphorylation of a
cofactor that is required for full activation of the transporter
by protein-protein interactions. Experiments using T4-
immunoprecipitales indicate these treatments inhibit trans¬
port by preventing phosphorylation of the transporter itself.
Non-specific inhibition of kinases by Mg2' -depletion
completely prevented any rise in phosphorylation or stimu¬
lation of transport when calyculin was added (Fig. 6).
kDa
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Fig. 4. Kinase inhibition reduces but does not abolish threonine
phosphorylation of the cotransporter. T4-iminunoprecipitates were prepared
from the membranes of ferret erythrocytes that had been incubated at 38 °C
in FBM containing 11 mM glucose and the following additions: none
(Con), 50 pM PP1 for 30 min (PP1), 0.3 mM genistein for 20 min (Gen), 2
pM staurosporine for 20 min (Sta) or with 2 mM EDTA and 10 pM A23187
for 15 min ( Mg). Immunoprecipitates were run on 3-8% Tris-acetate
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Fig. 5. Comparison of cotransporter threonine phosphorylation with fluxes.
Threonine phosphorylation of the cotransporter was detected in T4-
immunoprecipitates prepared from ferret erythrocytes that had been
incubated at 38 °C in FBM containing 11 mM glucose and the following
additions: none for 30 min (Con), 20-50 nM calyculin for 15 min (Cal), 1
mM Na+ arsenite for 60 min (Asn), 50 pM PP1 for 30 min (PP1). 2 pM
staurosporine for 20 min (Sta), 0.3 mM genistein for 20 min (Gen) or 2 mM
EDTA and 10 pM A23187 for 15 min (-Mg). Cotransporter rate, measured
as 86Rb influx rate constant, was determined under the same conditions.
Both phosphorylation and fluxes are normalized to the values seen in
controls. Values are given as means with their standard errors.
Inhibition of Src kinases with PP1 also greatly reduced the
stimulation of transport and the increase in phospho¬
rylation, though did not completely prevent them (Fig. 6).
In both cases, changes in transport parallel changes in
phosphorylation.
3.4. Inhibition of transport and phosphorylation by PPI or
Mg~+-removal after stimulation by calyculin
We have previously shown [20], and confirm here (Fig.
6) that Mg2+-removal, or addition of PPI, after cells have
been treated with calyculin partially inhibits transport over
a 30-min period. Fig. 6 also shows that this reduction in
transport is accompanied by a large reduction in threonine
phosphorylation. Given the concentrations of calyculin
used, this inhibition of transport and phosphorylation was
surprising. The simplest explanation is that residual PrP-1
activity is sufficient to dephosphorylate the transporter
when kinases arc inhibited. If this were true both transport
and phosphorylation should eventually fall back to the
control level, at a rate that is a function of calyculin
concentration, the higher the concentration, the less residual
PrP-1 activity and the slower the rate. Fig. 7 shows that
cotransport falls back to control al the same rate when PPI
or Mg~+-removal is used to inhibit kinases (Fig. 7A). It also
shows (Fig. 7B) that the rate of fall decreases with
increasing calyculin concentration. Kinetic experiments on
threonine phosphorylation are much harder to carry out.
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Fig. 6. PPI or Mg -depletion prevents and reverses cotvansporter
phosphorylation and fluxes stimulated by calyculin. A: T4-immunopreci-
pitates were prepared from the membranes of ferret erythrocytes that had
been incubated at 38 °C in FBM containing 11 mM glucose and the
following additions: none (Con), 50 nM calyculin for 15 min (Cal), 50 pM
PP1 for 30 min followed by 50 nM calyculin for 15 min (PP1 then Cal), 50
nM calyculin for 15 min followed by 50 pM PP1 for 30 min (Cal then PP1),
2 mM EDTAwith 10 pM A23187 for 15 min followed by 50 nM calyculin
for 15 min (—Mg then Cal), 50 nM calyculin for 15 min followed by 2 mM
EDTAwith 10 pM A23187 (Cal then —Mg). Immunoprecipitates were run
on 3-8% Tris-acetate gels, blotted and probed with an antibody to
phosphothreonine. B: 86Rb uptake was determined under the same
conditions. Both phosphorylation and fluxes are normalized to the values
seen in controls. Values are given as means with their standard errors.
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Fig. 8. Microcystin pulls down the cotransporter. Microcystin-Sepharose
was used to precipitate proteins from the membranes of ferret erythrocytes
that had been incubated at 38 °C in FBM containing 11 mM glucose and the
following additions: none (Con), l mM Na+ arscnite for 60 min (Asn), 50
nM calyculin A for 15 min (Cal), or with 2 mM EDTA and 10 pM A23187
for 15 min (—Mg). Eluates were run on 3 8% Tris-acetate gels, blotted and
probed with T4.
however, phosphorylation had fallen below control levels
in all samples taken 30 min after Mg2+ is removed (Fig. 6)
and in one third of samples treated with PP1. In the other
two thirds, it was about 50% above control, but very much
lower that in the presence of calyculin alone.
3.5. Microcystin pull-down is more efficient with
phosphorylated cotransporter
In view of the finding that PrP-1 may be one of the
cotransporter's regulatory phosphatases we examined
whether PrP-1 binds strongly to the cotransporter in ferret
erythrocytes, as it does in other species [16]. If this were so,
it should be possible to pull down the cotransporter with
microcystin, a molecule that binds tightly to PrP-1. This was
found to be the case (Fig. 8). Microcystin conjugated to
Sepharose pulled down the cotransporter in both its low and
high molecular weight forms. Interestingly, the amount of
cotransporter pulled down in these assays closely parallels
the phosphorylation state of the cotransporter. Thus, prc-
treatment of cells with calyculin or arsenite increased the
A Stimulated with 50 nM Calyculin B Kinase inhibition by Mg removal
JO
tr
kinase inhibition: o -Mg
* PP1


















Fig. 7. Cotransport rate returns to normal when kinases are inhibited after calyculin treatment. Cells were incubated at 38 °C in FBM containing 11 mM glucose
and the indicated calyculin concentration for 10 min. At this point, either 50 pM PP1 (PP1) or 10 pM A23187 with 2 mM F.DTA (-Mg) were added. Samples
of the suspension were transferred to separate tubes to which x6Rb was added to measure fluxes over 4 min. Influx rate constants were determined and plotted at
the mid point of the flux period timed from the addition of PP1 or A23187. Rate constants are shown with standard deviations if these are larger than point size.
Lines are best fits to data, assuming that rate constants fall exponentially with time to the control level. A: comparison of the effects of PP1 or Mg~+-removal on
fluxes stimulated with 50 nM calyculin. B: comparison of the effects of Mg2+-retnoval on fluxes stimulated with 20 or 100 nM calyculin.
32 /. Matskevich et al. /Biochimica et Biophysica Acta 1714 (20(15) 25-34
amount of cotransporter (1.61 ±0.1 («= 2) and 2.66 ±0.84
(n = 5) fold, respectively), whereas treatment of cells with
PP1, Mg2+-depletion, or genistein all reduced the amount of
cotransporter pulled down (to 0.69 ±0.12 control, n = 5).
4. Discussion
We describe a simple assay to measure threonine
phosphorylation of the Na-K-2C1 cotransporter in ferret
erythrocytes that has permitted us to address a number of
ongoing questions about cotransport regulation. The assay is
based on the immunoprecipitation of the cotransporter with
T4 followed by measurement of threonine phosphorylation
with an antibody. Although we cannot entirely rule out the
possibility that some NKCC2 is expressed in ferret
erythrocytes (though this would be highly unusual), we
show that the material detected by T4 in these cells is
consistent with it being, or containing, NKCC1. In order to
make appropriate measurements of phosphorylation, it was
necessary to understand the forms the cotransporter can
adopt when isolated from cell membranes.
Ferret erythrocyte Na-K-2C1 cotransporter runs on SDS
gels as a prominent broad band at 140-160 kDa. Often an
additional broad band is seen at 300-320 kDa together with
some sharp bands at intermediate weights. Some very high
molecular weight complexes are occasionally seen (Fig. 2).
Perhaps, up to half of the cotransporter molecules in the
membrane are in high molecular weight complexes as
indicated by the cross-linking study with gluteraldehyde
(Fig. 2C), and these can survive and also fonn during
sample preparation. The most likely explanation for the
300-320 kDa band is the formation of a dimer, as
previously proposed on the basis of cross-linking studies
in rat parotid glands [35], though binding to different
proteins to form a 300 kDa complex cannot be excluded. All
members of the cation-chloride-cotransporter (CCC) family
(Na-K-2CI, K-Cl, Na-Cl cotransporters, and CIP, a
regulatory protein), are able to form complexes with
themselves and with other members of the family, and the
formation of these complexes can affect transport [36-40].
The cotransporter has also been shown to interact with
unrelated proteins, for instance the anion-exchanger [41], It
would also appear that NKCC1 is one of the major
threonine phosphorylated proteins (>100 kDa) in ferret
erythrocyte membranes (Fig. 1).
Figs. 5 and 6 show there is a strong correlation between
transport rate and cotransporter threonine phosphorylation
in ferret erythrocytes. Calyculin and arsenite, compounds
that maximally stimulate cotransport (2.6-fold, means not
significantly different, P= 0.72), also cause a large increase
in threonine phosphorylation, 2.4-fold in the case of
calyculin and 3.1-fold for arsenite. Although phosphoryla¬
tion was almost always higher when cells from a particular
ferret were treated with arsenite, this difference was not
significant (P=0.09). On the other hand, inhibition of
protein kinases with PP1, staurosporine, genistein or by
removing intracellular Mg2+ reduced both transport and
threonine phosphorylation to about 60% control. The
correlation between transport and phosphorylation over this
wide range of conditions, which includes the minimum and
maximum rates of transport in these cells, is striking.
However, we must be cautious if attempting to infer
phosphorylation levels from transport rates. As discussed,
phosphorylation may be higher than predicted when arsenite
is used to stimulate transport, but most importantly, we have
been unable to detect a significant rise in threonine
phosphorylation when transport is maximally stimulated
by deoxygenation [42], We have yet to find a situation
where the cotransporter is phosphorylated more than in
resting cells without transport being stimulated in ferret
erythrocytes.
Our results show that the cotransporter is partially
threonine phosphorylated in ferret erythrocytes under
resting conditions, and this may account for the high fluxes
observed under these conditions. Importantly, we show that
the transporter remains partially phosphorylated when cells
are treated with kinase inhibitors or when their Mg2* content
is drastically reduced. This contradicts the hypothesis that
some cotransporter molecules are active when not phos¬
phorylated. It seems more likely that kinase inhibition
leaves some cotransportcr molecules phosphorylatcd and
active. This may be because the sites are not accessible to
phosphatases or that the appropriate phosphatases are
not active. Experiments are under way to explore these
possibilities.
The data in Fig. 7 show that PrP-1 is highly active in
ferret erythrocytes and support the view that it dephosphor-
ylates key threonine residues involved in regulating trans¬
port rate. They make less plausible the supposition that
calyculin also activates a kinase that phosphorylates the
transporter, an alternative explanation for the inhibition of
transport by kinase inhibitors in the presence of calyculin.
Thus, in the absence of kinase activity, residual PrP-1 can
still rapidly dephosphorylate the transporter leading to a
reduction in transport rate. With 20 nM calyculin, residual
PrP-1 dephosphorylates the cotransporter so transport falls
to within 5% of control in 16 min, with 100 nM calyculin
this takes 100 min. They are also consistent with an EC50
for calyculin of 1 -3 nM, values estimated from the amount
of calyculin required to activate transport ([20] and Flatman,
unpublished). The tight binding of PrP-1 to the cotrans¬
porter was exploited to precipitate the cotransporter from
membranes with microcystin-sepharose. Unexpectedly, we
found that the amount of cotransporter pulled down with
microcystin parallels the level of cotransportcr threonine
phosphorylation. It appears that phosphorylated cotrans¬
porter binds PrP-1 more avidly.
In conclusion, the method described for assessing total
threonine phosphorylation of the cotransporter provides
important information on transporter function that comple¬
ments that obtained using phospho-cotransporter specific
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antibodies which examine the phosphorylation of one out
of several threonine residues that can affect transport [31],
The combination of these methods would be particularly
useful where it is not possible to make an antibody to a
particular phosphorylated residue, as is the case with the
cotransporter.
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